<SUBMISSION>
<ACCESSION-NUMBER>0000930413-07-005367
<TYPE>424B2
<PUBLIC-DOCUMENT-COUNT>2
<FILING-DATE>20070621
<DATE-OF-FILING-DATE-CHANGE>20070621
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AML INC
<CIK>0001264344
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>DE
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-59
<FILM-NUMBER>07933750
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOLM AVE.
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>UNILAB ACQUISITION CORP
<CIK>0001264338
<IRS-NUMBER>460466856
<STATE-OF-INCORPORATION>DE
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-58
<FILM-NUMBER>07933749
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOLM AVE.
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS NICHOLS INSTITUTE INC
<CIK>0001264346
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>VA
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-68
<FILM-NUMBER>07933759
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOLM AVE.
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS LLC
<CIK>0001264363
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>MA
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-72
<FILM-NUMBER>07933763
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOLM AVE.
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS LLC
<CIK>0001264364
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>CT
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-19
<FILM-NUMBER>07933764
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOLM AVE.
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS INC
<CIK>0001264366
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>NV
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-23
<FILM-NUMBER>07933768
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOLM AVE.
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>RIGIONAL PATHOLOGY CONSULTANTS LLC
<CIK>0001287021
<IRS-NUMBER>870559208
<STATE-OF-INCORPORATION>UT
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-10
<FILM-NUMBER>07933733
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1>C/O AMERIPATH INC.
<STREET2>7289 GARDEN ROAD
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERICAN MEDICAL LABORATORIES INC
<CIK>0001124156
<ASSIGNED-SIC>8071
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>DE
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-71
<FILM-NUMBER>07933762
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>14225 NEWBROOK DR
<CITY>CHANTILLY
<STATE>VA
<ZIP>20153
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>14225 NEWBROOK DR
<CITY>CHANTILLY
<STATE>VA
<ZIP>20153
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>SPECIALTY LABORATORIES INC
<CIK>0001123333
<ASSIGNED-SIC>8071
<IRS-NUMBER>952961036
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-06
<FILM-NUMBER>07933729
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>2211 MICHIGAN AVENUE
<CITY>SANTA MONICA
<STATE>CA
<ZIP>90404-3900
<PHONE>3108286543
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ENTERIX INC
<CIK>0001157442
<IRS-NUMBER>000000000
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-03
<FILM-NUMBER>07933710
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>348 US ROUTE ONE
<CITY>FALMOUTH
<STATE>ME
<ZIP>04105
<PHONE>207-781-4990
</BUSINESS-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DPD HOLDINGS INC
<CIK>0000835472
<ASSIGNED-SIC>8071
<IRS-NUMBER>954415490
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-61
<FILM-NUMBER>07933752
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935000
</BUSINESS-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>UNILAB CORP
<DATE-CHANGED>19920703
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>DMC INTERNATIONAL INC
<DATE-CHANGED>19881121
</FORMER-COMPANY>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Central Plains Laboratories, LLC
<CIK>0001344965
<IRS-NUMBER>481218417
<STATE-OF-INCORPORATION>KS
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-29
<FILM-NUMBER>07933774
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8415
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>LabOne of Ohio, Inc.
<CIK>0001344966
<IRS-NUMBER>200310967
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-28
<FILM-NUMBER>07933773
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8415
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Osborn Group, Inc.
<CIK>0001344967
<IRS-NUMBER>481045507
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-27
<FILM-NUMBER>07933772
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8415
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Systematic Business Services, Inc.
<CIK>0001344968
<IRS-NUMBER>431336549
<STATE-OF-INCORPORATION>MO
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-26
<FILM-NUMBER>07933771
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8415
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ExamOne World Wide of NJ, Inc.
<CIK>0001344969
<IRS-NUMBER>222127674
<STATE-OF-INCORPORATION>NJ
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-31
<FILM-NUMBER>07933776
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729 8415
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Focus Technologies Holding CO
<CIK>0001403091
<IRS-NUMBER>521445953
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-01
<FILM-NUMBER>07933708
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8412
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>HemoCue, Inc.
<CIK>0001403093
<IRS-NUMBER>330882550
<STATE-OF-INCORPORATION>CA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-18
<FILM-NUMBER>07933707
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8412
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AmeriPath Hospital Services Florida, LLC
<CIK>0001403214
<IRS-NUMBER>161702356
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-53
<FILM-NUMBER>07933726
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8412
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AmeriPath Florida, LLC
<CIK>0001403215
<IRS-NUMBER>650641688
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-54
<FILM-NUMBER>07933727
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8412
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>LABONE INC/
<CIK>0000830158
<ASSIGNED-SIC>8071
<IRS-NUMBER>431039532
<STATE-OF-INCORPORATION>MO
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-33
<FILM-NUMBER>07933778
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>10101 RENNER BLVD
<STREET2>P. O. BOX 7568
<CITY>LENEXA
<STATE>KS
<ZIP>66219
<PHONE>9138881770
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>10101 RENNER BLVD
<STREET2>X
<CITY>LENEXA
<STATE>KS
<ZIP>66219
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>LAB HOLDINGS INC
<DATE-CHANGED>19980406
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>SEAFIELD CAPITAL CORP
<DATE-CHANGED>19920703
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>SEAFIELD CAPTIAL CORP
<DATE-CHANGED>19910520
</FORMER-COMPANY>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>UNILAB CORP /DE/
<CIK>0000899714
<ASSIGNED-SIC>8071
<IRS-NUMBER>954415490
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>0326
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-57
<FILM-NUMBER>07933748
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>18448 OXNARD ST
<CITY>TARZANA
<STATE>CA
<ZIP>91356
<PHONE>8187586642
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>UNILAB CORP
<STREET2>18448 OXNARD ST.
<CITY>TARZANA
<STATE>CA
<ZIP>91356
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>METCAL INC
<DATE-CHANGED>19930401
</FORMER-COMPANY>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>NICHOLS INSTITUTE DIAGNOSTICS
<CIK>0000921948
<ASSIGNED-SIC>8071
<IRS-NUMBER>952955451
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-69
<FILM-NUMBER>07933760
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>33608 ORTEGA HIWAY
<CITY>SAN JUAN CAPISTRANO
<STATE>CA
<ZIP>92690
<PHONE>7147284000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>33608 ORTEGA HWY
<CITY>SAN JUAN CAPISTRANO
<STATE>CA
<ZIP>92690-6130
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS INC
<CIK>0001022079
<ASSIGNED-SIC>8071
<IRS-NUMBER>161387862
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867
<FILM-NUMBER>07933706
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07601
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>CORNING CLINICAL LABORATORIES INC
<DATE-CHANGED>19960903
</FORMER-COMPANY>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CORNING CLINICAL LABORATORIES INC /MD/
<CIK>0001026675
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-21
<FILM-NUMBER>07933766
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>PO BOX ONE MALCOLM AVENUE
<CITY>TELEBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1901 SULPHUR SPRINGS RD
<CITY>BALTIMORE
<STATE>MD
<ZIP>21227
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CORNING CLINICAL LABORATORIES INC /MI/
<CIK>0001026676
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-22
<FILM-NUMBER>07933767
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>PO BOX ONE MALCOLM AVENUE
<CITY>TELEBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>4444 GIDDINGS RD
<CITY>AUBURN HILLS
<STATE>MI
<ZIP>48326
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CORNING CLINICAL LABORATORIES OF PENNSYLVANIA INC /DE/
<CIK>0001026677
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-64
<FILM-NUMBER>07933755
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>PO BOX ONE MALCOLM AVENUE
<CITY>TELEBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>875 GREENTREE RD
<STREET2>4 PARKWAY CENTER
<CITY>PITTSBURGHLS
<STATE>PA
<ZIP>15220
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CORNING NICHOLS INSTITUTE INC
<CIK>0001026679
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-65
<FILM-NUMBER>07933756
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>PO BOX ONE MALCOLM AVENUE
<CITY>TELEBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>33608 ORTEGA HWY
<CITY>SAN JUAN CAPISTRANO
<STATE>CA
<ZIP>926690-613
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DIAGNOSTIC REFERENCE SERVICE INC
<CIK>0001026684
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-60
<FILM-NUMBER>07933751
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>PO BOX ONE MALCOLM AVENUE
<CITY>TELEBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1901 SULPHUR SPRING RD
<CITY>BALTIMORE
<STATE>MD
<ZIP>21227
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS INVESTMENTS INC
<CIK>0001027506
<ASSIGNED-SIC>8731
<IRS-NUMBER>510314231
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-63
<FILM-NUMBER>07933754
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOM AVENUE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>ONE MALCOLM AVENUE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>CLMP INC
<DATE-CHANGED>19961125
</FORMER-COMPANY>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>PATHOLOGY BUILDING PARTNERSHIP
<CIK>0001027507
<STATE-OF-INCORPORATION>MD
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-67
<FILM-NUMBER>07933758
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MALCOM AVENUE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>ONE MALCOLM AVENUE
<CITY>TEARBORO
<STATE>NJ
<ZIP>07608
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH INC
<CIK>0001027532
<ASSIGNED-SIC>8071
<IRS-NUMBER>650642485
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-56
<FILM-NUMBER>07933747
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN RD
<STREET2>SUITE 200
<CITY>RIVER BEACH
<STATE>FL
<ZIP>33404
<PHONE>5618451850
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN RD
<STREET2>SUITE 200
<CITY>RIVER BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS LLC
<CIK>0001092328
<IRS-NUMBER>364257926
<STATE-OF-INCORPORATION>IL
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-20
<FILM-NUMBER>07933765
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07601
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS FINANCE INC /DE/
<CIK>0001092329
<IRS-NUMBER>510390719
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-66
<FILM-NUMBER>07933757
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07601
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS HOLDINGS INC /DE/
<CIK>0001092330
<IRS-NUMBER>232324658
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-25
<FILM-NUMBER>07933770
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07601
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>QUEST DIAGNOSTICS CLINICAL LABORATORIES INC /DE/
<CIK>0001092331
<IRS-NUMBER>382084239
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-24
<FILM-NUMBER>07933769
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>C/O QUEST DIAGNOSTICS INC
<STREET2>ONE MALCOLM AVE
<CITY>TETERBORO
<STATE>NJ
<ZIP>07601
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH CONSOLIDATED LABS INC
<CIK>0001229460
<IRS-NUMBER>260003506
<STATE-OF-INCORPORATION>FL
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-55
<FILM-NUMBER>07933746
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH INDIANA LLC
<CIK>0001229463
<IRS-NUMBER>351937874
<STATE-OF-INCORPORATION>IN
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-51
<FILM-NUMBER>07933725
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH KENTUCKY INC
<CIK>0001229464
<IRS-NUMBER>621373947
<STATE-OF-INCORPORATION>KY
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-50
<FILM-NUMBER>07933724
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH MARKETING USA INC
<CIK>0001229479
<IRS-NUMBER>651064707
<STATE-OF-INCORPORATION>FL
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-49
<FILM-NUMBER>07933723
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>METWEST INC
<CIK>0001026685
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-62
<FILM-NUMBER>07933753
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>PO BOX ONE MALCOLM AVENUE
<CITY>TELEBORO
<STATE>NJ
<ZIP>07608
<PHONE>2013935143
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>4771 REGENT BOULEVARD
<CITY>IRVING
<STATE>TX
<ZIP>75063
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH MICHIGAN INC
<CIK>0001229481
<IRS-NUMBER>381880648
<STATE-OF-INCORPORATION>MI
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-48
<FILM-NUMBER>07933722
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH MISSISSIPPI INC
<CIK>0001229482
<IRS-NUMBER>640504003
<STATE-OF-INCORPORATION>MS
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-47
<FILM-NUMBER>07933721
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH NEW YORK INC
<CIK>0001229488
<IRS-NUMBER>650819138
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-46
<FILM-NUMBER>07933720
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH NORTH CAROLINA INC
<CIK>0001229489
<IRS-NUMBER>561272454
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-45
<FILM-NUMBER>07933719
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH PENNSYLVANIA INC
<CIK>0001229495
<IRS-NUMBER>251680680
<STATE-OF-INCORPORATION>PA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-43
<FILM-NUMBER>07933717
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH PHILADELPHIA INC
<CIK>0001229497
<IRS-NUMBER>222163419
<STATE-OF-INCORPORATION>NJ
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-42
<FILM-NUMBER>07933716
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH SC INC
<CIK>0001229510
<IRS-NUMBER>113680559
<STATE-OF-INCORPORATION>SC
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-41
<FILM-NUMBER>07933715
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH TEXAS LP
<CIK>0001229514
<IRS-NUMBER>752530066
<STATE-OF-INCORPORATION>TX
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-40
<FILM-NUMBER>07933714
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH YOUNGSTOWN LABS INC
<CIK>0001229515
<IRS-NUMBER>341767704
<STATE-OF-INCORPORATION>OH
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-39
<FILM-NUMBER>07933713
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH LLC
<CIK>0001229520
<IRS-NUMBER>651046999
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-38
<FILM-NUMBER>07933712
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH WISCONSIN INC
<CIK>0001229523
<IRS-NUMBER>391091107
<STATE-OF-INCORPORATION>WI
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-37
<FILM-NUMBER>07933745
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ANATOMIC PATHOLOGY SERVICES INC
<CIK>0001229524
<IRS-NUMBER>731563221
<STATE-OF-INCORPORATION>OK
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-36
<FILM-NUMBER>07933744
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>API NO 2 LLC
<CIK>0001229527
<IRS-NUMBER>651046886
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-35
<FILM-NUMBER>07933743
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ARIZONA PATHOLOGY GROUP INC
<CIK>0001229528
<IRS-NUMBER>860864486
<STATE-OF-INCORPORATION>AZ
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-34
<FILM-NUMBER>07933742
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DERMATOPATHOLOGY SERVICES INC
<CIK>0001229540
<IRS-NUMBER>630984892
<STATE-OF-INCORPORATION>AL
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-52
<FILM-NUMBER>07933741
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DIAGNOSTIC PATHOLOGY MANAGEMENT SERVICES INC
<CIK>0001229543
<IRS-NUMBER>731402878
<STATE-OF-INCORPORATION>OK
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-17
<FILM-NUMBER>07933740
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>SHARMA KAILASH B MD INC
<CIK>0001229637
<IRS-NUMBER>581416059
<STATE-OF-INCORPORATION>GA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-16
<FILM-NUMBER>07933739
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>OCMULGEE MEDICAL PATHOLOGY ASSOCIATES INC
<CIK>0001229646
<IRS-NUMBER>581267100
<STATE-OF-INCORPORATION>GA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-15
<FILM-NUMBER>07933738
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>OQUINN MEDICAL PATHOLOGY ASSOCIATION INC
<CIK>0001229651
<IRS-NUMBER>581303376
<STATE-OF-INCORPORATION>GA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-14
<FILM-NUMBER>07933737
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>PCA OF DENVER INC
<CIK>0001229675
<IRS-NUMBER>621721242
<STATE-OF-INCORPORATION>TN
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-13
<FILM-NUMBER>07933736
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>PCA OF NASHVILLE INC
<CIK>0001229692
<IRS-NUMBER>621729315
<STATE-OF-INCORPORATION>TN
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-12
<FILM-NUMBER>07933735
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>KLACSMANN PETER G MD INC
<CIK>0001229718
<IRS-NUMBER>581441090
<STATE-OF-INCORPORATION>GA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-11
<FILM-NUMBER>07933734
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ROCKY MOUNTAIN PATHOLOGY LLC
<CIK>0001229720
<IRS-NUMBER>870526913
<STATE-OF-INCORPORATION>UT
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-09
<FILM-NUMBER>07933732
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DASPIT SHARON G MD INC
<CIK>0001229727
<IRS-NUMBER>581626140
<STATE-OF-INCORPORATION>GA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-08
<FILM-NUMBER>07933731
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>SHOALS PATHOLOGY ASSOCIATES INC
<CIK>0001229728
<IRS-NUMBER>630700856
<STATE-OF-INCORPORATION>AL
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-07
<FILM-NUMBER>07933730
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>STRIGEN INC
<CIK>0001229730
<IRS-NUMBER>870651722
<STATE-OF-INCORPORATION>UT
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-05
<FILM-NUMBER>07933728
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>TID ACQUISITION CORP
<CIK>0001229732
<IRS-NUMBER>223620117
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-04
<FILM-NUMBER>07933711
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AMERIPATH OHIO INC
<CIK>0001229755
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>TX
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-44
<FILM-NUMBER>07933718
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
<PHONE>5617126211
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7289 GARDEN ROAD SUITE 200
<CITY>RIVIERA BEACH
<STATE>FL
<ZIP>33404
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>APL PROPERTIES LTD LIABILITY CO
<CIK>0001264348
<IRS-NUMBER>860864218
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-70
<FILM-NUMBER>07933761
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8412
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>APL PROPERTIES LIMITED CO
<DATE-CHANGED>20030923
</FORMER-COMPANY>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ExamOne World Wide, Inc.
<CIK>0001344963
<IRS-NUMBER>232057350
<STATE-OF-INCORPORATION>PA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-32
<FILM-NUMBER>07933777
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<STREET2>LYNDHURST
<CITY>NEW JERSEY
<STATE>NJ
<ZIP>07071
<PHONE>201-729 8415
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<STREET2>LYNDHURST
<CITY>NEW JERSEY
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Central Plains Holdings, Inc.
<CIK>0001344964
<IRS-NUMBER>481219588
<STATE-OF-INCORPORATION>KS
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-30
<FILM-NUMBER>07933775
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729 8415
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Focus Diagnostics, Inc.
<CIK>0001403182
<IRS-NUMBER>521604494
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B2
<ACT>33
<FILE-NUMBER>333-143867-02
<FILM-NUMBER>07933709
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
<PHONE>201-729-8412
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1290 WALL STREET WEST
<CITY>LYNDHURST
<STATE>NJ
<ZIP>07071
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>c49043_424b2.htm
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
    <TITLE>3B2 EDGAR HTML from 49043 1..68 ++</TITLE>

</HEAD>
<BODY>
<P align="right" style="margin:4.2mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">Filed
    Pursuant to Rule 424b2<br>
Registration No. 333-143867</font></P>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2></font></p>

<table border="0" cellspacing=0 cellpadding=0 width="99%" style='margin-left:.6pt;border-collapse:collapse;  '>
  <tr>
    <td width="41%" valign=bottom style='border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;border-color:black; padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=1>Title
            of each Class of <br>
        Securities to be Registered</font></b></p></td>
    <td  colspan="2" valign=top style='border:solid black 1.0pt;border-color:black; border-left:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p>
        <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p>
        <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p>
        <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=1>Amount
              to be <br>
        Registered </font></b></p></td>
    <td width="15%" valign=top style='border:solid black 1.0pt;border-color:black; border-left:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p>
        <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=1>Proposed <br>
        Maximum <br>
        Offering Price <br>
        per Unit (1)</font></b></p></td>
    <td width="15%" valign=bottom style='border:solid black 1.0pt;border-color:black; border-left:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=1>Proposed <br>
        Maximum <br>
        Aggregate<br>
        Offering Price </font></b></p></td>
    <td width="13%" valign=bottom style='border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-color:black; border-left:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=1>Amount
            of</font></b></p>
        <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=1>Registration <br>
        Fee (1)(2)</font></b></p></td>
  </tr>
  <tr bgcolor="#e5FFFF">
    <td width="41%" valign=bottom bgcolor="#e5FFFF" style='border-right:solid black 1.0pt;border-color:black; border-top:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>6.40%
          Senior Notes due 2017</font></p></td>
    <td  colspan="2" valign=top style='border-top:none; border-left:none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$375,000,000</font></p></td>
    <td width="15%" valign=top style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>100%</font></p></td>
    <td width="15%" valign=bottom style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$375,000,000</font></p></td>
    <td width="13%" valign=bottom style='border-top:none;border-left: none;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$11,512.50</font></p></td>
  </tr>
  <tr>
    <td width="41%" valign=bottom style='border-right:solid black 1.0pt;border-color:black; border-top:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>6.95%
          Senior Notes due 2037</font></p></td>
    <td  colspan="2" valign=top style='border-top:none; border-left:none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$425,000,000</font></p></td>
    <td width="15%" valign=top style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>100%</font></p></td>
    <td width="15%" valign=bottom style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$425,000,000</font></p></td>
    <td width="13%" valign=bottom style='border-top:none;border-left: none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$13,047.50</font></p></td>
  </tr>
  <tr bgcolor="#e5FFFF">
    <td width="41%" valign=bottom style='border-right:solid black 1.0pt;border-color:black; border-top:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Guarantees
          of 6.40% Senior Notes due 2017(2)</font></p></td>
    <td  colspan="2" valign=top style='border-top:none; border-left:none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
    <td width="15%" valign=top style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
    <td width="15%" valign=bottom style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
    <td width="13%" valign=bottom style='border-top:none;border-left: none;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
  </tr>
  <tr>
    <td width="41%" valign=bottom style='border-right:solid black 1.0pt;border-color:black; border-top:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Guarantees
          of 6.95% Senior Notes due 2037(2)</font></p></td>
    <td  colspan="2" valign=top style='border-top:none; border-left:none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
    <td width="15%" valign=top style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
    <td width="15%" valign=bottom style='border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
    <td width="13%" valign=bottom style='border-top:none;border-left: none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>--</font></p></td>
  </tr>
  <tr bgcolor="#e5FFFF">
    <td width="41%" valign=bottom style='border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;border-color:black; border-top:none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:3.75pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Total</font></p></td>
    <td  colspan="2" valign=top style='border-bottom:solid black 1.0pt;border-top:none; border-left:none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$800,000,000</font></p></td>
    <td width="15%" valign=top style='border-bottom:solid black 1.0pt;border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>100%</font></p></td>
    <td width="15%" valign=bottom style='border-bottom:solid black 1.0pt;border-top:none;border-left: none;border-right:solid black 1.0pt;  padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$800,000,000</font></p></td>
    <td width="13%" valign=bottom style='border-bottom:solid black 1.0pt;border-top:none;border-left: none;padding:0in 6.0pt 0in 6.0pt'><p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$24,560.00</font></p></td>
  </tr>
  <tr bgcolor="#FFFFFF">
    <td valign=bottom style='border-bottom:solid black 1.0pt;border-color:black; border-top:none;padding:0in 6.0pt 0in 6.0pt'>&nbsp;</td>
    <td  colspan="2" valign=top style='border-bottom:solid black 1.0pt;border-top:none; border-left:none;padding:0in 6.0pt 0in 6.0pt'>&nbsp;</td>
    <td valign=top style='border-bottom:solid black 1.0pt;border-top:none;border-left: none;padding:0in 6.0pt 0in 6.0pt'>&nbsp;</td>
    <td valign=bottom style='border-bottom:solid black 1.0pt;border-top:none;border-left: none;padding:0in 6.0pt 0in 6.0pt'>&nbsp;</td>
    <td valign=bottom style='border-bottom:solid black 1.0pt;border-top:none;border-left: none;padding:0in 6.0pt 0in 6.0pt'>&nbsp;</td>
  </tr>
</table>
<p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.85%; text-indent:-3.85%;text-align:left;'><font size=1>(1)
    Calculated in accordance with Rule 457(r) under the Securities Act of 1933.</font></p>
<p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.85%; text-indent:-3.85%;text-align:left;'><font size=1>(2)
    Pursuant to Rule 457(n), no separate fee will be required to be paid in respect
    of guarantees of our senior debt securities which are being registered concurrently.</font></p>
<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>





<P style="margin:4.2mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; "><B><a name=prospectus1>PROSPECTUS SUPPLEMENT</a><br>
  (To Prospectus dated June 19, 2007)</B></FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><em><FONT style="font-size:5.2mm; color:#000cb2; "><B>$800,000,000</B></FONT></em></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-size:5.2mm; color:#000cb2; "><B><p align="center"><em><img src="questcolorlogo.jpg" style="margin:1.4058mm 0 0 0; border:   ;"></em></p></B></FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><em><FONT style="font-size:5.2mm; color:#000cb2; "><B>$375,000,000 6.40% Senior Notes due 2017<br>$425,000,000 6.95% Senior Notes due 2037</B></FONT></em></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></B></FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>Interest payable on July 1 and January 1</B></FONT></em></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></B></FONT></P>
<P style="margin:2.1mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>We will pay interest on the notes on July 1 and January 1 of each year, beginning January 1, 2008. The 6.40% notes will mature on July 1, 2017. The 6.95% notes will mature on July
  1, 2037. We may redeem some or all of the notes of either series at any time at the applicable redemption prices described in this prospectus supplement.</B></FONT></em></P>
<P style="margin:2.1mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>The notes will be senior unsecured obligations of ours and will rank equally with our other existing and future senior unsecured obligations. The notes will be guaranteed by certain of
  our domestic wholly owned subsidiaries. Each guarantee will be a senior unsecured obligation of the subsidiary guarantor issuing such guarantee and will rank equally with other
  existing and future senior unsecured obligations of such subsidiary guarantor. The notes will be issued only in registered form in denominations of $2,000 and integral multiples of
  $1,000.</B></FONT></em></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></B></FONT></P>
<P style="margin:2.1mm 0 0; "><em><FONT style="font-size:4.5mm; color:#000cb2; "><B>Investing in the notes involves risks that are described in the &#147;Risk Factors&#148; section of our Annual Report on Form 10-K for the year ended December 31,
  2006, incorporated by reference into this prospectus supplement, and in the &#147;Risk Factors&#148; section beginning on page S-8 of this prospectus supplement.</B></FONT></em></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></B></FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>NOTES DUE 2017 &#150; PRICE 99.786% AND ACCRUED INTEREST, IF ANY<br>NOTES DUE 2037 &#150; PRICE 98.891% AND ACCRUED INTEREST, IF ANY</B></FONT></em></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></B></FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD class="style28" style="width:51.00%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style29" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD colspan="6" class="style30" style="width:6.80%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style31" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD colspan="6" class="style32" style="width:12.94%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style33" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD colspan="6" class="style34" style="width:6.80%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style35" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD colspan="6" class="style36" style="width:12.94%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2" align="center" class="style38">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" class="style40" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-size:3.1mm; color:#000cb2; "><B>
      6.40% Senior<br>Notes due 2017</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" class="style42" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-size:3.1mm; color:#000cb2; "><B>
      6.95% Senior<br>Notes due 2037</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" class="style45" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-size:3.1mm; color:#000cb2; "><B>
      Per Note</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" class="style47" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-size:3.1mm; color:#000cb2; "><B>
      Total</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" class="style49" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-size:3.1mm; color:#000cb2; "><B>
      Per Note</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" class="style51" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-size:3.1mm; color:#000cb2; "><B>
      Total</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD class="style53">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-size:3.8mm; color:#000cb2; "><B>Public offering price(1)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td class="style55"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" class="style57"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      99.786</B></FONT></P></TD>
    <TD class="style58"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       %</B></FONT></P></TD>
    <td class="style59"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td class="style61"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD class="style62"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      $</B></FONT></P></TD>
    <td class="style63"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" class="style64"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       374,197,500</B></FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td class="style67"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" class="style69"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      98.891</B></FONT></P></TD>
    <TD class="style70"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       %</B></FONT></P></TD>
    <td class="style71"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td class="style73"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD class="style74"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      $</B></FONT></P></TD>
    <td class="style75"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" class="style76"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       420,286,750</B></FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD class="style79">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-size:3.8mm; color:#000cb2; "><B>Underwriting discount</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td class="style81"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" class="style83"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      0.650</B></FONT></P></TD>
    <TD class="style84"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       %</B></FONT></P></TD>
    <td class="style85"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td class="style87"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD class="style88"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      $</B></FONT></P></TD>
    <td class="style89"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" class="style90"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       2,437,500</B></FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td class="style93"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" class="style95"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      0.875</B></FONT></P></TD>
    <TD class="style96"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       %</B></FONT></P></TD>
    <td class="style97"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td class="style99"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD class="style100"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      $</B></FONT></P></TD>
    <td class="style101"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" class="style102"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       3,718,750</B></FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD class="style105">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-size:3.8mm; color:#000cb2; "><B>Proceeds, before expenses, to Quest Diagnostics</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td class="style107"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" class="style109"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      99.136</B></FONT></P></TD>
    <TD class="style110"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       %</B></FONT></P></TD>
    <td class="style111"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td class="style113"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD class="style114"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      $</B></FONT></P></TD>
    <td class="style115"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" class="style116"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       371,760,000</B></FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td class="style119"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" class="style121"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      98.016</B></FONT></P></TD>
    <TD class="style122"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       %</B></FONT></P></TD>
    <td class="style123"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td class="style125"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD class="style126"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      $</B></FONT></P></TD>
    <td class="style127"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" class="style128"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
       416,568,000</B></FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>


<P style="text-indent:7mm; margin:4mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="left" style="width:4.00pc; height:0.50pt;;"></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 -8.7mm; "><em><FONT style="font-size:3.8mm; "><B>&nbsp;</B></FONT></em></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">
  <TR valign="top">
    <TD class="style135">
    <P style="text-indent:0.7mm; margin:2.1mm 0 0; "><FONT style="font-size:0.7mm; color:#000cb2; "><B></B></FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD align="right" class="style137"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      (1)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td class="style139"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17" class="style141"><P><FONT style="font-size:3.8mm; color:#000cb2; "><B>
      Plus accrued interest from June 22, 2007, if settlement occurs after that date.</B></FONT>
    <P style="margin:2.1mm 0 0; ">&nbsp;</P></TD>
  </TR>

</TABLE>



<P style="margin:2.1mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this prospectus supplement or the
  accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></em></P>
<P style="margin:2.1mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>The notes will be ready for delivery in book-entry form only through The Depository Trust Company and its participants, including Euroclear and Clearstream Luxembourg, on or about
  June 22, 2007.</B></FONT></em></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></B></FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>Joint Book-Running Managers</B></FONT></em></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="top">
    <TD style="width:31.75%;"><em>
      </P>
    </em></TD>
    <TD class="style150" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style151" style="width:33.33%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style152" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <td class="style153"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
<TR valign="top">
  <TD style="width:31.75%;"><FONT style="font-size:4mm; color:#000cb2; "><B>MORGAN STANLEY</B></FONT></TD>
  <TD class="style150" style="width:2.63%">&nbsp;</TD>
  <TD class="style151" style="width:33.33%;"><div align="center"><FONT style="font-size:4mm; color:#000cb2; "><B>BANC&nbsp;OF&nbsp;AMERICA&nbsp;SECURITIES&nbsp;LLC</B></FONT></div></TD>
  <TD class="style152" style="width:2.63%">&nbsp;</TD>
  <td class="style153"><div align="right"><FONT style="font-size:4mm; color:#000cb2; "><B>MERRILL LYNCH &amp; CO.</B></FONT></div></td>
</TR>



  <TR valign="top">
    <TD colspan="5" align="center" class="style155"><P><FONT style="font-size:4mm; color:#000cb2; "><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD>
  </TR>
</TABLE>



<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; "><B><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></B></FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>Co-Managers</B></FONT></em></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="top">
    <TD class="style161" style="width:31.75%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style162" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style163" style="width:33.33%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD class="style164" style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <td class="style165"><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
<TR valign="top">
  <TD class="style161" style="width:31.75%;"><FONT style="font-size:4mm; color:#000cb2; "><B>Barclays Capital</B></FONT></TD>
  <TD class="style162" style="width:2.63%">&nbsp;</TD>
  <TD class="style163" style="width:33.33%;"><div align="center"><FONT style="font-size:4mm; color:#000cb2; "><B>JPMorgan</B></FONT></div></TD>
  <TD class="style164" style="width:2.63%">&nbsp;</TD>
  <td class="style165"><div align="right"><FONT style="font-size:4mm; color:#000cb2; "><B>Wachovia Securities</B></FONT></div></td>
</TR>


  <TR valign="top">
    <TD colspan="5" align="center" class="style167"><P><FONT style="font-size:4mm; color:#000cb2; "><B>      <font style="word-spacing: 11.50pc;">&nbsp;</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD>
  </TR>
</TABLE>


<P style="margin:4.9mm 0 0; "><em><FONT style="font-size:3.8mm; color:#000cb2; "><B>June 19, 2007.</B></FONT></em></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>TABLE OF CONTENTS</B></FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:40.60%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:4.13%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Page</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD colspan="8" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a href=#prospectus1>Prospectus Supplement</a></B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#summary1>Summary</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-1</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#risk1>Risk Factors</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-8</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#cautionary1>Cautionary Statement for Purposes of the &#147;Safe Harbor&#148; Provisions of the Private Securities Litigation Reform Act of 1995</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-11</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#ratio1>Ratio of Earnings to Fixed Charges</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-13</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#use1>Use of Proceeds</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-14</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#capitalization1>Capitalization</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-15</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#description1>Description of Certain Other Indebtedness</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-16</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#selected1>Selected Historical Financial Data for Quest Diagnostics</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-18</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#selected2>Selected Historical Financial Data for AmeriPath, Inc.</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-21</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#description2>Description of Notes</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-24</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#united1>United States Federal Income Tax Considerations</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-44</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#underwriting1>Underwriting</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-48</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#legal1>Legal Matters</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-50</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#experts1>Experts</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-50</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#where1>Where You Can Find More Information</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" nowrap><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      S-50</FONT></P></TD>
    <TD colspan="2" nowrap>&nbsp;</TD>
  </TR>
</TABLE>


<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:40.94%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.80%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Page</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD colspan="8" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#prospectus2><B>Prospectus</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#about1>About This Prospectus</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      ii</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#quest1>Quest Diagnostics Incorporated</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      ii</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#where2>Where You Can Find More<br>Information</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      iii</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#cautionary2>Cautionary Statement for Purposes of the &#147;Safe Harbor&#148; Provisions of the Private Securities Litigation Reform Act of 1995</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#use2>Use of Proceeds</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      3</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#ratio2>Ratio of Earnings to Fixed Charges</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      4</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#securities1>Securities We May Issue</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#description3>Description of Senior Debt Securities and Guarantees of Senior Debt Securities</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      6</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#plan1>Plan of Distribution</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      7</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#validity1>Validity of the Securities</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#experts2>Experts</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>


<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">You should rely only on the information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus. We have not, and the underwriters have not,
  authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the underwriters
  are not, making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus supplement, the
  accompanying prospectus and the documents incorporated by reference is accurate only as of their respective dates. Our business, financial condition, cash flows, results of operations and prospects
  may have changed since these dates.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">References to &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; &#147;Quest Diagnostics&#148; and the &#147;Company&#148; are to Quest Diagnostics Incorporated and its consolidated subsidiaries unless otherwise specified or the context
  otherwise requires.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; ">i</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=summary1>SUMMARY</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>This summary highlights selected information appearing elsewhere in this prospectus supplement and may not contain all of the information that is important to you. You should carefully read this
  prospectus supplement in its entirety, including the documents incorporated by reference.</I></FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Our Company</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We are the nation&#146;s leading provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve
  health. We offer patients and physicians the broadest access to diagnostic laboratory services through our nationwide network of laboratories and our own patient service centers. We provide
  interpretive consultation through the largest medical and scientific staff in the industry, with approximately 900 M.D.&#146;s and Ph.D.&#146;s around the country. We are the leading provider of esoteric testing,
  including gene-based testing, the leading provider of anatomic pathology services, including dermatopathology, and the leading provider of testing for drugs of abuse. We are also a leading provider of
  testing for clinical trials and risk assessment services for the life insurance industry. We empower healthcare organizations and clinicians with state-of-the-art information technology solutions that can
  improve patient care and medical practice.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we generated net revenues of $6.3 billion and processed approximately 151 million requisitions for testing. Each requisition form accompanies a patient specimen, indicating the tests
  to be performed and the party to be billed for the tests. Our customers include patients, physicians, hospitals, employers, governmental institutions and other commercial clinical laboratories. On May
  31, 2007, we acquired AmeriPath Group Holdings, Inc., the ultimate parent of AmeriPath, Inc., which generated net revenues of $752 million during 2006.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We operate a nationwide network of greater than 2,100 of our own patient service centers, principal clinical laboratories located in more than 30 major metropolitan areas throughout the United
  States and approximately 150 smaller &#147;rapid response&#148; laboratories (including, in each case, facilities operated at our joint ventures). We provide full esoteric testing services, including gene-based
  testing, on both coasts through our Quest Diagnostics Nichols Institute laboratory facilities, located in San Juan Capistrano, California and Chantilly, Virginia, and through our Specialty Laboratories
  facility located in Valencia, California, as well as infectious and immunologic disease testing through our Focus Diagnostics laboratory facility, located in Cypress, California. Our AmeriPath subsidiary
  operates 40 outpatient anatomic pathology laboratories and provides inpatient anatomic pathology and medical director services for approximately 200 hospitals throughout the country. We also have
  laboratory facilities in Mexico City, Mexico, San Juan, Puerto Rico and Heston, England.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our principal executive offices are located at 1290 Wall Street West, Lyndhurst, New Jersey 07071, telephone number: (201) 393-5000.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>The AmeriPath Acquisition</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On May 31, 2007, we completed the acquisition of AmeriPath Group Holdings, Inc., or AmeriPath, a Delaware corporation. As a result of the merger, AmeriPath is a wholly-owned subsidiary of
  ours. Prior to the acquisition, Welsh, Carson, Anderson &amp; Stowe IX, L.P. was the holder of a majority of the outstanding shares of common stock and participating preferred stock of AmeriPath.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The aggregate consideration paid in connection with the merger was approximately $2 billion, including the assumption of approximately $780 million of indebtedness (including interest). We
  funded the acquisition, as well as the refinancing of certain of our other debt, with borrowings of $1.6 billion under our term loan facility, borrowings of $780 million under our $1.0 billion bridge
  loan facility, and from cash on hand.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">As part of the refinancing of AmeriPath debt, on May 21, 2007, we commenced a tender offer and consent solicitation for the $350 million 10<SUP style="font-size: 70%; vertical-align: baseline; position: relative; top: -0.5em; left: 0.1em;">1</SUP>/<SUB style="font-size: 70%; vertical-align: baseline; position: relative;">2</SUB>% Senior Subordinated Notes of AmeriPath, Inc. </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-1</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On June 8, 2007, we purchased $348.03 million of such notes pursuant to an early settlement of the tender offer, at which time certain amendments to the indenture governing the notes became
  operative.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In addition, on May 31, 2007, we called for redemption the $125 million Senior Unsecured Floating Rate PIK Toggle Notes due 2014 of AmeriPath Intermediate Holdings, Inc., the direct parent
  of AmeriPath, Inc. and an indirect wholly-owned subsidiary of AmeriPath Group Holdings, Inc., and deposited sufficient funds with the trustee to pay for such notes on the redemption date.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>As Adjusted Combined Impact of the AmeriPath Acquisition and Related Transactions</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following discussion of as adjusted combined financial information reflects the impact of the following transactions, which we refer to in this prospectus supplement as &#147;the Transactions&#148;:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      our purchase, on May 31, 2007, of AmeriPath, including the all-cash purchase price and related transaction costs associated with the AmeriPath acquisition;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a $1.0 billion bridge loan facility entered into to fund the acquisition of AmeriPath, of which $780 million was drawn after March 31, 2007, and will be refinanced with the proceeds of this
      offering;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a new five-year $1.6 billion term loan facility entered into to fund the acquisition of AmeriPath;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the repayment of AmeriPath&#146;s existing debt of approximately $780 million (including interest);</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the repayment of the interim credit agreement of $450 million borrowed in connection with the acquisition of POCT Holding AB, or HemoCue; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the completion of this $800 million offering of senior notes.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>



<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The acquisition of AmeriPath will be accounted for under the purchase method of accounting. As such, the cost to acquire AmeriPath will be allocated to the respective assets acquired and
  liabilities assumed based on their estimated fair values as of the closing date. The as adjusted combined financial information discussion below reflects a preliminary allocation of the cost to acquire
  AmeriPath to the assets acquired and liabilities assumed based on preliminary estimates, which are subject to change. Management is in the early stages of assessing the estimated fair values of the
  assets acquired and the liabilities assumed. The following as adjusted combined financial information is not pro forma financial information prepared in accordance with Article 11 of Regulation S-X.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">As of March 31, 2007, our total assets approximated $6.2 billion and total liabilities approximated $3.2 billion. As of March 31, 2007, AmeriPath, Inc.&#146;s total assets and liabilities approximated
  $1.4 billion and $0.8 billion, respectively. Assuming the Transactions occurred on March 31, 2007, our unaudited as adjusted combined total assets are estimated to approximate $8.3 billion to $8.8
  billion, reflecting a preliminary purchase price allocation of the cost to acquire AmeriPath primarily associated with goodwill and other intangible assets. Assuming the Transactions occurred on March
  31, 2007, our unaudited as adjusted combined total liabilities are estimated to approximate $5.3 billion to $5.8 billion, reflecting primarily an increase in debt outstanding. See &#147;Capitalization&#148; for
  further details regarding total capitalization on an actual and as adjusted basis to reflect the impact of the Transactions.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">For the three months ended March 31, 2007 and year ended December 31, 2006, our income from continuing operations was $108 million and $626 million, respectively. For the three months
  ended March 31, 2007 and year ended December 31, 2006, AmeriPath, Inc.&#146;s net income was $0.2 million and $10.5 million, respectively. Assuming the Transactions occurred January 1, 2006, as
  adjusted combined income from continuing operations for the three months ended March 31, 2007 and the year ended December 31, 2006 are estimated to approximate $90 million and $567 million,
  respectively, reflecting primarily an increase in as adjusted combined interest expense as a result of the Transactions and excluding any net synergies anticipated from the AmeriPath acquisition.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-2</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>The Offering</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following is a brief summary of some of the terms of this offering. For a more complete description of the terms of the notes, see &#147;Description of Notes&#148; in this prospectus supplement.</FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="top">
    <TD style="width:42.11%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:53.07%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>



  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Issuer</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Quest Diagnostics Incorporated.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Notes offered</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $375,000,000 aggregate principal amount of 6.40% senior notes due 2017.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $425,000,000 aggregate principal amount of 6.95% senior notes due 2037.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Maturities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      6.40% senior notes due 2017: July 1, 2017.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      6.95% senior notes due 2037: July 1, 2037.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Interest payment dates</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      July 1 and January 1, beginning January 1, 2008.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Guarantees</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      The notes will be fully and unconditionally guaranteed, jointly and severally, by certain of our domestic wholly owned subsidiaries.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Ranking</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      The notes will be senior unsecured obligations of ours and will rank equally with our other existing and future senior unsecured obligations. Each
      guarantee will be a senior unsecured obligation of the subsidiary guarantor issuing such guarantee and will rank equally with other existing and future
      senior unsecured obligations of such subsidiary guarantor. The notes and the guarantees will&nbsp;effectively rank junior to all liabilities of our subsidiaries that
      are not guarantors. The notes and the guarantees will also effectively be subordinated to any existing and future secured obligations of ours or our
      subsidiary guarantors as to the assets securing such obligations.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      As of March 31, 2007, after giving effect to the Transactions:</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      we and our subsidiary guarantors would have had total debt outstanding of $3.64 billion, of which $5.5&nbsp;million is secured; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      our subsidiaries that are not guarantors (other than certain subsidiaries which will guarantee our term loans, our senior unsecured revolving credit
      facility and existing senior notes) would have had debt outstanding of $314 million, of which $300 million was incurred under our secured receivables
      credit facility.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      For more information, see &#147;Description of Certain Other Indebtedness,&#148; &#147;Capitalization&#148; and &#147;Description of Notes.&#148;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Optional redemption</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      We may redeem some or all of the notes of either series, at any time, at the applicable redemption prices described in this prospectus supplement. For a
      more detailed description, see &#147;Description of Notes&#151;Optional Redemption.&#148;</FONT></P></TD>
  </TR>
</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-3</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>

<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="top">
    <TD style="width:42.11%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:53.07%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>


  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Repurchase Upon a Change of Control</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Upon the occurrence of a Change of Control Triggering Event (as defined in this prospectus supplement), we will be required to make an offer to
      purchase the notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase. See &#147;Description of
      Notes&#151;Change of Control.&#148;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Covenants</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      The indenture governing the notes will contain covenants that, among other things, will limit our ability and the ability of our subsidiary guarantors to:</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      create certain liens;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      enter into certain sale and leaseback transactions;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      make payments to certain non-guarantor subsidiaries;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      consolidate, merge or transfer all or substantially all of our assets and the assets of our subsidiaries on a consolidated basis; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      incur indebtedness of non-guarantor subsidiaries.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      These covenants are subject to important exceptions and qualifications, which are described in this prospectus supplement. For a more detailed
      description, see &#147;Description of Notes.&#148;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Use of proceeds</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      We estimate that the net proceeds from this offering of notes after deducting underwriting discounts but before deducting other expenses of the offering
      will be approximately $788.3&nbsp;million. We intend to use these proceeds, together with cash on hand, to repay all borrowings under the bridge loan facility
      incurred to pay a portion of the purchase price and transaction expenses of the AmeriPath acquisition and to refinance the debt of AmeriPath. See &#147;Use
      of Proceeds&#148; and &#147;Summary&#151;The AmeriPath Acquisition.&#148;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Risk factors</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="3"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      See &#147;Risk Factors&#148; and the other information in this prospectus supplement and in our Annual Report on Form 10-K for the fiscal year ended December
      31, 2006, incorporated by reference into this prospectus supplement for a discussion of factors you should carefully consider before deciding to invest in
      the notes.</FONT></P></TD>
  </TR>
</TABLE>

<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-4</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Summary Selected Historical Financial Data of Quest Diagnostics</B></FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:1.75%;width:98.25%;" >
<TR valign="bottom">
    <TD style="width:27.44%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:10.71%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Three Months Ended<br>March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="20" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Year Ended December 31,</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2007 (a)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006 (b)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2005 (g)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="34" align="center"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      (in thousands, except for ratios)</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Operations Data:</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net revenues</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       1,526,208</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       1,553,105</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       6,268,659</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       5,456,726</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       5,066,986</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Operating income</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      200,870</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      258,718</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (e)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" nowrap><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,128,077</FONT></P></TD>
    <TD nowrap><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (c),(e)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,007,548</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (h)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      880,854</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (i)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Income from continuing operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      107,515</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      154,603</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (d)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      625,692</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (d)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      573,196</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (j)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      492,415</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
&nbsp;&nbsp; (k)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(Loss)/income from discontinued operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (1,622</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (9,967</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (39,271</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )(f)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right" nowrap><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (26,919</FONT></P></TD>
    <TD nowrap><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )(f)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      6,780</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net income</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      105,893</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      144,636</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      586,421</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      546,277</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      499,195</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Balance Sheet Data (at end of period):</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Cash and cash equivalents</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       158,397</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       156,461</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       149,640</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       92,130</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       73,302</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Accounts receivable, net</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      810,576</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      775,724</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      774,414</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      732,907</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      649,281</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Total assets</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      6,186,542</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5,434,568</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5,661,482</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5,306,115</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      4,203,788</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Long-term debt</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,238,265</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,240,501</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,239,105</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,255,386</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      724,021</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Total debt</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,005,306</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,532,390</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,555,979</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,592,225</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,098,822</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Total stockholders&#146; equity</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      3,029,232</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,865,296</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      3,019,171</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,762,984</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,288,651</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Other Data:</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net cash provided by operating activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       151,553</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       240,659</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       951,896</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       851,583</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       798,780</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net cash (used) in investing activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (345,947</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (27,991</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (414,402</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (1,079,793</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (173,700</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net cash (used in) provided by financing activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (203,151</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (148,337</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (479,984</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      247,038</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (706,736</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Provision for doubtful accounts</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      67,508</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      63,423</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      243,443</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      233,628</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      226,310</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Rent expense</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      40,183</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      38,722</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      153,185</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      139,660</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      132,883</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Capital expenditures</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      40,126</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      42,186</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      193,422</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      224,270</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      176,125</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Depreciation and amortization</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      50,335</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      49,060</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      197,398</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      176,124</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      168,726</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Ratio of earnings to fixed charges</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5.4x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9.9x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>


<P style="text-indent:7mm; margin:4mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="left" style="width:4.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 -8.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&nbsp;</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (a)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      On January 31, 2007, we completed the acquisition of HemoCue, which generated annualized revenues of approximately $90 million. Consolidated operating results for 2007 include the results of
      operations of HemoCue subsequent to the closing of the acquisition.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On July 3, 2006, we completed the acquisition of Focus Technologies Holding Company, or Focus Diagnostics, which generated annualized revenues of approximately $65 million. Consolidated
      operating results for 2006 include the results of operations of Focus Diagnostics subsequent to the closing of the acquisition. See Note 3 to the Consolidated Financial Statements included in our
      Annual Report on Form 10-K for the year ended December 31, 2006, which is incorporated by reference into this prospectus supplement.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(c)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $55 million of stock-based compensation expense in accordance with Statement of Financial Accounting Standards, or SFAS, No. 123, revised 2004, &#147;Share-Based
      Payment,&#148; or SFAS 123R.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(d)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $10 million related to net investment losses, which included a $15.8 million gain on the sale of an investment recorded during the first quarter of 2006.</FONT></P>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>
</TABLE>



<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-5</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<TABLE style="font-size:0.5mm; ">
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(e)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $23 million in charges as a result of finalizing our plan of integration of Lab<I>One</I>, Inc., or LabOne, and $4.1 million in charges related to consolidating operations in
      California into a new facility.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(f)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $32 million in charges as a result of discontinuing the operations of NID, a test kit manufacturing subsidiary. During the fourth quarter of 2005, we recorded a $16
      million charge to write-off certain assets in connection with a product hold at NID.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(g)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On November 1, 2005, we completed the acquisition of LabOne, which had annual revenues of approximately $468 million. Consolidated operating results for 2005 include the results of
      operations of LabOne subsequent to the closing of the acquisition. See Note 3 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended
      December 31, 2006, which is incorporated by reference into this prospectus supplement.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(h)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2005, we recorded a $6.2 million charge primarily related to forgiveness of amounts owed by patients and physicians, and related property damage as a result of hurricanes in the Gulf
      Coast.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(i)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2004, we recorded a $10.3 million charge associated with the acceleration of certain pension obligations in connection with the succession of our prior Chief Executive Officer.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(j)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2005, we recorded a $7.1 million charge associated with the write-down of an investment.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(k)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2004, we recorded a $2.9 million charge to interest expense, net representing the write-off of deferred financing costs associated with the refinancing of our bank debt and credit facility.</FONT></P>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>

<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-6</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Summary Selected Historical Financial Data of AmeriPath, Inc.</B></FONT><FONT style="font-family:serif; font-size:2.5mm; color:#000cb2; "><SUP><B>(a)</B></SUP></FONT></P>
<table cellspacing="0" style="margin-left:1.32%;margin-right:1.32%;width:97.36%;" >
<TR valign="bottom">
    <TD style="width:38.16%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.22%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.22%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Three Months Ended<br>March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="20" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Year Ended December 31,</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2007</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006(c)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2005</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="34" align="center"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      (in thousands)</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Operations Data:</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net revenues</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       200,694</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       170,936</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       752,321</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       563,617</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       507,271</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Operating income</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      15,072</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      14,569</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      79,877</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      65,931</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      49,789</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net income (loss)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      219</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (2,090</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      10,527</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9,921</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,514</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Balance Sheet Data (at end of period):</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Cash and cash equivalents (b)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       8,648</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       182</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       3,998</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       20,980</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Accounts receivable, net</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      153,279</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      122,122</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      137,947</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      84,968</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      76,567</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Total assets</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,437,234</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,340,786</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,411,101</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      984,149</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      964,309</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Long-term debt, including current portion</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      625,534</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      610,826</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      624,259</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      479,490</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      497,853</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Total stockholders&#146; equity</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      629,932</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      565,563</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      606,340</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      384,717</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      358,092</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Other Data:</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net cash (used in) provided by operating activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       (9,595</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       394</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       30,624</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       38,152</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       54,038</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net cash used in investing activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (14,079</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (185,127</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (262,672</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (52,740</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (70,808</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Net cash provided by (used in) financing activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      23,492</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      189,383</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      228,232</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (2,394</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      14,214</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Provision for doubtful accounts</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      19,358</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      19,840</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      84,936</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      73,766</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      76,463</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Rent expense</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      4,198</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,432</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      13,911</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9,624</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      7,634</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Capital expenditures</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      14,004</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      13,475</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      57,334</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      29,431</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      12,803</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Depreciation and amortization (d)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8,906</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      7,951</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      34,933</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      24,934</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      22,774</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>


<P style="text-indent:7mm; margin:4mm 0 0.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="left" style="width:4.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 -8.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&nbsp;</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (a)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      This presentation is for AmeriPath, Inc. We acquired AmeriPath Group Holdings, Inc., the ultimate parent of AmeriPath, Inc., whose principal assets consisted of cash (which was used to repay
      debt) and its indirect investment in AmeriPath, Inc., and whose principal liabilities consisted of debt, which was repaid in connection with the acquisition of AmeriPath Group Holdings, Inc. As
      of the date hereof, AmeriPath Group Holdings, Inc. has no significant assets other than its indirect investment in AmeriPath, Inc.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Cash and cash equivalents exclude restricted cash which consists of premium revenue received by AmeriPath, Inc.&#146;s insurance captive to be used for future insurance claims and expenses.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(c)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On January 31, 2006, AmeriPath, Inc. completed its acquisition of Specialty Laboratories, Inc., or Specialty, which generated net revenues in 2005 of approximately $150 million. Consolidated
      operating results for 2006 include the results of operations of Specialty subsequent to the closing of the acquisition.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(d)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Three months ended March 31, 2007 and 2006 exclude amortization of deferred debt costs of $0.7 million and $0.6 million, respectively, as these costs were included in interest expense.</FONT></P></TD>
  </TR>

</TABLE>



<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-7</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=risk1>RISK FACTORS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>You should carefully consider the risks described below and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006, incorporated by reference into this prospectus
  supplement, before making a decision to invest in our notes. Some of the following factors relate principally to our business and the industry in which we operate. Other factors relate principally to your
  investment in the notes. The risks and uncertainties described below are not the only ones facing our company. Additional risks and uncertainties not presently known to us or that we currently deem
  immaterial may also materially adversely affect our business and operations.</I></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>If any of the matters included in the following risks were to occur, our business, financial condition, results of operations, cash flows or prospects could be materially adversely affected. In such case,
  you may lose all or part of your original investment.</I></FONT></P>
<P style="margin:3.5mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=integrating1>Integrating our operations with AmeriPath may be difficult and, if unsuccessfully executed, may not produce the anticipated benefits and could adversely affect our business.</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On May 31, 2007, we completed the acquisition of AmeriPath. As a result of the merger, AmeriPath is a wholly-owned subsidiary of ours. The aggregate consideration paid in connection with
  the merger was approximately $2 billion, including the assumption of approximately $780 million of indebtedness (including interest).</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The acquisition involves the integration of a separate company that previously operated independently and has different systems, processes and cultures. The process of combining AmeriPath with
  our operations may be disruptive to both of our businesses and may cause an interruption of, or a loss of momentum in, such businesses as a result of the following difficulties, among others:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      loss of key customers or employees;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">failure to maintain the quality of services that our company has historically provided;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">diversion of management&#146;s attention from the day-to-day business of our company as a result of the need to deal with the foregoing disruptions and difficulties; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the added costs of dealing with such disruptions.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In addition, during this integration AmeriPath expects to complete the development and implementation of a new laboratory information system and billing information system to be used by all
  of AmeriPath&#146;s laboratories. Failure to properly implement the new information systems could cause disruptions in service and present significant conversion risks.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Even if we are able to successfully complete the integration of the operations of AmeriPath, we may not be able to realize all or any of the benefits that we expect to result from such
  integration.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Because most of our clinical laboratory testing is performed under arrangements that are terminable at will or on short notice, any interruption of or deterioration in our services may result in a
  customer&#146;s decision to stop using us for clinical laboratory testing. We cannot assure you that we will be able to retain key technical and management personnel or that we will realize the anticipated
  benefits of the AmeriPath acquisition, either at all or in a timely manner. As part of our growth strategy, we may in the future acquire additional clinical laboratories or other healthcare-related
  businesses.</FONT></P>
<P style="margin:3.5mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=our1>Our outstanding debt may impair our financial and operating flexibility.</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">As of March 31, 2007, after giving effect to the Transactions as if they occurred on that date, we would have had approximately $3.95 billion of debt outstanding, with $750 million of available
  capacity under our senior unsecured revolving credit facility. Except for outstanding letters of credit, bank guarantees and operating leases, we do not have any off-balance sheet financing
  arrangements in place or available. See Note 10 to our Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2006 and Note 5 to our Consolidated
  Financial Statements in our quarterly report on Form 10-Q for the quarter ended March 31, 2007 for further details related to our outstanding debt. Set forth in the table below, for each of the next
  five years, is the aggregate amount of scheduled principal, estimated interest and total payments related to our </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-8</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">outstanding debt as of March 31, 2007, after giving effect to the Transactions as if they had occurred on that date, including capital leases, assuming that maturing debt is refinanced for purposes of
  estimating interest.</FONT></P>
<table cellspacing="0" style="margin-left:4.39%;margin-right:4.39%;width:91.22%;" >
<TR valign="bottom">
    <TD style="width:54.09%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.22%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:11.15%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Twelve Months<br>Ended December 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Principal</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Interest</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Total</B></FONT></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      (in thousands)</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2007</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       357,041</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       178,009</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       535,050</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2008</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      142,091</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      209,242</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      351,333</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2009</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      122,055</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      210,573</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      332,628</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2010</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      560,246</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      201,853</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      762,099</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2011</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      915,258</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      228,639</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,143,897</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>



<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our debt portfolio is sensitive to changes in interest rates. As of March 31, 2007, after giving effect to the Transactions, we would have had approximately $1.97 billion of floating rate debt.
  Based on our net exposure to interest rate changes, an assumed 10% change in interest rates on our variable rate indebtedness (representing approximately 54 basis points) would impact annual net
  interest expense by approximately $10.6 million, assuming no changes to the debt outstanding at March 31, 2007. In addition, any future borrowings by us under the unsecured revolving credit facility,
  the secured receivables credit facility or the issuance of other floating rate debt will expose us to additional interest rate risk. Interest rates on our senior unsecured revolving credit facility, term loans
  and secured receivables credit facility are also subject to a pricing schedule that fluctuates based on changes in our credit rating.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our debt agreements contain various restrictive covenants. These restrictions could limit our ability to use operating cash flow in other areas of our business because we must use a portion of
  these funds to make principal and interest payments on our debt.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We have obtained ratings on our debt from Standard and Poor&#146;s Ratings Services and Moody&#146;s Investors Service. There can be no assurance that any rating so assigned will remain for any given
  period of time or that a rating will not be lowered or withdrawn entirely by a rating agency if in that rating agency&#146;s judgment future circumstances relating to the basis of the rating, such as adverse
  changes in our company or our industry, so warrant. If such ratings are lowered, the borrowing costs on our senior unsecured revolving credit facility, secured receivables facility and term loans would
  increase. Changes in our credit ratings do not require repayment or acceleration of any of our debt.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We, or our subsidiaries, may incur additional indebtedness in the future. The notes offered hereby do not limit our or our subsidiaries&#146; ability to incur indebtedness. Our ability to make principal
  and interest payments will depend on our ability to generate cash in the future. If additional debt is added to our current debt, a greater portion of our cash flows will be needed to satisfy our debt
  service obligations; and if we do not generate sufficient cash to meet our debt service requirements, we may need to seek additional financing. In this case, it may be more difficult, or we may be
  unable, to obtain financing on terms that are acceptable to us. As a result, we would be more vulnerable to general adverse economic, industry and capital markets conditions as well as the other
  risks associated with indebtedness.</FONT></P>
<P style="margin:3.5mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=federal1>Federal and state laws permit a court to void a guarantee issued by any of our subsidiaries if the court finds the guarantee to constitute a fraudulent conveyance.</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our obligations under the notes are guaranteed by our subsidiaries to the extent described in this prospectus supplement. These guarantees are subject to various federal and state fraudulent
  conveyance laws enacted for the protection of creditors.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The issuance of a guarantee by any of our subsidiaries will constitute a fraudulent conveyance if:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      the guarantee was incurred by the subsidiary with the intent to hinder, delay or defraud any present or future creditor; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the subsidiary did not receive fair consideration for issuing the guarantee and such subsidiary (1) was insolvent or rendered insolvent by reason of the issuance of the guarantee, (2) was engaged
      or about to engage in a business or transaction for which the remaining assets of the subsidiary constituted unreasonably small capital to carry on its business or (3) intended to incur debts
      beyond its ability to pay such debts as they matured.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>



<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-9</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Generally, an entity will be considered insolvent if:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      the sum of its debts is greater than the fair value of its property;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the present fair value of its assets is less than the amount that it will be required to pay on its existing debts as they become due; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">it cannot pay its debts as they become due.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If a court finds a guarantee issued by a subsidiary of ours to constitute a fraudulent conveyance, the court could give a lower priority to, or subordinate, the claims of the notes against this
  subsidiary to the claims of other creditors of this subsidiary. In addition, a court could void all or part of the guarantee. To the extent the guarantee issued by a subsidiary of ours was voided as a
  fraudulent conveyance, the holders of our notes guaranteed by our subsidiary guarantors would cease to have any claim against the subsidiary and would be creditors solely of Quest Diagnostics and
  any other subsidiary guarantor that was not found to have made a fraudulent conveyance. Furthermore, a court may be more likely to find that guarantees issued by subsidiaries after the date the
  notes are issued constitute a fraudulent conveyance. See &#147;Description of Notes&#151;Guarantees.&#148;</FONT></P>
<P style="margin:3.5mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=secured1>Secured indebtedness and existing and future obligations of our subsidiaries that are not guarantors, including the issuance of preferred stock, will be effectively senior to the notes.</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The notes and the guarantees are senior unsecured obligations and therefore will be effectively subordinated to any of our or our subsidiary guarantors&#146; secured obligations to the extent of the
  value of the assets securing such obligations. The indenture does not limit the amount of indebtedness that we and any of our subsidiary guarantors can incur, but does limit the amount of
  indebtedness our non-guarantor subsidiaries are permitted to incur (as described below). In addition, the indenture limits the amount of secured indebtedness pursuant to the covenant described under
  the heading &#147;Description of Notes&#151;Limitation on Liens.&#148; This covenant is subject to important exceptions described under such heading. As of March 31, 2007, after giving effect to the Transactions,
  we and our subsidiary guarantors would have had outstanding $5.5 million of secured debt.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We conduct our operations through subsidiaries, which generate a substantial portion of our operating income and cash flow. As a result, distributions or advances from our subsidiaries are a
  major source of funds necessary to meet our debt service and other obligations. Contractual provisions, laws or regulations, as well as any subsidiary&#146;s condition and operating requirements, may limit
  our ability to obtain cash required to pay our debt service and other obligations. The notes will be structurally subordinated to all existing and future obligations of our subsidiaries (unless such
  subsidiaries are subsidiary guarantors), including claims with respect to trade payables. In addition, the guarantees of our subsidiary guarantors will be structurally subordinated to all existing and
  future obligations of any subsidiary or Quest Diagnostics or a subsidiary guarantor (unless such subsidiaries are also subsidiary guarantors), including claims with respect to trade payables. This means
  that holders of our notes as guaranteed by our subsidiary guarantors will have a junior position with respect to such obligations of our direct and indirect subsidiaries that are not subsidiary
  guarantors on the assets and earnings of such subsidiaries. Except as disclosed in the next sentence, as of March 31, 2007, after giving effect to the Transactions our subsidiaries that are not
  guarantors would have had debt outstanding of $314 million, of which $300 million was incurred under our secured receivables credit facility. Certain AmeriPath subsidiaries and our MedPlus, Inc.
  subsidiary (which has approximately $65 million in assets) will not be guarantors of the notes, but will guarantee certain of our other indebtedness, including our term loans, our senior unsecured
  revolving credit facility and existing senior notes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our non-guarantor subsidiaries are limited in the amount of indebtedness they are permitted to incur pursuant to the covenant described under &#147;Description of Notes&#151;Limitation on Subsidiary
  Indebtedness and Preferred Stock.&#148; This covenant is subject to important exceptions described under such heading. In addition, the guarantees of our subsidiary guarantors may be released in certain
  circumstances, which are described under the heading &#147;Description of Notes&#151;Guarantees&#148; or may be avoided or subordinated in favor of the subsidiary guarantors&#146; other creditors as described in this
  prospectus supplement under the heading &#147;Risk Factors&#151;Federal and state laws permit a court to void a guarantee issued by any of our subsidiaries if the court finds the guarantee to constitute a
  fraudulent conveyance.&#148;</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-10</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=cautionary1>CAUTIONARY STATEMENT FOR PURPOSES OF THE &#147;SAFE HARBOR&#148;<br>PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Some statements and disclosures in this prospectus supplement, or any accompanying prospectus and the documents incorporated herein or therein by reference are forward-looking statements.
  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#147;may,&#148; &#147;believe,&#148; &#147;will,&#148; &#147;expect,&#148; &#147;project,&#148;
  &#147;estimate,&#148; &#147;anticipate,&#148; &#147;plan&#148; or &#147;continue.&#148; These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could
  significantly cause our plans and expectations, including actual results, to differ materially from the forward-looking statements. The Private Securities Litigation Reform Act of 1995, or the Litigation
  Reform Act, provides a &#147;safe harbor&#148; for forward-looking statements to encourage companies to provide prospective information about their companies without fear of litigation.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We would like to take advantage of the &#147;safe harbor&#148; provisions of the Litigation Reform Act in connection with the forward-looking statements included, or incorporated by reference, in this
  document. Investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented, or incorporated by reference, in this document. The following
  important factors could cause our actual financial results to differ materially from those projected, forecasted or estimated by us in forward-looking statements:</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(a) Heightened competition, including increased pricing pressure, competition from hospitals, and competition from physicians.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b) Impact of changes in payer mix, including any shift from fee-for-service to capitated fee arrangements.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(c) Adverse actions by government or other third-party payers, including unilateral reduction of fee schedules payable to us, competitive bidding, an increase in the practice of negotiating for
  exclusive arrangements that involve aggressively priced capitated or fee for service payments by healthcare insurers or other payers and threats by third-party payers against physicians and patients
  that effectively eliminate their choice to use an out-of-network provider under preferred provider organization and similar plans.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(d) The impact upon our testing volume and collected revenue or general or administrative expenses resulting from our compliance with Medicare and Medicaid administrative policies and
  requirements of third-party payers. These include:</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(1) the requirements of Medicare carriers to provide diagnosis codes for many commonly ordered tests and the possibility that third-party payers will increasingly adopt similar requirements;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(2) the policy of the Centers for Medicare and Medicaid Services to limit Medicare reimbursement for tests contained in automated chemistry panels to the amount that would have been
  paid if only the covered tests, determined on the basis of demonstrable &#147;medical necessity,&#148; had been ordered;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(3) continued inconsistent practices among the different local carriers administering Medicare;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(4) inability to obtain from patients an advance beneficiary notice form for tests that cannot be billed without prior receipt of the form;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(5) the potential need to monitor charges and lower certain fees to Medicare to comply with the Office of the Inspector General&#146;s proposed rule pertaining to exclusion of providers for
  submitting claims to Medicare containing charges that are substantially in excess of the provider&#146;s usual charges; and</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(6) increased challenges in operating as a non-contracted provider with respect to healthcare insurers.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(e) Adverse results from pending or future government investigations, lawsuits or private actions. These include, in particular, significant monetary damages, loss or suspension of licenses, and/or
  suspension or exclusion from the Medicare and Medicaid programs and/or criminal penalties.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-11</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(f) Failure to efficiently integrate acquired businesses and to manage the costs related to any such integration, or to retain key technical, medical and management personnel.</FONT></P>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(g) Inability to obtain professional liability or other insurance coverage or a material increase in premiums for such coverage or reserves for self-insurance.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(h) Denial of certification under the Clinical Laboratory Improvement Amendments of 1988, or CLIA, or denial of other licenses for any of our clinical laboratories under the CLIA standards,
  revocation or suspension of the right to bill the Medicare and Medicaid programs or other adverse regulatory actions by federal, state and local agencies.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(i) Changes in federal, state or local laws or regulations, including changes that result in new or increased federal or state regulation of commercial clinical laboratories, including regulation by
  the Food and Drug Administration.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(j) Inability to achieve expected benefits from our acquisitions of other businesses.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(k) Inability to achieve additional benefits from our Six Sigma and standardization initiatives.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(l) Adverse publicity and news coverage about the clinical laboratory industry or us.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(m) Computer or other IT system failures that affect our ability to perform tests, report test results or properly bill customers, including potential failures resulting from the standardization of our
  IT systems and other system conversions, telecommunications failures, malicious human acts (such as electronic break-ins or computer viruses) or natural disasters.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(n) Development of technologies that substantially alter the practice of laboratory medicine, including technology changes that lead to the development of more cost-effective tests such as (1)
  point-of-care tests that can be performed by physicians in their offices, (2) esoteric tests that can be performed by hospitals in their own laboratories or (3) home testing that can be carried out
  without requiring the services of clinical laboratories.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(o) Issuance of patents or other property rights to our competitors or others that could prevent, limit or interfere with our ability to develop, perform or sell our tests or operate our business.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(p) Development of tests by our competitors or others which we may not be able to license, or usage of our technology or similar technologies or our trade secrets by competitors, any of which
  could negatively affect our competitive position.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(q) Regulatory delay or inability to commercialize newly licensed tests or technologies or to obtain appropriate reimbursements for such tests.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(r) Inability to obtain or maintain adequate patent and other proprietary rights protections of our products and services or to successfully enforce our proprietary rights.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(s) Impact of any national healthcare information network and the adoption of standards for health information technology interoperability that are incompatible with existing software and
  hardware infrastructure requiring widespread replacement of systems and/or software.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(t) The impact of the privacy regulations, security regulations and standards for electronic transactions regulations issued under the Health Insurance Portability and Accountability Act of 1996
  and any applicable state laws or regulations.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(u) Inability to promptly or properly bill for our services or to obtain appropriate payments for services that we do bill.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(v) Changes in interest rates and changes in our credit ratings from Standard &amp; Poor&#146;s Rating Services and Moody&#146;s Investor Services causing an unfavorable impact on our cost of and access to
  capital.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(w) Inability to hire and retain qualified personnel or the loss of the services of one or more of our key senior management personnel.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(x) Terrorist and other criminal activities, hurricanes, earthquakes or other natural disasters, which could affect our customers, transportation or systems, or our facilities, and for which insurance
  may not adequately reimburse us.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-12</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=ratio1>RATIO OF EARNINGS TO FIXED CHARGES</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Set forth below is information concerning the historical ratio of earnings to fixed charges for Quest Diagnostics. This ratio shows the extent to which our business generates enough earnings after
  the payment of all expenses other than interest to make required interest payments on our debt.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">For this purpose, earnings consist of pretax income from continuing operations plus fixed charges. Fixed charges consist of interest expense and one-third of rental expense, representing that
  portion of rental expense we deemed representative of an appropriate interest factor.</FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:39.47%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:14.47%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Three Months<br>Ended March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="34" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Year Ended December 31,</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2007</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2005</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2003</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2002</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Ratio of earnings to fixed charges</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5.4x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9.9x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8.4x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      7.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>



<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-13</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=use1>USE OF PROCEEDS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We estimate that the net proceeds from this offering of notes after deducting underwriting discounts but before deducting other expenses of the offering will be approximately $788.3&nbsp;million. We
  intend to use these proceeds, together with cash on hand to repay all borrowings under the bridge loan facility incurred to pay a portion of the purchase price and transaction expenses of the
  AmeriPath acquisition and to refinance the debt of AmeriPath. The amount drawn on the bridge loan facility was $780 million. The interest rate on the bridge loan facility was 5.72% as of May&nbsp;31,
  2007. The facility matures on May 30, 2008. See &#147;Summary&#151;The AmeriPath Acquisition&#148; and &#147;Description of Certain Other Indebtedness&#151;Bridge Loan.&#148;</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-14</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=capitalization1>CAPITALIZATION</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following table sets forth our cash and cash equivalents, debt, and total capitalization at March 31, 2007 on an actual basis and as adjusted to reflect the following transactions, or the
  Transactions, as if they had occurred on that date:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      our purchase, on May 31, 2007, of AmeriPath, including the all-cash purchase price and related transaction costs associated with the AmeriPath acquisition;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a $1.0 billion bridge loan facility entered into to fund the acquisition of AmeriPath, of which $780 million was drawn after March 31, 2007, and will be refinanced with the proceeds of this
      offering;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a new five-year $1.6 billion term loan facility entered into to fund the acquisition of AmeriPath;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the repayment of AmeriPath&#146;s existing debt of approximately $780 million (including interest);</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the repayment of the interim credit agreement of $450 million borrowed in connection with the acquisition of POCT Holding AB, or HemoCue; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the completion of this $800 million offering of senior notes.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>



<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">This table should be read in conjunction with our consolidated financial statements and the related notes and the consolidated financial statements and related notes of AmeriPath, Inc.
  incorporated by reference into this prospectus supplement. This table does not reflect a new $750 million senior unsecured revolving credit facility, which replaced our prior $500 million senior
  unsecured revolving credit facility in May 2007. Nothing was outstanding under this revolving credit facility on March 31, 2007.</FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:74.96%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.87%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:9.91%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      March 31, 2007</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Actual</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      As Adjusted</B></FONT></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (in thousands)</FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Cash and cash equivalents</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       158,397</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       38,446</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:2.5mm; color:#000cb2; "><SUP>
      (a)</SUP></FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Debt (including current maturities):</FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Short-term borrowings under receivables financing</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       300,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       300,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">HemoCue interim credit agreement</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      450,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">AmeriPath interim credit agreement</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Term loan due 2008</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      60,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      60,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Term loan due 2012</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1,600,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">7.5% Senior notes due 2011</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      274,530</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      274,530</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">5.125% Senior notes due 2010</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      399,461</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      399,461</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">5.45% Senior notes due 2015</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      498,627</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      498,627</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">3<SUP style="font-size: 70%; vertical-align: baseline; position: relative; top: -0.5em; left: 0.1em;">1</SUP>/<SUB style="font-size: 70%; vertical-align: baseline; position: relative;">2</SUB>% Convertible notes due 2034</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,971</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,971</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Industrial revenue bonds due 2009</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5,378</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5,378</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Senior notes offered hereby (b)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      794,484</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 10.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Other</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      14,340</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      14,408</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 24.6mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Total debt</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      2,005,307</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      3,949,859</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Stockholders&#146; equity</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      3,029,232</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      3,029,232</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Total capitalization</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       5,034,539</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       6,979,091</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
  </TR>
</TABLE>



<P style="text-indent:7mm; margin:4mm 0 0.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="left" style="width:4.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 -8.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&nbsp;</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (a)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Cash and cash equivalents as adjusted include the assumption of AmeriPath&#146;s cash balances of $26.6 million as of March 31, 2007, (adjusted to exclude $74 million of cash and cash equivalents
      used to repay amounts outstanding under AmeriPath, Inc.&#146;s revolving credit facility subsequent to March 31, 2007). Cash and cash equivalents also exclude restricted cash of approximately $30
      million.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Consists of $375 million 6.40% senior notes due 2017 and $425 million 6.95% senior notes due 2037.</FONT></P>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>



<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-15</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=description1>DESCRIPTION OF CERTAIN OTHER INDEBTEDNESS</a></B></FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Letter of Credit Lines</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We have two lines of credit with two financial institutions totaling $85 million for the issuance of letters of credit. The letter of credit lines mature in December 2007, are guaranteed by the
  subsidiary guarantors and are expected to be renewed. As of March 31, 2007, there were $62.3 million of outstanding letters of credit under the letter of credit lines. In addition, at March 31, 2007,
  AmeriPath had $12.1 million of outstanding letters of credit.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Secured Receivables Credit Facility</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In May 2007, Quest Diagnostics Receivables Inc., a wholly owned subsidiary of ours, increased its existing receivables securitization facility from $300 million to $375 million. The facility matures
  on May 23, 2008. The secured receivables credit facility is supported by one-year back-up facilities provided by two banks on a committed basis. Interest on the secured receivables credit facility is
  based on rates that are intended to approximate commercial paper rates for highly rated issuers. Borrowings outstanding under the secured receivables credit facility, if any, are classified as a current
  liability on our consolidated balance sheet. The borrower under the secured receivables credit facility is not a guarantor of the notes offered hereby.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Term Loans and Revolving Credit Facility</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In December 2003, we entered into a $75 million amortizing term loan due December 2008. Interest is based on LIBOR plus an applicable margin that can fluctuate over a range of up to 119
  basis points, based on changes in our public debt ratings. Currently, our borrowing rate for LIBOR-based loans is LIBOR plus 0.50%. The term loan due December 2008 requires principal
  repayments of the initial amount borrowed equal to 20% on each of the third and fourth anniversary dates of the funding and the remainder of the outstanding balance on December 31, 2008. As of
  May 31, 2007, the interest rate was 5.82%. The term loan due December 2008 is guaranteed by the Subsidiary Guarantors and the Specified Subsidiaries (as such terms are defined in the &#147;Description
  of Notes&#148;).</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In May 2007, we entered into a $1.6 billion term loan facility and a $750 million senior unsecured revolving credit facility which matures in May 2012. The term loan requires principal
  repayments of 1.25% of the amount borrowed on the last day of each calendar quarter starting on September 30, 2007, with the quarterly payments increasing on September 30, 2009 to 2.5% of the
  amount borrowed and on September 30, 2011 to 17.5% of the amount borrowed, with the remainder of the outstanding balance due on May 31, 2012. Interest under each facility is based on certain
  published rates plus an applicable margin that will vary over a range from 40 basis points to 125 basis points based on changes in our public debt ratings. At our option, we may elect to enter into
  LIBOR-based interest rate contracts for periods up to six months. Interest on any outstanding amounts not covered under the LIBOR-based interest rate contracts is based on an alternate base rate,
  which is calculated by reference to the prime rate or federal funds rate. As of May 31, 2007, the interest rate was 5.72%. The term loan and the senior unsecured revolving credit facility are
  guaranteed by the Subsidiary Guarantors and the Specified Subsidiaries (as such terms are defined in the &#147;Description of Notes&#148;).</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Bridge Loan</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In May 2007, we entered into a $1 billion bridge loan facility, of which $780 million was drawn to fund the acquisition of AmeriPath. We intend to use the proceeds from this offering to repay
  all borrowings under the bridge loan facility. The loan under the bridge credit agreement is due on May 30, 2008. Interest is based on certain published rates plus an applicable margin that will vary
  over a range from 40 basis points to 125 basis points based on changes in our public debt ratings. At our option, we may elect to enter into LIBOR-based interest rate contracts for periods up to six
  months. Interest on any outstanding amounts not covered under the LIBOR-based interest rate </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-16</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">contracts is based on an alternate base rate, which is calculated by reference to the prime rate or federal funds rate. As of May 31, 2007, the interest rate was 5.72%.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Senior Notes</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We completed a $550 million senior notes offering in June 2001, of which a tranche of $275 million matured in July 2006. The other tranche of $275 million aggregate principal amount of 7.5%
  senior notes due 2011 was issued at a discount of approximately $1.1 million. After considering the discount, the effective interest rate on the senior notes due 2011 is 7.6%. The senior notes require
  semiannual interest payments which commenced January 12, 2002.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We completed a $900 million senior notes offering in October 2005. The notes were issued in two tranches: (a) $400 million aggregate principal amount of 5.125% senior notes due November 1,
  2010 issued at a discount of approximately $0.8 million and (b) $500 million aggregate principal amount of 5.45% senior notes due November 1, 2015, issued at a discount of approximately $1.6
  million. After considering the discounts, the effective interest rates on the senior notes due 2010 and the senior notes due 2015 are approximately 5.3% and 5.6%, respectively. The senior notes
  require semiannual interest payments, which commenced on May 1, 2006. The senior notes are unsecured obligations of ours and rank equally with our other unsecured senior obligations. The senior
  notes are guaranteed by the Subsidiary Guarantors and the Specified Subsidiaries (as such terms are defined in the &#147;Description of Notes&#148;). Each guarantee is a senior unsecured obligation of the
  subsidiary guarantor issuing such guarantee and ranks equally with other existing and future senior unsecured obligations of such subsidiary guarantor. The covenants and events of default under the
  senior notes are substantially the same as the senior notes offered hereby except that such indebtedness does not contain a change of control redemption right for the holders and the senior notes
  offered hereby contain a limitation on restricted payments to certain non-guarantor subsidiaries and permit these subsidiaries to guarantee certain debt.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-17</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=selected1>SELECTED HISTORICAL FINANCIAL DATA FOR QUEST DIAGNOSTICS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following table summarizes our selected historical financial data of our company and our subsidiaries at the dates and for each of the periods presented. We derived the selected historical
  financial data for the years 2002 through 2006 from our audited consolidated financial statements. We derived the selected historical financial data for the three months ended March 31, 2007 and
  2006 from our unaudited interim consolidated financial statements. The unaudited interim consolidated financial statements reflect all adjustments which, in our opinion, are necessary for a fair
  statement of the financial condition and results of operations as of and for the periods presented. The unaudited interim consolidated financial statements have been compiled without audit and are
  subject to year-end adjustments. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year. In September 2004, the Emerging Issues Task
  Force reached a final consensus on Issue 04-8, &#147;The Effect of Contingently Convertible Instruments on Diluted Earnings per Share,&#148; or Issue 04-8, effective December 31, 2004. Pursuant to Issue 04-
  8, we included the dilutive effect of our 1<SUP style="font-size: 70%; vertical-align: baseline; position: relative; top: -0.5em; left: 0.1em;">3</SUP>/<SUB style="font-size: 70%; vertical-align: baseline; position: relative;">4</SUB>% contingent convertible debentures issued November 26, 2001 in our dilutive earnings per common share calculations using the if-converted method,
  regardless of whether or not the holders of these securities were permitted to exercise their conversion rights, and retroactively restated previously reported diluted earnings per common share.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Effective January 1, 2006, we adopted SFAS 123R using the modified prospective approach and therefore we have not restated results for prior periods. Under this approach, equity awards that
  are granted, modified or settled after January 1, 2006 will be measured and accounted for in accordance with SFAS 123R. Unvested awards that were granted prior to January 1, 2006 will continue to
  be accounted for in accordance SFAS No. 123, &#147;Accounting for Stock-Based Compensation,&#148; as amended by SFAS No. 148, &#147;Accounting for Stock-Based Compensation-Transition and Disclosure&#151;an
  amendment to SFAS No. 123,&#148; except that compensation cost will be recognized in our results of operations. During the third quarter of 2006, we completed our wind down of NID, a test kit
  manufacturing subsidiary, and classified the operations of NID as discontinued operations. The selected historical financial data presented below has been restated to report the results of NID as
  discontinued operations for all periods presented.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The selected historical financial data is only a summary and should be read together with our audited consolidated financial statements and related notes and management&#146;s discussion and
  analysis of financial condition and results of operations included in our quarterly reports on Form 10-Q for the three months ended March 31, 2007 and 2006 and our Annual Report on Form 10-K
  for the year ended December 31, 2006, incorporated by reference in this prospectus supplement.</FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:21.71%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      Three Months Ended<br>March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="34" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      Year Ended December 31,</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2007(a)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2006 (b)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2005 (g)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2003 (h)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2002 (i)</B></FONT></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="48" align="center"><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      (in thousands, except for per share data)</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>Operations Data:</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net revenues</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1,526,208</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1,553,105</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       6,268,659</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       5,456,726</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       5,066,986</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       4,686,030</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       4,065,426</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Operating income</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      200,870</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      258,718</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (e)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,128,077</FONT></P></TD>
    <TD nowrap><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (c),(e)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,007,548</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (j)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      880,854</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (k)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      784,691</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      584,316</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Income from continuing operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      107,515</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      154,603</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (d)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      625,692</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (d)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      573,196</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (l)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      492,415</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (m)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      429,173</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      317,445</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">(Loss)/income from discontinued operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (1,622</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (9,967</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (39,271</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )(f)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (26,919</FONT></P></TD>
    <TD nowrap><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )(f)</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      6,780</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      7,544</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      4,708</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net income</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      105,893</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      144,636</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      586,421</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      546,277</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      499,195</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      436,717</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      322,154</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Earnings per common share&#151;basic: (n)</FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Income from continuing operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.56</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.78</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       3.18</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.84</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.42</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.07</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1.65</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">(Loss)/income from discontinued operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.01</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.05</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.20</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.13</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      0.03</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      0.04</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      0.02</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net income</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.55</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.73</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.98</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.71</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.45</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.11</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1.67</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>



<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-18</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:21.03%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.57%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.90%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      Three Months Ended<br>March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="34" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      Year Ended December 31,</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2007(a)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2006 (b)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2005 (g)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2003 (h)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      2002 (i)</B></FONT></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="48" align="center"><P><FONT style="font-family:serif; font-size:2.8mm; color:#000cb2; "><B>
      (in thousands, except for per share data)</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Earnings per common share&#151;diluted: (n) (o)</FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Income from continuing operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.55</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.77</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       3.14</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.79</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.32</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1.99</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1.57</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">(Loss)/income from discontinued<br>operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.01</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.05</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.20</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (0.13</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      0.03</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      0.03</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      0.02</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net income</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.54</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.72</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.94</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.66</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.35</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       2.02</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1.59</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Dividends per common share (n)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.10</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.10</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.40</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.36</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.30</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       0.075</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>Balance Sheet Data (at end of period):</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Cash and cash equivalents</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       158,397</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       156,461</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       149,640</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       92,130</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       73,302</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       154,958</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       96,777</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Accounts receivable, net</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      810,576</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      775,724</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      774,414</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      732,907</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      649,281</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      609,187</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      522,131</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Goodwill, net</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,724,768</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,199,238</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,391,046</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,197,227</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,506,950</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,518,875</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,788,850</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Total assets</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      6,186,542</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      5,434,568</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      5,661,482</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      5,306,115</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      4,203,788</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      4,301,418</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,324,197</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Long-term debt</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,238,265</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,240,501</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,239,105</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,255,386</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      724,021</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,028,707</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      796,507</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Total debt</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,005,306</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,532,390</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,555,979</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,592,225</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,098,822</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,102,657</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      822,539</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Total stockholders&#146; equity</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,029,232</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,865,296</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,019,171</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,762,984</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,288,651</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,394,694</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,768,863</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>Other Data:</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net cash provided by operating activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       151,553</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       240,659</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       951,896</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       851,583</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       798,780</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       662,799</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       596,371</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net cash used in investing activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (345,947</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (27,991</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (414,402</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (1,079,793</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (173,700</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (417,050</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (477,212</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net cash (used in) provided by financing activities</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (203,151</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (148,337</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (479,984</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      247,038</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (706,736</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (187,568</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (144,714</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Provision for doubtful accounts</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      67,508</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      63,423</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      243,443</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      233,628</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      226,310</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      228,222</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      217,360</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Rent expense</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      40,183</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      38,722</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      153,185</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      139,660</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      132,883</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      120,748</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      96,547</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Capital expenditures</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      40,126</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      42,186</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      193,422</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      224,270</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      176,125</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      174,641</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      155,196</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Depreciation and amortization</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      50,335</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      49,060</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      197,398</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      176,124</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      168,726</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      153,903</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      131,391</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>


<P style="text-indent:7mm; margin:4mm 0 0.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="left" style="width:4.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 -8.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&nbsp;</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (a)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      On January 31, 2007, we completed the acquisition of HemoCue, which generated annualized revenues of approximately $90 million. Consolidated operating results for 2007 include the results of
      operations of HemoCue subsequent to the closing of the acquisition.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On July 3, 2006, we completed the acquisition of Focus Diagnostics, which generated annualized revenues of approximately $65 million. Consolidated operating results for 2006 include the results
      of operations of Focus Diagnostics subsequent to the closing of the acquisition. See Note&nbsp;3 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year
      ended December 31, 2006, which is incorporated by reference into this prospectus supplement.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(c)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $55 million of stock-based compensation expense in accordance with SFAS 123R.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(d)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $10 million related to net investment losses. The net investment losses of $10 million include a $15.8 million gain on the sale of an investment recorded during the first
      quarter of 2006.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(e)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $23 million in charges as a result of finalizing our plan of integration of LabOne, and $4.1 million in charges related to consolidating operations in California into a
      new facility.</FONT></P>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>
</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-19</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">

  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(f)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we recorded $32 million in charges as a result of discontinuing NID&#146;s operations. During the fourth quarter of 2005, we recorded a $16 million charge to write-off certain assets in
      connection with a product hold at NID.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(g)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On November 1, 2005, we completed the acquisition of LabOne, which had annual revenues of approximately $468 million<I>. </I>Consolidated operating results for 2005 include the results of
      operations of LabOne subsequent to the closing of the acquisition. See Note 3 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended
      December 31, 2006, which is incorporated by reference into this prospectus supplement.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(h)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On February 28, 2003, we completed the acquisition of Unilab Corporation, or Unilab. Consolidated operating results for 2003 include the results of operations of Unilab subsequent to the
      closing of the acquisition.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(i)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On April 1, 2002, we completed the acquisition of American Medical Laboratories, Incorporated, or AML. Consolidated operating results for 2002 include the results of operations of AML
      subsequent to the closing of the acquisition.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(j)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2005, we recorded a $6.2 million charge primarily related to forgiveness of amounts owed by patients and physicians, and related property damage as a result of hurricanes in the Gulf
      Coast.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(k)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2004, we recorded a $10.3 million charge associated with the acceleration of certain pension obligations in connection with the succession of our prior Chief Executive Officer.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(l)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2005, we recorded a $7.1 million charge associated with the write-down of an investment.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(m)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2004, we recorded a $2.9 million charge to interest expense, net representing the write-off of deferred financing costs associated with the refinancing of our bank debt and credit facility.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(n)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Previously reported basic and diluted earnings per share have been restated to give retroactive effect of our two-for-one stock split effected on June 20, 2005.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:22pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(o)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Potentially dilutive common shares primarily include the dilutive effect of our 1<SUP style="font-size: 70%; vertical-align: baseline; position: relative; top: -0.5em; left: 0.1em;">3</SUP>/<SUB style="font-size: 70%; vertical-align: baseline; position: relative;">4</SUB>% contingent convertible debentures issued November 26, 2001, which were redeemed principally through a
      conversion into common shares as of January 18, 2005, and outstanding stock options, performance share units and restricted common shares granted under our Amended and Restated Employee
      Long-Term Incentive Plan and our Amended and Restated Director Long-Term Incentive Plan.</FONT></P>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>

<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-20</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=selected2>SELECTED HISTORICAL FINANCIAL DATA FOR AMERIPATH, INC.</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following table summarizes selected historical financial data for AmeriPath, Inc. at the dates and for each of the periods presented. AmeriPath, Inc. derived the selected historical financial
  data for the years 2002 through 2006 from its audited financial statements. AmeriPath, Inc. derived the selected historical financial data for the three months ended March 31, 2007 and 2006 from its
  unaudited interim consolidated financial statements. On December 8, 2002, Amy Holding Company and its wholly-owned subsidiary, Amy Acquisition Corp., entered into a merger agreement with the
  predecessor of AmeriPath, Inc., pursuant to which Amy Acquisition Corp. merged with and into the predecessor, with AmeriPath, Inc. continuing as the surviving corporation (the &#147;March 2003
  Transaction&#148;). As a result of the March 2003 Transaction, AmeriPath, Inc. became a wholly-owned subsidiary of Amy Holding Company, which was renamed AmeriPath Holdings, Inc., or Holdings.
  Amy Holding Company and Amy Acquisition Corp. were Delaware corporations formed at the direction of Welsh, Carson, Anderson &amp; Stowe IX, L.P., or WCAS. The March 2003 Transaction was
  approved by AmeriPath, Inc.&#146;s stockholders and subsequently consummated on March 27, 2003. References herein to the &#147;predecessor&#148; refer to the activities, financial position and results of
  operations of AmeriPath, Inc. prior to the March 2003 Transaction. AmeriPath, Inc.&#146;s consolidated financial statements for the years ended December 31, 2006, 2005, and 2004, for the period from
  March 28, 2003 through December 31, 2003, for the period from January 1, 2003 through March 27, 2003, and for the year ended December 31, 2002 have been audited by Ernst &amp; Young LLP,
  AmeriPath, Inc.&#146;s independent auditors.</FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>STATEMENTS OF OPERATIONS</B></FONT><FONT style="font-family:serif; font-size:2.5mm; color:#000cb2; "><SUP><B>(a)</B></SUP></FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:31.76%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:6.58%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:6.58%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.15%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.15%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.15%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.15%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.15%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.15%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="41" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Successor (b)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Predecessor (b)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Three Months Ended<br>March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Year Ended<br>December 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Year Ended<br>December 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Year Ended<br>December 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Period from<br>March 28<br>through<br>December 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Period from<br>January 1<br>through<br>March 27,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      Year Ended<br>December 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2007</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2006(j)</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2005</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2003</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2003</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      2002</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD align="center"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="55" align="center"><P><FONT style="font-family:serif; font-size:2.4mm; color:#000cb2; "><B>
      (dollars in thousands)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net revenues</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       200,694</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       170,936</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       752,321</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       563,617</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       507,271</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       366,046</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       118,957</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       478,818</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Operating costs and expenses:</FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD colspan="6"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Cost of services</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      117,005</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      96,926</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      418,082</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      298,932</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      270,959</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      189,771</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      62,145</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      238,573</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Selling, general and administrative expenses</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      46,635</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      35,751</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      154,235</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      110,520</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      95,688</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      65,579</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      21,726</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      84,868</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Provision for doubtful accounts</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      19,358</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      19,840</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      84,936</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      73,766</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      76,463</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      56,376</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      14,997</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      58,170</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Amortization expense </FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(c) (k)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,515</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,264</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      13,127</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      13,585</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      13,761</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      10,379</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,107</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      11,641</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Merger-related charges </FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(d)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      109</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      586</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,064</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,404</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      10,010</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,836</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Restructuring costs </FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(e)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,044</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,196</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Asset impairment and related charges&nbsp;</FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(f)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      883</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      611</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      425</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,753</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 5.6mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Total operating costs and expenses</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      185,622</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      156,367</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      672,444</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      497,686</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      457,482</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      326,978</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      113,181</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      398,841</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Income from operations</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      15,072</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      14,569</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      79,877</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      65,931</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      49,789</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      39,068</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      5,776</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      79,977</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Interest expense </FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(k)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (15,043</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (13,693</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (57,432</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (46,527</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (42,136</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (32,442</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (1,180</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (3,764</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Change in value of derivative </FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(g)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      293</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,295</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (280</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (1,015</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Write-off of Genomics investment </FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(h)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (1,000</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Write-off of deferred financing costs </FONT><FONT style="font-family:serif; font-size:2.1mm; color:#000cb2; "><SUP>(i)</SUP></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (3,360</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (3,388</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (468</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (3,829</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (957</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Other income, net</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      393</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      338</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,516</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      620</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      66</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      318</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      33</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      548</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Income (loss) before income taxes</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      422</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      (1,853</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      21,868</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      19,276</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,875</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      6,944</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,672</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      75,761</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Provision for income taxes</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      203</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      237</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      11,341</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      9,355</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      1,361</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      3,090</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      2,131</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      31,120</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">Net income (loss)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       219</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       (2,090</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       )</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       10,527</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       9,921</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1,514</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       3,854</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       1,541</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; ">
       44,641</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-2.8mm; margin:0 0 0 2.8mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD colspan="6" style="border-top:double #000cb2; "><P><font style="font-size:0.2mm;">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-21</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>CONSOLIDATED BALANCE SHEET DATA</B></FONT><FONT style="font-family:serif; font-size:2.5mm; color:#000cb2; "><SUP><B>(a)</B></SUP></FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:22.07%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.88%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.88%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:8.88%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.40%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.40%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.40%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.40%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="34" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      December 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2007</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2005</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2003</B></FONT></P></TD>
    <TD width="3" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2002</B></FONT></P></TD>
    <TD width="3"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD align="center"><P><font style="font-size:0.2mm">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="48" align="center"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      (dollars in thousands)</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">Cash and cash equivalents</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      &#151;</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
       8,648</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
       182</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
       3,998</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
       20,980</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
       23,536</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
       964</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">Restricted cash</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      29,601</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      26,829</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      30,906</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      26,684</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      17,940</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      12,825</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      8,453</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">Total assets</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      1,437,234</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      1,340,786</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      1,411,101</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      984,149</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      964,309</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      912,753</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      708,460</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">Long-term debt, including current portion</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      625,534</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      610,826</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      624,259</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      479,490</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      497,853</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      492,458</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      116,253</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.2mm; margin:0 0 0 3.2mm; "><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">Stockholders&#146; equity</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      629,932</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      565,563</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      606,340</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      384,717</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      358,092</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      338,675</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.5mm; color:#000cb2; ">
      451,326</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
  </TR>
</TABLE>


<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (a)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      This presentation is for AmeriPath, Inc. We acquired AmeriPath Group Holdings, Inc., the ultimate parent of AmeriPath, Inc., whose principal assets consisted of cash (which was used to repay
      debt) and its indirect investment in AmeriPath, Inc., and whose principal liabilities consisted of debt, which was repaid in connection with the acquisition of AmeriPath Group Holdings, Inc. As
      of the date hereof, AmeriPath Group Holdings, Inc. has no significant assets other than its indirect investment in AmeriPath, Inc.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Consolidated financial data for periods subsequent to March 27, 2003 reflect the fair value of assets acquired and liabilities assumed in connection with the March 2003 Transaction. The
      comparability of the operating results for the periods presented is affected by the revaluation of the assets acquired and liabilities assumed on the date of the March 2003 Transaction. The
      financial data for the periods prior to March 28, 2003 consist of the historical data of AmeriPath, Inc. and subsidiaries prior to the March 2003 Transaction.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(c)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The predecessor adopted the provisions of SFAS No. 142 as of January 1, 2002. SFAS 142 clarifies the criteria to recognize intangible assets separately from goodwill and promulgates that
      goodwill and certain indefinite-lived intangible assets not be amortized.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(d)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In connection with the March 2003 Transaction, AmeriPath, Inc. recorded $2.8 million of transaction fees in the fourth quarter of 2002 and $12.4 million during 2003. In 2006, AmeriPath, Inc.
      recorded $2.1 million of transaction fees related to the Specialty acquisition.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(e)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Represents restructuring costs that were recognized based upon criteria set forth in SFAS 146 of (i) $1.2 million for employee severance costs in connection with a reduction in workforce at
      AmeriPath, Inc.&#146;s Southern California, Philadelphia, Central Florida and North Texas laboratories, and (ii) $2.0 million incurred for remaining severance costs and the closure of AmeriPath, Inc.&#146;s
      Southern California laboratory. The Southern California facility was closed as a result of a loss of revenue from Quest Diagnostics, which historically accounted for a significant portion of
      revenues for this individual lab.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(f)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2002, AmeriPath, Inc. recorded charges consisting of approximately $2.1 million in connection with the write-off of its remaining Quest Diagnostics laboratory contract intangibles and
      approximately $0.7 million in connection with its termination of a management service agreement in Georgia. During 2003, AmeriPath, Inc. recorded a pre-tax, non-cash charge of approximately
      $0.4 million in connection with the sale of two hospital-based practices in Florida. During 2004, AmeriPath, Inc. recorded a pre-tax, non-cash charge of approximately $0.6 million in connection
      with the sale of a practice in Michigan. In August 2005, AmeriPath, Inc. sold its managed practice in Memphis, Tennessee. As a result of the sale, AmeriPath, Inc. recognized a loss of
      approximately $1.3 million. As a result of the sale and termination of the Memphis managed service agreement, AmeriPath, Inc. performed an impairment analysis relative to the carrying value of
      this identifiable intangible and determined that no impairment existed at September 30, 2005. In February 2005, AmeriPath, Inc. sold a managed practice in Los Gatos, California resulting in a
      gain of approximately $0.4 million.</FONT></P>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>
</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-22</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">

  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(g)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2004, AmeriPath, Inc. entered into a swap agreement, and recorded its change in market value as of December 31, 2004, 2005, and 2006, respectively. On October 2, 2006, AmeriPath, Inc.
      terminated the agreement.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(h)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2002, AmeriPath, Inc. wrote off the $1.0 million carrying value of its interest in a genomics company as a result of a decline in the fair value of this investment.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(i)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Consists of write-offs of deferred financing costs relating to the March 2003 Transaction, and two voluntary paydowns on AmeriPath, Inc.&#146;s current credit facility in both 2004 and 2005. In January
      2006, in connection with the acquisition of Specialty, AmeriPath, Inc. terminated its existing credit facility and entered into a new senior credit facility. As a result of terminating the credit
      facility, AmeriPath, Inc. wrote-off approximately $3.4 million of its deferred debt financing costs.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(j)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The statement of income for 2006 includes the results of Specialty from the effective date of the acquisition by AmeriPath, Inc., which was January 31, 2006. Net revenues from Specialty for the
      year ended December 31, 2006 were $148.1 million.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:19pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(k)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">For the three months ended March 31, 2007 and 2006, amortization of deferred debt costs of $0.7 million and $0.6 million, respectively, are included in interest expense versus amortization
      expense as it is presented in the annual information.</FONT></P>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>

<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-23</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=description2>DESCRIPTION OF NOTES</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Each of the 6.40% senior notes due 2017 (the &#147;Notes due 2017&#148;) and the 6.95% senior notes due 2037 (the &#147;Notes due 2037&#148; and, together with the Notes due 2017, the &#147;Notes&#148;) are a separate
  issue of debt securities. The notes will be issued under an indenture dated as of June 27, 2001 as supplemented by a supplemental indenture, dated as of June 27, 2001, each among Quest Diagnostics,
  as issuer, the Initial Subsidiary Guarantors, as guarantors, and The Bank of New York, as trustee, as further supplemented by a second supplemental indenture, dated as of November 26, 2001, among
  Quest Diagnostics, the Subsidiary Guarantors and The Bank of New York, as further supplemented by a third supplemental indenture, dated as of April 4, 2002, among Quest Diagnostics, the
  additional Subsidiary Guarantors and The Bank of New York, as further supplemented by a fourth supplemental indenture, dated as of March 19, 2003, among Quest Diagnostics, the additional
  Subsidiary Guarantors and The Bank of New York, as further supplemented by a supplemental indenture, dated as of April 16, 2004, among Quest Diagnostics, the additional Subsidiary Guarantor
  and The Bank of New York, as further supplemented by a sixth supplemental indenture dated October 31, 2005, as further supplemented by a seventh supplemental indenture dated November 21,
  2005, among Quest Diagnostics, the additional Subsidiary Guarantors and The Bank of New York, as further supplemented by an eighth supplemental indenture dated July 31, 2006, among Quest
  Diagnostics, the additional Subsidiary Guarantors and The Bank of New York and as further supplemented by the ninth supplemental indenture dated September 30, 2006, among Quest Diagnostics,
  the additional Subsidiary Guarantors and The Bank of New York and as to be amended by a tenth supplemental indenture to be dated as of the closing date of this offering (collectively, the
  &#147;Indenture&#148;). On June 7, 2001, we completed a $550 million senior notes offering under the Indenture and on October 31, 2005, we completed a $900 million senior notes offering under the
  Indenture. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939. A copy of the Indenture is available
  for inspection at the office of the trustee.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Whenever we refer in this &#147;Description of Notes&#148; to terms defined in the Indenture below, such defined terms are incorporated herein by reference. As used in this &#147;Description of Notes,&#148; the
  terms &#147;we,&#148; &#147;our,&#148; &#147;us&#148; and &#147;Quest Diagnostics&#148; do not include any current or future subsidiary of Quest Diagnostics Incorporated, unless the context indicates otherwise.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>General</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes due 2017 will be initially limited to $375,000,000 aggregate principal amount and will mature and become due and payable, together with any accrued and unpaid interest thereon, on
  July 1, 2017. The Notes due 2037 will be initially limited to $425,000,000 aggregate principal amount and will mature and become due and payable, together with any accrued and unpaid interest
  thereon, on July 1, 2037.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics may from time to time, without the consent of the holders of the Notes, issue additional Notes of either series having the same ranking and the same interest rate, maturity
  and other terms as the Notes of the applicable series. Any additional Notes and the Notes of such series will generally constitute a single series under the Indenture. This type of offering is often
  referred to as a &#147;re-opening.&#148; Additional Notes may constitute a separate issuance for United States federal income tax purposes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Notes of either series will bear interest at the annual rate noted on the cover page of this prospectus supplement. Interest will be payable semiannually on July 1 and January 1 of each year,
  beginning January 1, 2008. Interest on the Notes will be paid to holders of record on the June 15 or December 15 immediately before the applicable interest payment date.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes do not provide for any sinking fund.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Guarantees</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Each Subsidiary Guarantor will fully and unconditionally guarantee, on a joint and several basis, the payment of the principal of, and any premium and interest on the Notes. The guarantees of
  the </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-24</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Notes will be endorsed on the Notes. In addition, each future domestic Subsidiary of Quest Diagnostics, or any Subsidiary Guarantor which has been released and discharged from its obligations
  under the guarantee of the Notes, will be required to guarantee Quest Diagnostics&#146; obligations under the Notes, if such Subsidiary:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      guarantees any Indebtedness of Quest Diagnostics when the amount of such Indebtedness, together with any other outstanding Indebtedness of Quest Diagnostics guaranteed by its Subsidiaries
      that are not Subsidiary Guarantors, exceeds $50 million in the aggregate at any time; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">incurs Indebtedness, unless such Indebtedness is permitted under the &#147;&#151;Limitation on Subsidiary Indebtedness and Preferred Stock&#148; covenant described below;</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>provided, however, </I>for the avoidance of doubt, the Specified Subsidiaries are not subject to the foregoing until such time, if any, the Specified Subsidiaries become Subsidiary Guarantors.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Specified Subsidiaries are not guaranteeing the Notes, but will guarantee the term loans, the senior unsecured revolving credit facility and the existing senior notes of Quest Diagnostics.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Indenture provides that the obligations of each Subsidiary Guarantor under its guarantee will be limited so as to not constitute a fraudulent conveyance under any United States federal or
  state laws. Application of this clause could limit the amount which holders of Notes may be entitled to collect under the guarantees. Holders, by their acceptance of the Notes, will have agreed to
  such limitations. See &#147;Risk Factors&#151;Federal and state laws permit a court to void a guarantee issued by any of our subsidiaries if the court finds the guarantee to constitute a fraudulent conveyance.&#148;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The guarantees of the Subsidiary Guarantors with respect to the Notes will remain in effect with respect to each Subsidiary Guarantor until the entire amount of principal of, premium, and
  interest on the Notes shall have been paid in full or otherwise discharged in accordance with the provisions of the Indenture; <I>provided</I>, <I>however</I>, that if (a) a Subsidiary Guarantor does not guarantee
  Indebtedness of Quest Diagnostics the amount of which, when added together with any other outstanding Indebtedness of Quest Diagnostics guaranteed by its Subsidiaries that are not Subsidiary
  Guarantors, would exceed $50 million in the aggregate, excluding the Notes, and all outstanding Indebtedness of such Subsidiary Guarantor would have been permitted to be incurred under the
  &#147;&#151;Limitation on Subsidiary Indebtedness and Preferred Stock&#148; covenant described below measured at the time of the release and discharge as described in this paragraph, (b) the Notes are defeased
  and discharged as described under &#147;Defeasance&#148; or (c) all or substantially all of the assets of such Subsidiary Guarantor or all of the capital stock of such Subsidiary Guarantor is sold (including by
  issuance, merger, consolidation or otherwise) by Quest Diagnostics or any of its Subsidiaries, then in each case of (a), (b) or (c) above, such Subsidiary Guarantor or the corporation acquiring such
  assets (in the event of a sale or other disposition of all or substantially all of the assets or capital stock of such Subsidiary Guarantor) shall be released and discharged from its obligations under its
  guarantee of the Notes.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Seniority; Ranking</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes will be senior unsecured obligations of Quest Diagnostics and will rank equally with other existing and future senior unsecured obligations of Quest Diagnostics. Each guarantee will be
  a senior unsecured obligation of the Subsidiary Guarantor issuing such guarantee and will rank equally with other existing and future senior unsecured obligations of such Subsidiary Guarantor. As of
  March 31, 2007, after giving effect to the Transactions, Quest Diagnostics and the Subsidiary Guarantors would have had total debt outstanding of $3.64 billion.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes and the guarantees will be effectively subordinated to any secured obligations of Quest Diagnostics or Subsidiary Guarantors, as the case may be, to the extent of the value of the
  assets securing such obligations. The Indenture does not limit the amount of indebtedness that Quest Diagnostics and any of its subsidiary guarantors can incur, but does limit the amount of
  indebtedness its non-guarantor subsidiaries are permitted to incur (as described below). In addition, the Indenture limits the amount of secured indebtedness pursuant to the covenant described under
  the heading &#147;Description of Notes&#151;Limitation on Liens.&#148; This covenant is subject to important exceptions </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-25</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">described under such heading. As of March 31, 2007, after giving effect to the Transactions, Quest Diagnostics and the Subsidiary Guarantors would have had secured debt outstanding of $5.5 million.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics conducts its operations through subsidiaries, which generate a substantial portion of its operating income and cash. As a result, distributions or advances from subsidiaries of
  Quest Diagnostics are a major source of funds necessary to meet its debt service and other obligations. Contractual provisions, laws or regulations, as well as any subsidiary&#146;s financial condition and
  operating requirements, may limit the ability of Quest Diagnostics to obtain cash required to pay Quest Diagnostics&#146; debt service obligations, including payments on the Notes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes will be structurally subordinated to all existing and future obligations of Quest Diagnostics&#146; subsidiaries (unless such subsidiaries are Subsidiary Guarantors), including claims with
  respect to trade payables. In addition, the guarantees of our Subsidiary Guarantors will be structurally subordinated to all existing and future obligations of any subsidiary of ours or a Subsidiary
  Guarantor (unless such subsidiaries are also Subsidiary Guarantors), including claims with respect to trade payables. This means that holders of the Notes as guaranteed by the Subsidiary Guarantors
  will have a junior position to the claims of creditors of the direct and indirect subsidiaries of Quest Diagnostics which are not Subsidiary Guarantors on the assets and earnings of such subsidiaries.
  The non-guarantor subsidiaries of Quest Diagnostics are limited in the amount of Indebtedness they are permitted to incur pursuant to the covenant described under &#147;&#151;Limitation of Subsidiary
  Indebtedness and Preferred Stock.&#148; This covenant is subject to important exceptions described under such heading. In addition, the guarantees of the Subsidiary Guarantors may be released in certain
  circumstances, which are described under the heading &#147;&#151;Guarantees.&#148; As of March 31, 2007, after giving effect to the Transactions, the non-guarantor subsidiaries of Quest Diagnostics would have had
  outstanding $314 million of debt (including the current portion thereof) of which $300 million was comprised of the Existing Receivables Credit Facility. In addition, after giving effect to the
  Transactions, the Specified Subsidiaries will not be required to guarantee the notes offered hereby but will guarantee the term loans and the senior notes of Quest Diagnostics ($2.83 billion
  collectively as of March 31, 2007) after giving effect to the Transactions. For a more detailed description of our Existing Receivables Credit Facility, see &#147;Description of Certain Other
  Indebtedness&#151;Secured Receivables Credit Facility.&#148;</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Optional Redemption</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">At any time and from time to time, the Notes of each series will be redeemable, as a whole or in part, at the option of Quest Diagnostics, on at least 30 days, but not more than 60 days, prior
  notice mailed to the registered address of each holder of the Notes of the applicable series, at a redemption price equal to the greater of:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      100% of principal amount of the Notes to be redeemed, and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the sum of the present values of the Remaining Scheduled Payments (as defined below) discounted, on a semiannual basis, assuming a 360-day year consisting of twelve 30-day months, at the
      Treasury Rate (as defined below) plus:</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">25 basis points for the 6.40% Notes due 2017, or</FONT></P>
<P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">30 basis points for the 6.95% Notes due 2037,</FONT></P>
<P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">plus accrued interest to the date of redemption which has not been paid.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On and after the redemption date for the Notes of either series, interest will cease to accrue on the Notes of that series or any portion thereof called for redemption, unless Quest Diagnostics
  defaults in the payment of the redemption price and accrued interest. On or before the redemption date for the Notes of that series, Quest Diagnostics shall deposit with a paying agent, or the
  trustee, funds sufficient to pay the redemption price of and accrued interest on such Notes to be redeemed on such date. If less than all of the Notes of a series are to be redeemed, the Notes of that
  series to be redeemed shall be selected by the trustee by such method as the trustee shall deem fair and appropriate.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-26</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Remaining Scheduled Payments&#148; means, with respect to the Notes of either of the series to be redeemed, the remaining scheduled payments of the principal thereof and interest thereon that
  would be due after the related redemption date but for such redemption; <I>provided</I>, <I>however</I>, that, if such redemption date is not an interest payment date with respect to the Notes, the amount of the
  next succeeding scheduled interest payment thereon will be deemed to be reduced by the amount of interest accrued thereon to such redemption date.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Treasury Rate&#148; means, with respect to any redemption date for the Notes of either series:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      the yield, which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated &#147;H.15(519)&#148; or any successor publication
      which is published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant
      maturity under the caption &#147;Treasury Constant Maturities,&#148; for the maturity corresponding to the Comparable Treasury Issue; <I>provided</I> that if no maturity is within three months before or after
      the maturity date for the Notes, yields for the two published maturities most closely corresponding to the Comparable Treasury Issue will be determined and the Treasury Rate will be
      interpolated or extrapolated from those yields on a straight line basis, rounding to the nearest month; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">if that release, or any successor release, is not published during the week preceding the calculation date or does not contain such yields, the rate per annum equal to the semiannual equivalent
      yield to maturity of the Comparable Treasury Issue, calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable
      Treasury Price for that redemption date.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Treasury Rate will be calculated on the third business day preceding the redemption date.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Comparable Treasury Issue&#148; means the United States Treasury security selected by an Independent Investment Banker as having a maturity comparable to the remaining term of the Notes due
  2017 or the Notes due 2037, as the case may be, to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate
  debt securities of comparable maturity to the remaining term of the Notes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Independent Investment Banker&#148; means one of the Reference Treasury Dealers, to be appointed by Quest Diagnostics.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Comparable Treasury Price&#148; means, with respect to any redemption date for the Notes:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      the average of four Reference Treasury Dealer Quotations for that redemption date, after excluding the highest and lowest of such Reference Treasury Dealer Quotations; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">if the trustee obtains fewer than four Reference Treasury Dealer Quotations, the average of all quotations obtained by the trustee.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Reference Treasury Dealer Quotations&#148; means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the trustee, of the bid and asked prices
  for the Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, quoted in writing to the trustee by such Reference Treasury Dealer at 3:30 p.m., New York City
  time, on the third business day preceding such redemption date.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Reference Treasury Dealer&#148; means a primary U.S. Government securities dealer, which we refer to as &#147;Primary Treasury Dealer,&#148; selected by Quest Diagnostics.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Change of Control</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If a Change of Control Triggering Event occurs, unless Quest Diagnostics has exercised its option to redeem the Notes as described above, Quest Diagnostics will be required to make an offer
  (the &#147;Change of Control Offer&#148;) to each holder of the Notes to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that holder&#146;s Notes on the terms set
  forth in the Notes. In the Change of Control Offer, Quest Diagnostics will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased, plus accrued
  and unpaid interest, if any, on the Notes repurchased to the date of repurchase (the </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-27</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Change of Control Payment&#148;). Within 30 days following any Change of Control Triggering Event or, at Quest Diagnostics&#146; option, prior to any Change of Control, but after public announcement of
  the transaction that constitutes or may constitute the Change of Control, a notice will be mailed to holders of the Notes describing the transaction that constitutes or may constitute the Change of
  Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is
  mailed (the &#147;Change of Control Payment Date&#148;). The notice will, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change
  of Control Triggering Event occurring on or prior to the Change of Control Payment Date.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">On the Change of Control Payment Date, Quest Diagnostics will, to the extent lawful:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      accept for payment all Notes or portions of Notes properly tendered pursuant to the Change of Control Offer;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">deposit with the paying agent an amount equal to the Change of Control Payment in respect of all Notes or portions of Notes properly tendered; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">deliver or cause to be delivered to the trustee the Notes properly accepted together with an officers&#146; certificate stating the aggregate principal amount of Notes or portions of Notes being
      repurchased.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics will not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at
  the times and otherwise in compliance with the requirements for an offer made by Quest Diagnostics and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In
  addition, Quest Diagnostics will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of default under the indenture, other than a
  default in the payment of the Change of Control Payment upon a Change of Control Triggering Event.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and any other securities laws and regulations
  thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
  provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the Notes, Quest Diagnostics will comply with those securities laws and regulations and
  will not be deemed to have breached its obligations under the Change of Control Offer provisions of the Notes by virtue of any such conflict. For purposes of the Change of Control Offer provisions
  of the Notes, the following terms will be applicable:</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Change of Control&#148; means the occurrence of any of the following: (1) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that
  any &#147;person&#148; (as that term is used in Section 13(d) (3) of the Exchange Act) (other than Quest Diagnostics or one of its subsidiaries) becomes the beneficial owner (as defined in Rules 13d-3 and
  13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the voting stock of Quest Diagnostics or other voting stock into which the voting stock of Quest Diagnostics is reclassified,
  consolidated, exchanged or changed, measured by voting power rather than number of shares; (2) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or
  consolidation), in one or more series of related transactions, of all or substantially all of Quest Diagnostics&#146; assets and the assets of its subsidiaries, taken as a whole, to one or more &#147;persons&#148; (as
  that term is defined in the indenture) (other than Quest Diagnostics or one of its subsidiaries); or (3) the first day on which a majority of the members of the Board of Directors of Quest Diagnostics
  are not Continuing Directors. Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1) Quest Diagnostics becomes a direct or indirect wholly-owned
  subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders
  of the voting stock of Quest Diagnostics immediately prior to that transaction or (B) immediately following that transaction no person (other than a holding company satisfying the requirements of
  this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the voting stock of such holding company.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-28</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Change of Control Triggering Event&#148; means the occurrence of both a Change of Control and a Rating event.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Continuing Directors&#148; means, as of any date of determination, any member of Quest Diagnostics&#146; Board of Directors who (1) was a member of such Board of Directors on the date the Notes
  were issued or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of
  Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of the proxy statement of Quest Diagnostics in which such member was named as a
  nominee for election as a director, without objection to such nomination).</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Fitch&#148; means Fitch Ratings.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Investment Grade Rating&#148; means a rating equal to or higher than Baa3 (or the equivalent) by Moody&#146;s and BBB&#150; (or the equivalent) by S&amp;P, and the equivalent investment grade credit rating
  from any additional rating agency or Rating Agencies selected by Quest Diagnostics.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Moody&#146;s&#148; means Moody&#146;s Investors Service, Inc.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Rating Agencies&#148; means (1) each of Moody&#146;s and S&amp;P and Fitch, to the extent Fitch makes a rating of the Notes publicly available; and (2) if any of Moody&#146;s and S&amp;P or Fitch, to the extent Fitch
  makes a rating of the Notes publicly available, ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the control of Quest Diagnostics, a &#147;nationally
  recognized statistical rating organization&#148; within the meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act selected by Quest Diagnostics (as certified by a resolution of the Board of Directors)
  as a replacement agency for Moody&#146;s or S&amp;P or Fitch (if applicable), or all of them, as the case may be.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Rating event&#148; means the rating on the Notes is lowered by each of the Rating Agencies and the Notes are rated below an Investment Grade Rating by each of the Rating Agencies on any day
  within the 60-day period (which 60-day period will be extended so long as the rating of the Notes is under publicly announced consideration for a possible downgrade by any of the Rating Agencies)
  after the earlier of (1) the occurrence of a Change of Control and (2) public notice of the occurrence of a Change of Control or the intention of Quest Diagnostics to effect a Change of Control;<I>
  provided, however, </I>that a rating event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
  not be deemed a rating event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise
  apply do not announce or publicly confirm or inform the trustee in writing at its request or the request of Quest Diagnostics that the reduction was the result, in whole or in part, of any event or
  circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the rating event).</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;S&amp;P&#148; means Standard &amp; Poor&#146;s Rating Services, a division of The McGraw-Hill Companies, Inc.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Voting stock&#148; means, with respect to any specified &#147;person&#148; (as that term is used in Section 13(d)(3) of the Exchange Act) as of any date, the capital stock of such person that is at the time
  entitled to vote generally in the election of the board of directors of such person.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Sinking Fund</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes will not be entitled to the benefit of any sinking fund.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Limitation on Liens</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Other than as provided under &#147;&#151;Exempted Liens and Sale and Leaseback Transactions,&#148; Quest Diagnostics will not, and will not permit any Restricted Subsidiary to, create or assume any
  Indebtedness secured by any Lien on any Principal Property or shares of stock or Indebtedness of any Restricted Subsidiary, unless: (1) in the case of Quest Diagnostics, the Notes are secured by </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-29</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien, or (2) in the case of any Subsidiary Guarantor, such Subsidiary Guarantor&#146;s guarantee of the Notes is secured
  by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien. The restrictions do not apply to Indebtedness that is secured by:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Liens existing on the date of the issuance of the Notes;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens securing only the Notes;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens in favor of only Quest Diagnostics or any Restricted Subsidiary;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens on property or shares of stock or indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary or is merged into or consolidated with, or its assets are
      acquired by, Quest Diagnostics or any Restricted Subsidiary (<I>provided</I> that such Lien was not incurred in anticipation of such transaction and was in existence prior to such transaction) so long
      as such Lien does not extend to any other property and the Indebtedness so secured is not increased;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens on property existing immediately prior to the acquisition thereof (<I>provided</I> that such Lien was not incurred in anticipation of such transaction and was in existence prior to such
      transaction) so long as such Lien does not extend to any other property and the Indebtedness so secured is not increased;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens to secure Indebtedness incurred for the purpose of all or any part of a property&#146;s purchase price or cost of construction or additions, repairs, alterations, or other improvements; <I>provided</I>
      that (1) the principal amount of any Indebtedness secured by such Lien does not exceed 100% of such property&#146;s purchase price or cost, (2) such Lien does not extend to or cover any other
      property other than the property so purchased, constructed or on which such additions, repairs, alterations or other improvements were so made, and (3) such Lien is incurred prior to or within
      270 days after the acquisition of such property or the completion of construction or such additions, repairs, alterations or other improvements and the full operation of such property thereafter;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens in favor of the United States or any state thereof, or any instrumentality of either, to secure certain payments pursuant to any contract or statute;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens for taxes or assessments or other governmental charges or levies which are being contested in good faith and for which adequate reserves are being maintained, to the extent required by
      generally accepted accounting principles;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">title exceptions, easements and other similar Liens that are not consensual and that do not materially impair the use of the property subject thereto;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens to secure obligations under workmen&#146;s compensation laws, unemployment compensation, old-age pensions and other social security benefits or similar legislation, including Liens with
      respect to judgments which are not currently dischargeable;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens arising out of legal proceedings, including Liens arising out of judgments or awards;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">warehousemen&#146;s, materialmen&#146;s and other similar Liens for sums being contested in good faith and for which adequate reserves are being maintained, to the extent required by generally
      accepted accounting principles;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens incurred to secure the performance of statutory obligations, surety or appeal bonds, performance or return-of-money bonds or other obligations of a like nature incurred in the ordinary
      course of business; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Liens to secure any extension, renewal, refinancing or refunding (or successive extensions, renewals, refinancings or refundings), in whole or in part, of any Indebtedness secured by Liens
      referred to in the foregoing bullets or liens created in connection with any amendment, consent or waiver relating to such Indebtedness, so long as such Lien does not extend to any other
      property and the Indebtedness so secured does not exceed the fair market value (as determined by our board of directors) of the assets subject to such Liens at the time of such extension,
      renewal, refinancing or refunding, or such amendment, consent or waiver, as the case may be.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-30</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Limitation on Sale and Leaseback Transactions</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Other than as provided under &#147;&#151;Exempted Liens and Sale and Leaseback Transactions,&#148; Quest Diagnostics will not, and will not permit any Restricted Subsidiary to, enter into any Sale and
  Leaseback Transaction with respect to any Principal Property unless:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      the Sale and Leaseback Transaction is solely with Quest Diagnostics or a Subsidiary Guarantor; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the lease is for a period not in excess of five years, including renewal rights; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics or the Restricted Subsidiary, prior to or within 270 days after the sale of such Principal Property in connection with the Sale and Leaseback Transaction is completed, applies
      the net cash proceeds of the sale of the Principal Property leased to:</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<TABLE cellspacing=0 cellpadding=0 style="margin-left:2.50pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:18pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (1)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      the retirement of the Notes or debt ranking equally with the Notes of Quest Diagnostics or any Restricted Subsidiary, or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:18pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(2)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the acquisition of different property, facilities or equipment or the expansion of Quest Diagnostics&#146; existing business, including the acquisition of other businesses.</FONT></P>
    <P style="text-indent:10.5mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Exempted Liens and Sale and Leaseback Transactions</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Notwithstanding the restrictions described under the headings &#147;&#151;Limitation on Liens&#148; or &#147;&#151;Limitation on Sale and Leaseback Transactions,&#148; Quest Diagnostics or any Restricted Subsidiary may
  create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted as described above, if the sum of the following does not exceed 5% of Consolidated Total
  Assets:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      the outstanding Indebtedness secured by such Liens (not including any Liens permitted under &#147;&#151;Limitation on Liens&#148; which amount does not include any Liens permitted under the provisions of
      this &#147;&#151;Exempted Liens and Sale and Leaseback Transactions&#148;); plus</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions permitted under &#147;&#151;Limitation on Sale and Leaseback
      Transactions&#148; which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this &#147;&#151;Exempted Liens and Sale and Leaseback Transactions&#148;),</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by Quest Diagnostics or the Restricted Subsidiary.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Limitation on Subsidiary Indebtedness and Preferred Stock</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">None of the Subsidiaries of Quest Diagnostics other than the Subsidiary Guarantors may, directly or indirectly, create, incur, issue, assume or extend the maturity of any Indebtedness (including
  Acquired Indebtedness) or Preferred Stock except for the following, <I>provided</I> that, for purposes of this covenant, any Acquired Indebtedness shall not be deemed to have been incurred until 270 days
  from the date (1) the Person obligated on such Acquired Indebtedness becomes a Subsidiary of Quest Diagnostics or (2) the acquisition of assets, in connection with which such Acquired
  Indebtedness was assumed, is consummated:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Indebtedness outstanding on the date of the Indenture;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Indebtedness representing the assumption by one Subsidiary of Indebtedness of another Subsidiary;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Indebtedness outstanding under any Receivables Credit Facility;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Indebtedness secured by a Lien incurred for the purpose of all or any part of a property&#146;s purchase price or cost of construction or additions, repairs, alterations or other improvements,<I>
      provided</I> that such Indebtedness and Lien is incurred prior to or within 270 days after the acquisition of such property or the completion of construction or such additions, repairs, alterations or
      other improvements and the full operation of such property thereafter;</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>
</TABLE>

<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-31</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">

  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Indebtedness of any Subsidiary of Quest Diagnostics, the proceeds of which are used to renew, extend, refinance or refund outstanding Indebtedness of such Subsidiary; <I>provided</I> that such
      Indebtedness is scheduled to mature no earlier than the Indebtedness being renewed, extended, refinanced or refunded; <I>provided further</I> that such Indebtedness shall be permitted hereunder
      only to the extent that the aggregate principal amount of such Indebtedness (or, if such Indebtedness is issued at a price less than the principal amount thereof, the aggregate amount of gross
      proceeds therefrom) does not exceed the aggregate principal amount then outstanding under the Indebtedness being renewed, extended, refinanced or refunded (or if the Indebtedness being
      renewed, extended, refinanced or refunded, was issued at a price less than the principal amount thereof, then not in excess of the amount of liability in respect thereof determined in accordance
      with generally accepted accounting principles) plus the lesser of (A) the stated amount of any premium or other payment required to be paid in connection with such a refinancing pursuant to
      the terms of the Indebtedness being refinanced or (B) the amount of premium or other payment actually paid at such time to refinance the Indebtedness, plus, in either case, the amount of
      expenses of such Subsidiary incurred in connection with such refinancing;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Indebtedness of a Subsidiary of Quest Diagnostics to Quest Diagnostics or to another Subsidiary of Quest Diagnostics;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">any Indebtedness resulting from a Sale and Leaseback Transaction which is permitted by the &#147;&#151;Limitation on Sale and Leaseback Transactions&#148; covenant (but not including any Sale and
      Leaseback Transaction which is permitted by the &#147;&#151;Exempted Liens and Sale and Leaseback Transactions&#148; provisions relating thereto);</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">any Permitted Acquired Indebtedness;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">any guarantee of Indebtedness of Quest Diagnostics by the Specified Subsidiaries or any other Subsidiary of Quest Diagnostics in anticipation of such Subsidiary becoming a Subsidiary
      Guarantor pursuant to the &#147;&#151;Guarantees&#148; provision;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Preferred Stock to the extent that the aggregate liquidation preference of Preferred Stock, outstanding at any one time, does not exceed 5% of Consolidated Total Assets; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">any Indebtedness, including any Acquired Indebtedness that is not Permitted Acquired Indebtedness, the outstanding aggregate principal amount of which does not at any one time exceed the
      greater of (1) 10% of Consolidated Total Assets or (2) $200 million, measured in each case at the time such Indebtedness is incurred.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>

<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Limitation on restricted payments to certain non-guarantor subsidiaries</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics will not, and will not permit any Subsidiary to, (1) declare or pay any dividend or make any distribution to the Specified Subsidiaries on or in respect of its Capital Stock, (2)
  purchase, redeem, retire or otherwise acquire for value from the Specified Subsidiaries any of its Capital Stock, or (3) purchase or otherwise acquire any assets, or purchase or otherwise acquire,
  redeem, retire or repay any Indebtedness of the Specified Subsidiaries, or (4) make any investment in or make any loan to or transfer any assets to any of the Specified Subsidiaries. This covenant
  will permanently cease to be in effect when each of the Specified Subsidiaries becomes a Subsidiary Guarantor.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Capital Stock&#148; means, with respect to any Person, any and all shares or common stock or Preferred Stock.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Merger, Consolidation or Sale of Assets</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics may merge or consolidate with another Person and may sell, transfer or lease all or substantially all of its assets to another Person if all the following conditions are met:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      The merger, consolidation or sale of assets must not cause an event of default. See &#147;&#151;Events of Default.&#148; An event of default for this purpose would also include any event that would be an
      event of default if the notice or time requirements were disregarded;</FONT>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>
</TABLE>

<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-32</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">

  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If Quest Diagnostics is not the surviving entity, the Person we would merge or consolidate with, or sell all or substantially all of our assets to, must be organized under the laws of the United
      States or any state thereof;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If Quest Diagnostics is not the surviving entity, the Person we would merge or consolidate with, or sell all or substantially all of our assets to, must expressly assume by supplemental indenture
      all of our obligations under the Notes and the Indenture; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics must deliver specific certification and documents to the trustee.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>

<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Events of Default</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The term &#147;Event of Default&#148; in respect of the Notes means any of the following:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Quest Diagnostics or any Subsidiary Guarantor does not pay the principal of or any premium on the Notes of that series on its due date;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics or any Subsidiary Guarantor does not pay interest on the Notes of that series within 30 days of its due date whether at maturity, upon redemption or upon acceleration;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics or any Subsidiary Guarantor remains in breach of a covenant in respect of the Notes of that series for 60 days after it receives a written notice of default stating it is in
      breach and requiring that it remedy the breach. The notice must be sent by either the trustee or holders of 25% of the aggregate principal amount of the Notes of that series;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">An event of default under any indenture or instrument evidencing or under which Quest Diagnostics or any Subsidiary Guarantor then has outstanding any Indebtedness shall occur and be
      continuing and either:</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<TABLE cellspacing=0 cellpadding=0 style="margin-left:2.50pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:18pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (1)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      such event of default results from the failure to pay the principal of such Indebtedness in excess of $200 million at final maturity of such Indebtedness, individually or in the aggregate; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:18pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(2)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">as a result of such event of default the maturity of such Indebtedness shall have been accelerated so that the same shall be or become due and payable prior to the date on which the same
      would otherwise have become due and payable and the principal amount of such Indebtedness, together with the principal of any other Indebtedness of Quest Diagnostics or such
      Subsidiary Guarantor in default, or the maturity of which has been accelerated, aggregates at least $200 million, individually or in the aggregate;</FONT></P>
    <P style="text-indent:10.5mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Any Subsidiary Guarantor repudiates its obligations under its guarantee of the Notes or, other than by reason of the termination of the Indenture or the release of any such guarantee in
      accordance with the Indenture, any such guarantee ceases to be in full force and effect or is declared null and void and such condition shall have continued for a period of 30 days after written
      notice of such failure requiring Quest Diagnostics or the Subsidiary Guarantor to remedy the same shall have been given to Quest Diagnostics by the trustee or to Quest Diagnostics and the
      trustee by the holders of 25% in aggregate principal amount of the Notes then outstanding; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics or any Subsidiary Guarantor files for bankruptcy or certain other events of bankruptcy, insolvency or reorganization occur.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The trustee may withhold notice to the holders of Notes of any default (except in the payment of principal or interest) if it considers such withholding of notice to be in the best interests of the
  holders.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If an event of default with respect to the Notes of either series has occurred and has not been cured, the trustee or the holders of 25% in aggregate principal amount of the Notes of that series
  may declare the entire principal amount (and premium, if any) of, and all the accrued interest on the Notes of that series to be due and immediately payable. This is called a declaration of
  acceleration of maturity. If an event of default with respect to the Notes of either series occurs because of certain events in bankruptcy, insolvency or reorganization, the principal amount of the </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-33</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Notes of that series will be automatically accelerated, without any action by the trustee or any holder. Holders of a majority in principal amount of the Notes of either series may also waive certain
  past defaults under the Indenture on behalf of all of the holders of the Notes of that series. A declaration of acceleration of maturity with respect to the Notes of either series may be canceled, under
  specific circumstances, by the holders of at least a majority in principal amount of the Notes of that series.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Except in cases of default, where the trustee has some special duties, the trustee is not required to take any action under the Indenture at the request of any of the holders unless the holders
  offer the trustee protection reasonably satisfactory to it from expenses and liability called an &#147;indemnity.&#148; If indemnity reasonably satisfactory to the trustee is provided, the holders of a majority in
  principal amount of the Notes of either series may, with respect to the Notes of that series, direct the time, method and place of conducting any lawsuit or other formal legal action seeking any
  remedy available to the trustee. The trustee may refuse to follow those directions in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of the
  right, remedy or event of default.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Before you are allowed to bypass the trustee and bring a lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to the Notes of either
  series, the following must occur:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      You must give the trustee written notice that an event of default has occurred and remains uncured;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The holders of at least 25% in principal amount of the outstanding Notes of that series must make a written request that the trustee take action because of the default and must offer the
      trustee indemnity reasonably satisfactory to it against the cost and other liabilities of taking that action;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The trustee must not have taken action for 60 days after receipt of the above notice and offer of indemnity; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Holders of a majority in principal amount of the Notes of that series must not have given the trustee a direction inconsistent with the above notice.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">However, you are entitled at any time to bring a lawsuit for the payment of money due on your Notes on or after the due date.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Defeasance</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Full Defeasance</I>. If there is a change in federal tax law, as described below, we can legally release ourselves and our Subsidiary Guarantors from any payment or other obligations on the Notes,
  called &#147;full defeasance,&#148; if we put in place the following other arrangements for you to be repaid:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      We must deposit in trust for your benefit and the benefit of all other registered holders of the Notes a combination of money and U.S. government or U.S. government agency notes or bonds
      that will generate enough cash to make interest, principal and any other payments on the Notes on their various due dates including, possibly, their earliest redemption date.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In order for us to effect a full defeasance, we must deliver to the trustee a legal opinion confirming that you will not recognize income, gain or loss for United States federal income tax
      purposes as a result of the defeasance and that you will not be taxed on the Notes any differently than if the defeasance had not occurred.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If we accomplish full defeasance, as described above, you would have to rely solely on the trust deposit for repayment on the Notes. You could not look to us or our Subsidiary Guarantors for
  repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from claims of our lenders and other creditors if we ever become bankrupt or insolvent.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Covenant Defeasance</I>. Under current federal tax law, we can make the same type of deposit described above and be released and cause our Subsidiary Guarantors to be released from the
  restrictive covenants in the Notes, if any. This is called &#147;covenant defeasance.&#148; In that event, you </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-34</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">would lose the protection of those restrictive covenants but would gain the protection of having money and securities set aside in trust to repay the Notes. In order to achieve covenant defeasance,
  we must do the following:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      We must deposit in trust for your benefit and the benefit of all other registered holders of the Notes a combination of money and U.S. government or U.S. government agency notes or bonds
      that will generate enough cash to make interest, principal and any other payments on the Notes on their various due dates.</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We must deliver to the trustee a legal opinion confirming that under current United States federal income tax law you will not recognize income, gain or loss for United Sates federal income
      tax purposes as a result of the covenant defeasance and that you will not be taxed on the Notes any differently than if the covenant defeasance had not occurred.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If we accomplish covenant defeasance, the following provisions of the Indenture and the Notes would no longer apply unless otherwise specified:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      any promises of our Subsidiary Guarantors relating to their guarantees, the conduct of their business and any other covenants applicable to the series of Notes;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">our promises regarding conduct of our business and other matters and any other covenants applicable to the series of Notes; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">the definition of an event of default as a breach of such covenants.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If we accomplish covenant defeasance, you can still look to us and our Subsidiary Guarantors for repayment of the Notes if there were a shortfall in the trust deposit. In fact, if one of the
  remaining events of default occurred (such as our bankruptcy) and the Notes become immediately due and payable, there may be such a shortfall. Depending on the event causing the default, of
  course, you may not be able to obtain payment of the shortfall.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In order to exercise either full defeasance or covenant defeasance, we must comply with certain conditions, and no event or condition can exist that would prevent us and our Subsidiary
  Guarantors from making payments of principal, premium, and interest, if any, on the Notes of such series on the date the irrevocable deposit is made or at any time during the period ending on the
  91st day after the deposit date.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Notices</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">With respect to the Notes, we and the trustee will send notices regarding the Notes only to registered holders, using their addresses as listed in the list of registered holders.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Global Notes: Book-Entry System</B></FONT></P>
<P style="margin:3.5mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><I>The Global Notes</I></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes of each series will be represented by one or more fully registered global notes, without interest coupons and will be deposited upon issuance with the trustee as custodian for The
  Depository Trust Company, New York, New York (&#147;DTC&#148;), and registered in the name of DTC or its nominee, in each case, for credit to an account of a direct or indirect participant as described
  below.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Except as set forth below, the global notes may be transferred, in whole and not in part, only to another nominee of DTC or to a successor of DTC or its nominee. Beneficial interests in the
  global notes may not be exchanged for definitive notes in registered certificated form (&#147;certificated notes&#148;) except in the limited circumstances described below. See &#147;&#151;Certain Book-Entry Procedures
  for the Global Notes.&#148;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Except in the limited circumstances described below, owners of beneficial interests in the global notes will not be entitled to receive physical delivery of notes in certificated form.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Transfers of beneficial interests in the global notes are subject to the applicable rules and procedures of DTC and its direct or indirect participants, which may change.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-35</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Notes may be presented for registration of transfer and exchange at the offices of the trustee.</FONT></P>
<P style="margin:6.3mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><I>Certain Book-Entry Procedures for the Global Notes</I></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">All interests in the global notes will be subject to the operations and procedures of DTC, Euroclear and Clearstream Luxembourg. The descriptions of the operations and procedures of DTC,
  Euroclear and Clearstream Luxembourg set forth below are provided solely as a matter of convenience. These operations and procedures are solely within the control of the respective settlement
  systems and are subject to change by them from time to time. We obtained the information in this section and elsewhere in this prospectus supplement concerning DTC, Euroclear and Clearstream
  Luxembourg and their respective book-entry systems from sources that we believe are reliable, but we take no responsibility for the accuracy of any of this information, and investors are urged to
  contact the relevant system or its participants directly to discuss these matters.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>DTC. </I>DTC has advised us that it is:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      a limited-purpose trust company organized under the laws of the State of New York;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a &#147;banking organization&#148; within the meaning of the New York State Banking Law;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a member of the Federal Reserve System;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a &#147;clearing corporation&#148; within the meaning of the New York Uniform Commercial Code, as amended; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a &#147;clearing agency&#148; registered pursuant to Section 17A of the Exchange Act.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">DTC was created to hold securities for its participants (collectively, the &#147;participants&#148;) and to facilitate the clearance and settlement of securities transactions between its participants through
  electronic book-entry changes to the accounts of its participants, thereby eliminating the need for physical transfer and delivery of certificates. DTC&#146;s participants include securities brokers and dealers
  (including some or all of the underwriters), banks and trust companies, clearing corporations and certain other organizations. Indirect access to DTC&#146;s system is also available to other entities such as
  Clearstream Luxembourg, Euroclear, banks, brokers, dealers and trust companies (collectively, the &#147;indirect participants&#148;) that clear through or maintain a custodial relationship with a participant,
  either directly or indirectly. Investors who are not participants may beneficially own securities held by or on behalf of DTC only through participants or indirect participants in DTC.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Clearstream Luxembourg. </I>Clearstream Luxembourg is incorporated under the laws of Luxembourg as a professional depositary. Clearstream Luxembourg holds securities for its participating
  organizations (&#147;Clearstream Luxembourg Participants&#148;) and facilitates the clearance and settlement of securities transactions between Clearstream Luxembourg Participants through electronic book-
  entry changes in accounts of Clearstream Luxembourg Participants, thereby eliminating the need for physical movement of certificates. Clearstream Luxembourg provides Clearstream Luxembourg
  Participants with, among other things, services for safekeeping, administration, clearance and establishment of internationally traded securities and securities lending and borrowing. Clearstream
  Luxembourg interfaces with domestic markets in several countries. As a professional depositary, Clearstream Luxembourg is subject to regulation by the Luxembourg Monetary Institute. Clearstream
  Luxembourg Participants are recognized financial institutions around the world, including underwriters, securities brokers and dealers, banks, trust companies, clearing corporations and certain other
  organizations, and may include the underwriters. Indirect access to Clearstream Luxembourg is also available to others, such as banks, brokers, dealers and trust companies that clear through or
  maintain a custodial relationship with a Clearstream Luxembourg Participant either directly or indirectly.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Distributions with respect to Notes held beneficially through Clearstream Luxembourg will be credited to cash accounts of Clearstream Luxembourg Participants in accordance with its rules and
  procedures to the extent received by the U.S. depositary for Clearstream Luxembourg.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Euroclear. </I>Euroclear was created in 1968 to hold securities for participants of Euroclear (&#147;Euroclear Participants&#148;) and to clear and settle transactions between Euroclear Participants </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-36</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">through simultaneous electronic book-entry delivery against payment, thereby eliminating the need for physical movement of certificates and any risk from lack of simultaneous transfers of securities
  and cash. Euroclear includes various other services, including securities lending and borrowing and interfaces with domestic markets in several markets in several countries. Euroclear is operated by
  Euroclear Bank S.A./N.V. (the &#147;Euroclear Operator&#148;), under contract with Euro-clear Clearance Systems S.C., a Belgian cooperative corporation (the &#147;Cooperative&#148;). All operations are conducted by
  the Euroclear Operator, and all Euroclear securities clearance accounts and Euroclear cash accounts are accounts with the Euroclear Operator, not the Cooperative. The Cooperative establishes policy
  for Euroclear on behalf of Euroclear Participants. Euroclear Participants include banks (including central banks), securities brokers and dealers and other professional financial intermediaries and may
  include the underwriters. Indirect access to Euroclear is also available to other firms that clear through or maintain a custodial relationship with a Euroclear Participant, either directly or indirectly.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Euroclear Operator is regulated and examined by the Belgian Banking Commission. Distributions of principal and interest with respect to Notes held through Euroclear or Clearstream
  Luxembourg will be credited to the cash accounts of Euroclear or Clearstream Luxembourg participants in accordance with the relevant system&#146;s rules and procedures, to the extent received by such
  system&#146;s depositary.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Links have been established among DTC, Clearstream Luxembourg and Euroclear to facilitate the initial issuance of the Notes and cross-market transfers of the Notes associated with secondary
  market trading. DTC will be linked indirectly to Clearstream Luxembourg and Euroclear through the DTC accounts of their respective U.S. depositaries.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Book-Entry Procedures. </I>We expect that, pursuant to procedures established by DTC:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      upon deposit of each global note, DTC will credit, on its book-entry registration and transfer system, the accounts of participants designated by the underwriters with an interest in that global
      note; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">ownership of beneficial interests in the global notes will be shown on, and the transfer of ownership interests in the global notes will be effected only through, records maintained by DTC (with
      respect to the interests of participants) and by participants and indirect participants (with respect to the interests of persons other than participants).</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The laws of some jurisdictions may require that some purchasers of Notes take physical delivery of those Notes in definitive form. Accordingly, the ability to transfer beneficial interests in notes
  represented by a global note to those persons may be limited. In addition, because DTC can act only on behalf of its participants, who in turn act on behalf of persons who hold interests through
  participants, the ability of a person holding a beneficial interest in a global note to pledge or transfer that interest to persons or entities that do not participate in DTC&#146;s system, or to otherwise take
  actions in respect of that interest, may be affected by the lack of a physical note in respect of that interest.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">So long as DTC or its nominee is the registered owner of a global note, DTC or that nominee, as the case may be, will be considered the sole legal owner or holder of the notes represented by
  that global note for all purposes of the Notes and the Indenture. Except as provided below, owners of beneficial interests in a global note (1) will not be entitled to have the Notes represented by
  that global note registered in their names, (2) will not receive or be entitled to receive physical delivery of certificated notes, and (3) will not be considered the owners or holders of the Notes
  represented by that beneficial interest under the indenture for any purpose, including with respect to the giving of any direction, instruction or approval to the trustee. Accordingly, each holder
  owning a beneficial interest in a global note must rely on the procedures of DTC and, if that holder is not a participant or an indirect participant, on the procedures of the participant through which
  that holder owns its interest, to exercise any rights of a holder of Notes under the Indenture or that global note. We understand that under existing industry practice, in the event that we request any
  action of holders of notes, or a holder that is an owner of a beneficial interest in a global note desires to take any action that DTC, as the holder of that global note, is entitled to take, DTC would
  authorize the participants to take that action and the participants would authorize holders owning through those </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-37</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">participants to take that action or would otherwise act upon the instruction of those holders. Neither we nor the Trustee will have any responsibility or liability for any aspect of the records relating
  to or payments made on account of notes by DTC, or for maintaining, supervising or reviewing any records of DTC relating to the Notes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Payments with respect to the principal of and interest on a global note will be payable by the trustee to or at the direction of DTC or its nominee in its capacity as the registered holder of the
  global note under the Indenture. Under the terms of the Indenture, we and the trustee may treat the persons in whose names the Notes, including the global notes, are registered as the owners
  thereof for the purpose of receiving payment thereon and for any and all other purposes whatsoever. Accordingly, neither we nor the trustee has or will have any responsibility or liability for the
  payment of those amounts to owners of beneficial interests in a global note. Payments by the participants and the indirect participants to the owners of beneficial interests in a global note will be
  governed by standing instructions and customary industry practice and will be the responsibility of the participants and indirect participants and not of DTC.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Transfers between participants in DTC will be effected in accordance with DTC&#146;s procedures, and will be settled in same-day funds. Transfers between participants in Euroclear or Clearstream
  Luxembourg will be effected in the ordinary way in accordance with their respective rules and operating procedures.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Cross-market transfers between the participants in DTC, on the one hand, and Euroclear or Clearstream Luxembourg participants, on the other hand, will be effected through DTC in accordance
  with DTC&#146;s rules on behalf of Euroclear or Clearstream Luxembourg, as the case may be, by its respective depositary. However, those cross-market transactions will require delivery of instructions to
  Euroclear or Clearstream Luxembourg, as the case may be, by the counterparty in that system in accordance with the rules and procedures and within the established deadlines (Brussels time) of that
  system. Euroclear or Clearstream Luxembourg, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its respective depositary to take action to effect
  final settlement on its behalf by delivering or receiving interests in the relevant global notes in DTC, and making or receiving payment in accordance with normal procedures for same-day funds
  settlement applicable to DTC. Euroclear participants and Clearstream Luxembourg participants may not deliver instructions directly to the depositaries for Euroclear or Clearstream Luxembourg.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Although we understand that DTC, Euroclear and Clearstream Luxembourg have agreed to the foregoing procedures to facilitate transfers of interests in the global notes among participants in
  DTC, Euroclear and Clearstream Luxembourg, they are under no obligation to perform or to continue to perform those procedures, and those procedures may be discontinued at any time. Neither
  we nor the trustee will have any responsibility for the performance by DTC, Euroclear or Clearstream Luxembourg or their respective participants or indirect participants of their respective
  obligations under the rules and procedures governing their operations.</FONT></P>
<P style="margin:6.3mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><I>Same-Day Settlement and Payment</I></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We will make payments in respect of the Notes represented by the global notes (including principal and interest) by wire transfer of immediately available funds to the accounts specified by the
  global note holder. We will make all payments of principal and interest with respect to certificated notes by wire transfer of immediately available funds to the accounts specified by the holders of the
  certificated notes or, if no such account is specified, by mailing a check to each such holder&#146;s registered address. The notes represented by the global notes are expected to trade in DTC&#146;s Same-Day
  Funds Settlement System.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Because of time zone differences, the securities account of a Euroclear or Clearstream Luxembourg participant purchasing an interest in a global note from a participant in DTC will be credited,
  and any such crediting will be reported to the relevant Euroclear or Clearstream Luxembourg participant, during the securities settlement processing day (which must be a business day for Euroclear
  and Clearstream Luxembourg) immediately following the settlement date of DTC. DTC has advised us that cash received in Euroclear or Clearstream Luxembourg as a result of sales </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-38</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">of interests in a global note by or through a Euroclear or Clearstream Luxembourg participant to a participant in DTC will be received with value on the settlement date of DTC but will be
  available in the relevant Euroclear or Clearstream Luxembourg cash account only as of the business day for Euroclear or Clearstream Luxembourg following DTC&#146;s settlement date.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">None of Quest Diagnostics, any underwriter or agent, the trustee or any applicable paying agent will have any responsibility or liability for any aspect of the records relating to or payments made
  on account of beneficial interests in a global note, or for maintaining, supervising or reviewing any records.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Modification or Waiver</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">There are three types of changes we can make to the Indenture and the Notes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Changes Requiring Your Approval</I>. First, there are changes that cannot be made to your Notes without your specific approval. Following is a list of those types of changes:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      changing the stated maturity of the principal of or interest on the Notes;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">reducing any amounts due on the Notes or payable upon acceleration of the maturity of the security following a default;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">adversely affecting any right of repayment at the holder&#146;s option;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">changing the place (except as otherwise described in this prospectus supplement) or currency of payment on the Notes;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">impairing your right to sue for payment or to convert or exchange Notes;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">modifying the Notes to subordinate the Notes to other indebtedness;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">reducing the percentage of holders of Notes whose consent is needed to modify or amend the Indenture;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">reducing the percentage of holders of Notes whose consent is needed to waive compliance with certain provisions of the Indenture or to waive certain defaults;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">reducing the requirements for quorum or voting with respect to the Notes;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">modifying any other aspect of the provisions of the Indenture dealing with modification and waiver except to increase the voting requirements; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">change in any of our obligations to pay additional amounts to holders with respect to taxes imposed on such holders in certain circumstances.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Changes Requiring a Majority Vote</I>. The second type of change to the Indenture and the outstanding Notes is the kind that requires a vote in favor by holders of outstanding Notes owning a
  majority of the principal amount of Notes. Most changes fall into this category, except for clarifying changes and certain other changes that would not adversely affect holders of the outstanding
  Notes in any material respect. The same vote would be required for us and our Subsidiary Guarantors to obtain a waiver of all or part of certain covenants in the Indenture, or a waiver of a past
  default. However, we and our Subsidiary Guarantors cannot obtain a waiver of a payment default or any other aspect of the Indenture or the outstanding Notes listed in the category described
  previously under &#147;&#151;Changes Requiring Your Approval&#148; unless we and our Subsidiary Guarantors obtain your individual consent to the waiver.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Changes Not Requiring Approval</I>. The third type of change does not require any vote by holders of outstanding Notes. This type is limited to clarifications, curing ambiguities, defects or
  inconsistencies and certain other changes that would not adversely affect holders of the outstanding Notes in any material respect. Qualifying or maintaining the qualification of the Indenture under
  the Trust Indenture Act does not require any vote by holders of Notes.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-39</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Satisfaction and Discharge</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Indenture will cease to be of further effect, and we and our Subsidiary Guarantors will be deemed to have satisfied and discharged the Indenture with respect to the Notes, when the
  following conditions have been satisfied:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      all Notes not previously delivered to the trustee for cancellation have become due and payable or will become due and payable at their stated maturity or on a redemption date within one
      year;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">we deposit with the trustee, in trust, funds sufficient to pay the entire indebtedness on the Notes that had not been previously delivered for cancellation, for the principal and interest to the
      date of the deposit (for Notes that have become due and payable) or to the stated maturity or the redemption date, as the case may be (for Notes that have not become due and payable);</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">we have paid or caused to be paid all other sums payable under the Indenture; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">we have delivered to the trustee an officer&#146;s certificate and opinion of counsel, each stating that all these conditions have been complied with.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We will remain obligated to provide for registration of transfer and exchange and to provide notices of redemption.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>The Trustee</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The trustee will be The Bank of New York. The Bank of New York also will be the initial paying agent and registrar for the Notes. The Bank of New York is also the trustee and note registrar
  for our 5.125% senior notes due 2010, our 7.5% senior notes due 2011 and our 5.45% senior notes due 2015.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Indenture provides that, except during the continuance of an event of default under the Indenture, the trustee under the Indenture will perform only such duties as are specifically set forth
  in the Indenture. Under the Indenture, the holders of a majority in outstanding principal amount of the Notes will have the right to direct the time, method and place of conducting any proceeding or
  exercising any remedy available to the trustee under the Indenture, subject to certain exceptions. If an event of default has occurred and is continuing, the trustee under the Indenture will exercise
  such rights and powers vested in it under the Indenture and use the same degree of care and skill in its exercise as a prudent person would exercise under the circumstances in the conduct of such
  person&#146;s own affairs.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Indenture and provisions of the Trust Indenture Act incorporated by reference in the Indenture contain limitations on the rights of the trustee under such Indenture, should it become a
  creditor of our company, to obtain payment of claims in certain cases or to realize on certain property received by it in respect of any such claims, as security or otherwise. The trustee under the
  Indenture is permitted to engage in other transactions. However, if the trustee under the Indenture acquires any prohibited conflicting interest, it must eliminate the conflict or resign.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The trustee may resign or be removed and a successor trustee may be appointed.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Governing Law</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The Indenture and the Notes will be governed by, and construed in accordance with, the laws of the State of New York without application of principles of conflicts of law thereunder.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Definitions</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following definitions are applicable to this Description of Notes:</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Acquired Indebtedness&#148; means Indebtedness of a Person (1) existing at the time such Person becomes a Restricted Subsidiary or (2) assumed in connection with the acquisition of assets by such
  Person, in each case, other than Indebtedness incurred in connection with, or in contemplation of, such Person becoming a Restricted Subsidiary or such acquisition, as the case may be.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-40</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Attributable Debt&#148; means, with respect to a Sale and Leaseback Transaction, an amount equal to the lesser of: (1) the fair market value of the property (as determined in good faith by our
  board of directors); and (2) the present value of the total net amount of rent payments to be made under the lease during its remaining term, discounted at the rate of interest set forth or implicit in
  the terms of the lease, compounded semi-annually. The calculation of the present value of the total net amount of rent payments is subject to adjustments specified in the Indenture.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Capitalized Lease&#148; means any obligation of a Person to pay rent or other amounts incurred with respect to real property or equipment acquired or leased by such Person and used in its
  business that is required to be recorded as a capital lease in accordance with generally accepted accounting principles.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Consolidated Total Assets&#148; means, with respect to any Person as of any date, the amount of total assets as shown on the consolidated balance sheet of such Person for the most recent fiscal
  quarter for which financial statements have been filed with the Securities and Exchange Commission, prepared in accordance with accounting principles generally accepted in the United States.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Existing Receivables Credit Facility&#148; means the receivables-backed financing transaction pursuant to (1) the Second Amended and Restated Receivables Sales Agreement, dated as of April 20,
  2004 between Quest Diagnostics and each of its direct and indirect wholly owned Subsidiaries that is a seller thereunder, and Quest Diagnostics Receivables Inc., as the buyer, (2) the Third Amended
  and Restated Credit and Security Agreement, dated as of April 20, 2004, as amended, among Quest Diagnostics Receivables Inc., as borrower, Quest Diagnostics, as initial servicer, each of the
  lenders from time to time party thereto, and Wachovia Bank, N.A., as administrative agent, and (3) the various related ancillary documents.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Indebtedness&#148; of any Person means, without duplication (1) any obligation of such Person for money borrowed, (2) any obligation of such Person evidenced by bonds, debentures, notes or other
  similar instruments, (3) any reimbursement obligation of such Person in respect of letters of credit or other similar instruments which support financial obligations which would otherwise become
  Indebtedness, and (4) any obligation of such Person under Capitalized Leases; <I>provided</I>, <I>however</I>, that &#147;Indebtedness&#148; of such Person shall not include any obligation of such Person to any Subsidiary
  of such Person or to any Person with respect to which such Person is a Subsidiary.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Initial Subsidiary Guarantors&#148; means each of American Medical Laboratories Incorporated, AmeriPath Consolidated Labs, Inc., AmeriPath Florida, LLC, AmeriPath Hospital Services Florida,
  LLC, AmeriPath Indiana, LLC, AmeriPath Kentucky, Inc., AmeriPath Marketing USA, Inc., AmeriPath Michigan, Inc., AmeriPath Mississippi, Inc., AmeriPath New York, LLC, AmeriPath North
  Carolina, Inc., AmeriPath Ohio, Inc., AmeriPath Pennsylvania, LLC, AmeriPath Philadelphia, Inc., AmeriPath SC, Inc., AmeriPath Texas, LP, AmeriPath Wisconsin, LLC, AmeriPath Youngstown
  Labs, Inc., AmeriPath, Inc., AmeriPath, LLC, AML Inc., Anatomic Pathology Services, Inc., API No. 2, LLC, APL Properties Limited Liability Company, Arizona Pathology Group, Inc., Central
  Plains Holdings, Inc., Central Plains Laboratories, LLC, Dermatopathology Services, Inc., Diagnostic Pathology Management Services, LLC, Diagnostic Reference Services Inc., DPD Holdings, Inc.,
  Enterix Inc., ExamOne World Wide of NJ, Inc., ExamOne World Wide, Inc., FNA Clinics of America, Inc. (f/k/a Unilab Acquisition Corporation), Focus Diagnostics, Inc., Focus Technologies
  Holding Company, HemoCue, Inc., Kailash B. Sharma, M.D., Inc., LabOne of Ohio, Inc., LabOne, Inc., MetWest Inc., Nichols Institute Diagnostics, Ocmulgee Medical Pathology Association, Inc.,
  O&#146;Quinn Medical Pathology Association, LLC, Osborn Group Inc., Pathology Building Partnership, PCA of Denver, Inc., PCA of Nashville, Inc., Peter G. Klacsmann, M.D., Inc., Quest Diagnostics
  Clinical Laboratories, Inc., Quest Diagnostics Finance Incorporated, Quest Diagnostics Holdings Incorporated, Quest Diagnostics Incorporated (MD), Quest Diagnostics Incorporated (MI), Quest
  Diagnostics Incorporated (NV), Quest Diagnostics Investments Incorporated, Quest Diagnostics LLC (CT), Quest Diagnostics LLC (IL), Quest Diagnostics LLC (MA), Quest Diagnostics Nichols
  Institute (f/k/a Quest Diagnostics Incorporated (CA)), Quest Diagnostics Nichols Institute, Inc., Quest Diagnostics of Pennsylvania Inc., Regional Pathology Consultants, LLC, Rocky Mountain
  Pathology, LLC, Sharon G. Daspit, M.D., Inc., Shoals Pathology </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-41</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Associates, Inc., Specialty Laboratories, Inc., Strigen, Inc., Systematic Business Services, Inc., TID Acquisition Corp., Unilab Corporation.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Lien&#148; means any pledge, mortgage, lien, encumbrance or other security interest.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Officer&#146;s Certificate&#148; means a certificate signed by any Officer of Quest Diagnostics or any Subsidiary Guarantor, as the case may be, in his or her capacity as such Officer and delivered to the
  trustee.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Permitted Acquired Indebtedness&#148; means any Acquired Indebtedness that remains outstanding following the expiration of a good faith offer by Quest Diagnostics or the Subsidiary of Quest
  Diagnostics obligated under such Acquired Indebtedness to acquire such Acquired Indebtedness, including, without limitation, an offer to exchange such Acquired Indebtedness for debt securities of
  Quest Diagnostics, on terms, which in the opinion of an independent investment banking firm of national reputation and standing, are consistent with market practices in existence at the time for
  offers of a similar nature; <I>provided</I> that the initial expiration date of any such offer shall be not later than the expiration of the 270-day period referred to in the first paragraph of the &#147;Limitation on
  Subsidiary Indebtedness and Preferred Stock&#148; covenant; <I>provided further</I> that the amount of Acquired Indebtedness that shall constitute &#147;Permitted Acquired Indebtedness&#148; shall only be equal to the
  amount of Acquired Indebtedness that Quest Diagnostics or such Subsidiary has made an offer to acquire in accordance with the foregoing.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Person&#148; means any individual, corporation, limited liability company, partnership, joint venture, association, joint stock company, trust, unincorporated organization or government or any agency
  or political subdivision thereof or other similar entity.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Preferred Stock&#148; means, with respect to any Person, any and all shares of preferred stock (however designated) issued by such Person, that is entitled to preference or priority over one or more
  series or classes of capital stock issued by such Person upon any distribution of such Person&#146;s property and assets, whether by dividend or on liquidation, whether now outstanding, or issued after the
  date that the Notes are issued.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Principal Property&#148; means any real property and any related buildings, fixtures or other improvements located in the United States owned by Quest Diagnostics or its Subsidiaries (1) on or in
  which one of its 30 largest domestic clinical laboratories conducts operations, as determined by net revenues for the four most recent fiscal quarters for which financial statements have been filed with
  the Securities and Exchange Commission, or (2) the net book value of which at the time of the determination exceeds 1% of the Consolidated Total Assets of Quest Diagnostics. As of the date of
  this prospectus supplement, Quest Diagnostics and its Subsidiaries owned 13 of the 30 largest domestic clinical laboratories operated by Quest Diagnostics and its Subsidiaries. These 13 owned
  domestic clinical laboratories are &#147;Principal Properties&#148; under the above definition.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Receivables Credit Facility&#148; means any receivables-backed financing transaction including the Existing Receivables Credit Facility, in each case as such transaction may be amended or otherwise
  modified from time to time or refinanced or replaced with respect to all or any portion of the indebtedness under such transaction.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Restricted Subsidiary&#148; means any Subsidiary of Quest Diagnostics that owns a Principal Property.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Sale and Leaseback Transaction&#148; means any arrangement with any person providing for the leasing by Quest Diagnostics or any Restricted Subsidiary of any Principal Property that has been or
  is to be sold or transferred by Quest Diagnostics or any Restricted Subsidiary to such person, as the case may be.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Specified Subsidiaries&#148; means AmeriPath Group Holdings, Inc., AmeriPath Holdings, Inc., AmeriPath Intermediate Holdings, Inc. and MedPlus, Inc.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Subsidiary&#148; of any Person means (1) a corporation, a majority of the outstanding voting stock of which is, at the time, directly or indirectly, owned by such Person by one or more Subsidiaries
  of such Person, or by such Person and one or more Subsidiaries thereof or (2) any other Person (other than a corporation), including, without limitation, a partnership or joint venture, in which such </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-42</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Person, one or more Subsidiaries thereof or such Person and one or more Subsidiaries thereof, directly or indirectly, at the date of determination thereof, has at least majority ownership interest
  entitled to vote in the election of directors, managers or trustees thereof (or other Person performing similar functions).</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Subsidiary Guarantors&#148; means, at any time, (1) each Initial Subsidiary Guarantor and (2) each existing and future domestic Subsidiary of Quest Diagnostics which is required to guarantee the
  obligations of Quest Diagnostics under the Notes, <I>provided</I> that, in each case, such Initial Subsidiary Guarantor or such other domestic Subsidiary continues to guarantee the Notes at such time.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-43</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=united1>UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following discussion is a summary of the material United States federal income tax consequences and, in the case of a non-United States Holder (as defined below), the material United
  States federal estate tax consequences, relevant to the purchase, ownership and disposition of the Notes, but does not purport to be a complete analysis of all potential tax effects. The discussion is
  based upon the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), United States Treasury Regulations issued thereunder, Internal Revenue Service (&#147;IRS&#148;) rulings and pronouncements and
  judicial decisions now in effect, all of which are subject to change at any time. Any such change may be applied retroactively in a manner that could adversely affect a beneficial owner of the Notes.
  This discussion does not address all of the United States federal income tax consequences that may be relevant to a beneficial owner of the Notes in light of its particular circumstances or to
  beneficial owners of the Notes subject to special rules, such as certain financial institutions, U.S. expatriates, insurance companies, dealers in securities or foreign currencies, traders in securities,
  &#147;United States Holders&#148; (as defined below) whose functional currency is not the U.S. dollar, partnerships and other pass through entities and their beneficial owners, tax-exempt organizations and
  persons holding the notes as part of a &#147;straddle,&#148; &#147;hedge,&#148; &#147;conversion transaction&#148; or other integrated transaction. In addition, this discussion is limited to beneficial owners of the Notes that
  purchase the Notes for cash in this offering at a price equal to their &#147;issue price&#148; within the meaning of Section 1273 of the Code. Moreover, the effect of any applicable state, local or foreign tax
  laws is not discussed. The discussion deals only with Notes held as &#147;capital assets&#148; within the meaning of Section 1221 of the&nbsp;Code.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">As used in this prospectus supplement, &#147;United States Holder&#148; means a beneficial owner of the Notes that is for United States federal income tax purposes:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      a citizen or resident alien individual of the United States;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a corporation or other entity taxable as a corporation created or organized in or under the laws of the United States, any State thereof or the District of Columbia;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">an estate the income of which is subject to United States federal income tax regardless of its source; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a trust, if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if the
      trust was in existence on August 20, 1996 and has elected to continue to be treated as a United States person.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">A &#147;non-United States Holder&#148; is a beneficial owner of Notes that is neither a United States Holder nor a partnership or other entity treated as a partnership for United States federal income tax
  purposes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If a beneficial owner of the Notes is a partnership or other entity treated as a partnership for United States federal income tax purposes, the tax treatment of the partnership and each partner in
  such partnership generally will depend on the activities of the partnership and the status of the partner. Partnerships that hold Notes, and partners in such partnerships, should consult their own tax
  advisors.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Prospective investors should consult their own tax advisors with regard to the application of the tax consequences discussed below to their particular situations as well as the application of any
  state, local, foreign or other tax laws, including gift and estate tax laws.</B></FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>United States Holders</B></FONT></P>
<P style="margin:3.5mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Interest</I></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Payments of stated interest on the Notes will be taxable to a United States Holder as ordinary income at the time that such payments are received or accrued, in accordance with such United
  States Holder&#146;s regular method of accounting for United States federal income tax purposes.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-44</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="margin:4.2mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Sale or Other Taxable Disposition of the Notes</I></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">A United States Holder will recognize gain or loss on the sale, exchange (including, in certain circumstances, a deemed exchange as a result of an assumption by any Person of our obligations
  under the Notes and the Indenture as described under &#147;Description of Notes&#151;Merger, Consolidation or Sale of Assets&#148;), redemption, retirement or other taxable disposition of a Note in an amount
  equal to the difference between the amount realized upon the disposition (less any portion allocable to any accrued and unpaid interest, which will be taxable as ordinary interest income to the extent
  not previously included in gross income) and the United States Holder&#146;s tax basis in the Note. Such gain or loss generally will be a capital gain or loss, and will be a long-term capital gain or loss if
  the United States Holder has held the Note for more than one year at the time of the disposition. A United States Holder&#146;s tax basis in a Note generally will be the price such holder paid for the
  Note. Long-term capital gains of individuals generally are eligible for reduced rates of United States federal income tax. The deductibility of capital losses is subject to limitations under the Code.</FONT></P>
<P style="margin:6.3mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Backup Withholding</I></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">A United States Holder may be subject to backup withholding tax, currently at a 28% rate, when such holder receives interest and principal payments on the Notes, or upon the proceeds
  received from the sale or other disposition of such Notes. Certain United States Holders (including, among others, corporations and certain tax-exempt organizations) generally are exempt from
  backup withholding. A non-exempt United States Holder will be subject to this backup withholding tax if such holder:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      fails to furnish its taxpayer identification number (&#147;TIN&#148;), which, for an individual, ordinarily is his or her social security number;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">furnishes an incorrect TIN;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">is notified by the IRS that the United States Holder has failed to properly report payments of interest or dividends; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">fails to certify, under penalties of perjury, that the United States Holder is a United States person, has furnished a correct TIN and that the IRS has not notified the United States Holder that
      it is subject to backup withholding.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">United States Holders should consult their personal tax advisors regarding their qualification for an exemption from backup withholding and the procedures for obtaining such an exemption, if
  applicable. The backup withholding tax is not an additional tax and United States Holders may use amounts withheld as a refund or credit against their United States federal income tax liability so
  long as the requisite information is timely furnished to the IRS.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Non-United States Holders</B></FONT></P>
<P style="margin:3.5mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Interest Payments and Gains from Dispositions</I></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Interest paid to a non-United States Holder generally will not be subject to United States federal income tax, and United States federal withholding tax of 30% (or, if applicable, a lower treaty
  rate) will not apply, provided:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      such holder does not directly or indirectly, actually or constructively, own 10% or more of our voting stock;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">such holder is not a controlled foreign corporation that is related to us through sufficient stock ownership and is not a bank that receives the interest on an extension of credit made pursuant to
      a loan agreement entered into in the ordinary course of its trade or business;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">such interest is not effectively connected with a trade or business conducted by the non-United States Holder within the United States (or, if an income tax treaty applies, is not attributable to
      a United States &#147;permanent establishment&#148; maintained by the non-United States Holder); and</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>
</TABLE>

<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-45</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">

  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">either (1) the non-United States Holder certifies to us or our paying agent, under penalties of perjury, that it is not a &#147;United States person&#148; within the meaning of the Code and provides its
      name and address, or (2) a securities clearing organization, bank or other financial institution that holds customers&#146; securities in the ordinary course of its trade or business and holds the Notes
      on behalf of the non-United States Holder certifies to us or our paying agent under penalties of perjury that it, or the financial institution between it and the non-United States Holder, has
      received from the non-United States Holder a statement, under penalties of perjury, that such non-United States Holder is not a &#147;United States person&#148; and provides us or our paying agent
      with a copy of this statement.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>

<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If you cannot satisfy the requirements described above, payments of interest made to you will be subject to the 30% United States federal withholding tax, unless you provide us or our paying
  agent with a properly executed (1) IRS Form W-8BEN (or other applicable form) claiming an exemption from or reduction in withholding under the benefit of an applicable tax treaty or (2) IRS
  Form W-8ECI (or other applicable form) stating that interest paid on your Note is not subject to withholding tax because it is effectively connected with your conduct of a trade or business in the
  United States. The certification requirement described above may require a non-United States Holder that provides an IRS form to also provide its TIN. Prospective investors should consult their tax
  advisors regarding the certification requirements for non-United States Holders.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">A non-United States Holder generally will not be subject to United States federal income or withholding tax on gain and any accrued interest recognized on the sale, exchange, redemption,
  retirement or other disposition of a Note unless (1) such gain is effectively connected with a trade or business conducted by the non-United States Holder within the United States (and, if required by
  an applicable income tax treaty, is attributable to a United States &#147;permanent establishment&#148; maintained by the non-United States Holder), (2) such holder is an individual who was present in the
  United States for 183 days or more in the taxable year of the disposition and certain other conditions are met (in which case, except as otherwise provided by an applicable income tax treaty, such
  gain, which may be offset by United States source capital losses, generally will be subject to a flat 30% United States federal income tax, even though the holder is not considered a resident alien
  under the Code) or (3) in the case of accrued interest, such accrued interest does not qualify for the exemption from United States federal income tax and United States federal withholding tax
  discussed above.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If interest on the Notes or gain from a disposition of the Notes is effectively connected with a non-United States Holder&#146;s conduct of a United States trade or business (and, if required by an
  applicable income tax treaty, is attributable to a United States &#147;permanent establishment&#148; maintained by the non-United States Holder), the non-United States Holder generally will be subject to
  United States federal income tax on the interest or gain on a net basis in the same manner as United States Holders. For effectively-connected interest, the 30% withholding tax described above will
  not apply (assuming an appropriate certification is timely provided). A foreign corporation that is a holder of a Note also may be subject to a branch profits tax equal to 30% of its effectively
  connected earnings and profits for the taxable year, subject to certain adjustments, unless it qualifies for a lower rate under an applicable income tax treaty.</FONT></P>
<P style="margin:6.3mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>United States Federal Estate Tax</I></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If you are an individual and are not a United States citizen or a resident of the United States (as specially defined for United States federal estate tax purposes) at the time of your death, your
  Notes generally will not be subject to the United States federal estate tax, unless, at the time of your death:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      you directly or indirectly, actually or constructively, own 10% or more of our voting stock; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">interest on your Notes is effectively connected with your conduct of a United States trade or business.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-46</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="margin:4.2mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><I>Backup Withholding and Information Reporting</I></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Backup withholding and information reporting generally will not apply to payments made by us or our paying agents, in their capacities as such, to a non-United States Holder of a Note if the
  holder has provided the required certification that it is not a United States person as described above, provided that neither we nor our paying agent has actual knowledge that the holder is a United
  States person. However, we or our paying agent may be required to report to the IRS and to non-United States Holders payments of interest on the Notes and the amount of tax, if any, withheld
  with respect to those payments. Copies of the information returns reporting such interest payments and any withholding may also be made available to the tax authorities in the country in which such
  non-United States Holders reside under the provisions of a treaty or agreement.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">If a non-United States Holder sells a Note outside the United States through a non-U.S. office of a non-U.S. broker and the sales proceeds are paid to the non-United States Holder outside the
  United States, then backup withholding and information reporting generally will not apply to that payment. However, information reporting, but not backup withholding, will apply to a payment of
  sales proceeds, even if that payment is made outside the United States, if a non-United States Holder sells a Note through a non-U.S. office of a broker that is:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-size:3.8mm; color:#000cb2; ">
      &#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      a United States person;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a controlled foreign corporation for United States federal income tax purposes:</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a foreign person 50% or more of whose gross income is effectively connected with a United States trade or business for a specified three-year period; or</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:4pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-size:3.8mm; color:#000cb2; ">&#149;</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">a foreign partnership, if at any time during its tax year, one or more of its partners are United States persons, as defined in Treasury regulations, who in the aggregate hold more than 50% of
      the income or capital interest in the partnership or if, at any time during its tax year, the foreign partnership is engaged in a United States trade or business;</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">unless such broker has documentary evidence in its possession of the non-United States Holder&#146;s foreign status and has no knowledge to the contrary, or the non-United States Holder otherwise
  establishes an exemption.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Payment of the proceeds from a disposition by a non-United States Holder of a Note made to or through the United States office of a broker will be subject to information reporting and backup
  withholding unless the non-United States Holder certifies that it is not a &#147;United States person&#148; or otherwise establishes an exemption from information reporting and backup withholding.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Non-United States Holders should consult their own tax advisors regarding application of backup withholding in their particular circumstance and the availability of and procedure for obtaining
  an exemption from backup withholding under current Treasury Regulations. Any amounts withheld under the backup withholding rules from a payment to a non-United States Holder will be allowed
  as a refund or a credit against the holder&#146;s United States federal income tax liability, provided the required information is timely furnished to the IRS.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-47</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=underwriting1>UNDERWRITING</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Under the terms and subject to the conditions contained in an underwriting agreement dated the date of this prospectus supplement, the underwriters named below for whom Morgan Stanley &amp;
  Co. Incorporated, Banc of America Securities LLC and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated are acting as joint book-running managers and representatives, have severally agreed to
  purchase, and we have agreed to sell to them, severally, the principal amount of notes indicated in the table below:</FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:63.50%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:15.62%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:15.62%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2"><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
       <font style="word-spacing: 4.67pc;">&nbsp;</font> <u style="border-bottom: 0.50pt black;">Name</u></B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>Principal Amount of</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; ">
    <P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>6.40% Senior Notes<br>due 2017</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; ">
    <P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>6.95% Senior Notes<br>due 2037</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Morgan Stanley &amp; Co. Incorporated</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 131,250,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 148,750,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Banc of America Securities LLC</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 93,750,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 106,250,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Merrill Lynch, Pierce, Fenner &amp; Smith<br>Incorporated</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 93,750,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 106,250,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Barclays Capital Inc.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 18,750,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 21,250,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">J.P. Morgan Securities Inc.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 18,750,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 21,250,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Wachovia Capital Markets, LLC</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 18,750,000</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 21,250,000</FONT></P></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> <font style="word-spacing: 4.67pc;">&nbsp;</font>Total</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></div></TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></div></TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></div></td>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 375,000,000</FONT></P></div></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; ">
	<DIV style="border-bottom:solid 0.2mm #000cb2; "><p>&nbsp;</p></div></TD>
    <TD width="3">&nbsp;</TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><font style="font-size:0.2mm">&nbsp;</font></P></div></TD>
    <TD style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">$</FONT></P></div></TD>
    <td style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; "><P><font style="font-size:0.2mm">&nbsp;</font></P></div></td>
    <TD align="right" style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; ">
    <P style="text-indent:-19.7mm; margin:0 0 0 19.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "> 425,000,000</FONT></P></div></TD>
    <TD colspan="2" style="border-bottom:solid 0.2mm #000cb2; "><DIV style="border-bottom:solid 0.2mm #000cb2; ">
    <p>&nbsp;</p></div></TD>
  </TR>
</TABLE>



<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The underwriters are offering the notes subject to their acceptance of the notes from us and subject to prior sale. The underwriting agreement provides that the obligations of the several
  underwriters to pay for and accept delivery of the notes offered by this prospectus supplement are subject to the approval of certain legal matters by their counsel and to certain other conditions. The
  underwriters are obligated to take and pay for all the notes offered by this prospectus supplement if any such notes are taken.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The underwriters initially propose to offer part of the notes directly to the public at the public offering prices set forth on the cover page of this prospectus supplement and part to certain dealers
  at a price that represents a concession not in excess of .40% of the principal amount of the 6.40% Senior Notes due 2017 and .50% of the principal amount of the 6.95% Senior Notes due 2037. Any
  such dealers may resell any notes purchased from the underwriters to certain other brokers or dealers at a discount not to exceed .20% of the principal amount of the 6.40% Senior Notes due 2017
  and .25% of the principal amount of the 6.95% Senior Notes due 2037. After the initial offering of the notes, the offering price and other selling terms may from time to time be varied by the
  representatives.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The following table shows the per note and total public offering price, underwriting discount, and proceeds before expenses to us.</FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:50.94%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.21%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:12.06%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:7.21%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:12.06%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>
  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      6.40% Senior Notes<br>due 2017</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="13" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      6.95% Senior Notes<br>due 2037</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Per Note</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Total</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Per Note</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Total</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Public offering price (1)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      99.786</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       %</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       374,197,500</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      98.891</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       %</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       420,286,750</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Underwriting discount</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      0.650</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       %</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       2,437,500</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      0.875</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       %</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       3,718,750</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Proceeds, before expenses, to us</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      99.136</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       %</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       371,760,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      98.016</FONT></P></TD>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       %</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      $</FONT></P></TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
       416,568,000</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>


<P style="text-indent:7mm; margin:4mm 0 0.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="left" style="width:4.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 -8.7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&nbsp;</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:0.00pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:18pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      (1)</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Plus accrued interest from June 22, 2007, if settlement occurs after that date.</FONT>
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>



<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The estimated offering expenses payable by us, exclusive of the underwriting discount, are approximately $0.4<font style="word-spacing: 1.00pc;"></font> million.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In order to facilitate the offering of the notes, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the prices of the notes. Specifically, the underwriters may
  over-allot in connection with the offering, creating short positions in the notes for their own account. In addition, to cover over-allotments or to stabilize the prices of the notes, the underwriters may
  bid for, and purchase notes on the open market. Finally, the underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for distributing the notes in the offering, if
  the syndicate repurchases previously distributed notes in transactions to cover syndicate short positions, </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-48</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the notes above independent market levels. The underwriters are not required to engage
  in these activities, and may end any of these activities at any time.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Prior to the offering, there have been no active markets for the notes. The underwriters have advised us that certain of the underwriters presently intend to make markets in the notes as
  permitted by applicable laws and regulations. Such underwriters are not obligated, however, to make the markets in the notes and any such market making may be discontinued at any time at the
  discretion of such underwriters. Accordingly, no assurance can be given as to the liquidity of, or trading markets for, the notes.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The prospectus as supplemented by this prospectus supplement in electronic format may be made available on websites maintained by one or more underwriters, or selling group members, if any,
  participating in this offering. The representatives may agree to allocate a number of notes of each series to underwriters for sale to their online brokerage account holders. Internet distributions will
  be allocated by the representatives to underwriters that may make Internet distributions on the same basis as other allocations.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The underwriters and their affiliates have from time to time provided, and expect to provide in the future, investment banking, commercial banking and other financial transactions with us and
  our affiliates, for which they have received and may continue to receive customary fees and commissions. Affiliates of the underwriters are lenders under our May 2007 term loan and bridge loan
  facility, for which they receive customary fees, and may receive a portion of amounts to be repaid under our May 2007 bridge credit loan facility from the proceeds of this offering. See &#147;Use of
  Proceeds.&#148; Because more than 10% of the net proceeds of this offering may be received by National Association of Securities Dealers, Inc., or NASD, members participating in the offering or their
  affiliates or associated persons, this offering will be conducted in accordance with NASD Conduct Rule 2710(h).</FONT></P>
<P style="margin:6.3mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>European Economic Area</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a Relevant Member State), each underwriter has represented and agreed
  that with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State (the Relevant Implementation Date) it has not made and will not make an
  offer of notes to the public in that Relevant Member State prior to the publication of a prospectus in relation to the notes which has been approved by the competent authority in that Relevant Member
  State or, where appropriate, approved in another Relevant Member State and notified to the competent authority in that Relevant Member State, all in accordance with the Prospectus Directive, except
  that it may, with effect from and including the Relevant Implementation Date, make an offer of notes to the public in that Relevant Member State at any time:</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(a) to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b) to any legal entity which has two or more of (1) an average of at least 250 employees during the last financial year; (2) a total balance sheet of more than </FONT><FONT style="font-size:3.8mm; color:#000cb2; ">&#128;<FONT style="font-family:serif; ">43,000,000 and (3) an annual
  net turnover of more than </FONT>&#128;<FONT style="font-family:serif; ">50,000,000, as shown in its last annual or consolidated accounts; or</FONT></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(c) in any other circumstances which do not require the publication by the Issuer of a prospectus pursuant to Article 3 of the Prospectus Directive.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">For the purposes of this provision, the expression an &#147;offer of notes to the public&#148; in relation to any notes in any Relevant Member State means the communication in any form and by any
  means of sufficient information on the terms of the offer and the notes to be offered so as to enable an investor to decide to purchase or subscribe the notes, as the same may be varied in that
  Member State by any measure implementing the Prospectus Directive in that Member State and the </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-49</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">expression Prospectus Directive means Directive 2003/71/EC and includes any relevant implementing measure in each Relevant Member State.</FONT></P>
<P style="margin:6.3mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>United Kingdom</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Each underwriter has represented and agreed that it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement
  to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of the notes in circumstances in which Section
  21(1) of such Act does not apply to us and it has complied and will comply with all applicable provisions of such Act with respect to anything done by it in relation to any notes in, from or
  otherwise involving the United Kingdom.</FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=legal1>LEGAL MATTERS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Certain legal matters in connection with the notes offered hereby will be passed upon for us by Leo C. Farrenkopf, Vice President and Assistant General Counsel of Quest Diagnostics, and by
  Shearman &amp; Sterling LLP, New York, New York. Certain legal matters in connection with the notes offered hereby will be passed upon for the underwriters by Fried, Frank, Harris, Shriver &amp; Jacobson
  LLP, New York, New York.</FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=experts1>EXPERTS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The consolidated statements and management&#146;s assessment of the effectiveness of internal control over financial reporting of Quest Diagnostics (which is included in Management&#146;s Report on
  Internal Control over Financial Reporting) incorporated in this prospectus supplement by reference to Quest Diagnostics&#146; Annual Report on Form 10-K for the year ended December 31, 2006, have
  been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and
  accounting.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The consolidated financial statements of AmeriPath, Inc. incorporated by reference in this prospectus supplement for the year ended December&nbsp;31, 2006 have been audited by Ernst &amp; Young LLP,
  independent auditors, as set forth in their report thereon incorporated by reference herein. Such consolidated financial statements are incorporated herein by reference in reliance upon such report
  given on the authority of such firm as experts in accounting and auditing.</FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=where1>WHERE YOU CAN FIND MORE INFORMATION</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission, or the SEC. You may read and copy any reports, statements
  or other information we file with the SEC at its public reference rooms at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public
  reference rooms. Our filings are also available to the public on the Internet, through a database maintained by the SEC at http://www.sec.gov. In addition, you can inspect and copy our reports, proxy
  statements and other information at the offices of the New York Stock Exchange, Inc., 20 Broad Street, New York, New York 10005.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our subsidiary guarantors do not file separate financial statements with the SEC and do not independently publish their financial statements. Instead, our subsidiary guarantors&#146; financial
  condition, results of operations and cash flows are consolidated into our financial statements. Summarized financial information illustrating our subsidiary guarantors&#146; financial condition, results of
  operations and cash flows, on a combined basis, is disclosed in the notes to our consolidated financial statements which are incorporated by reference into this prospectus supplement, as noted below.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The SEC allows us to incorporate by reference into this document the information we filed with it. This means that we can disclose important business, financial and other information to you by </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-50</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">referring you to other documents separately filed with the SEC. All information incorporated by reference is part of this document, unless and until that information is updated and superseded by the
  information contained in this document or any information incorporated later.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We incorporate by reference the documents listed below:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Our current reports on Form 8-K, filed February 5, 2007, February 16, 2007, April 2, 2007, April 16, 2007, April 19, 2007, May 22, 2007, May 31, 2007, June 6, 2007 and June 14, 2007;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2007;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">3.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our Annual Report on Form 10-K for the fiscal year ended December 31, 2006;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">4.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Item 8. Financial Statements and Supplementary Data; Index to Consolidated Financial Statements&#148; in the Annual Report on Form 10-K of AmeriPath, Inc., for the fiscal year ended
      December 31, 2006; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">5.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Item 1. Financial Statements&#148; in the Quarterly Report on Form 10-Q of AmeriPath, Inc., for the quarter ended March 31, 2007.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our filings with the SEC, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, current reports on Form 8-K and amendments to those reports, are available free of
  charge on our website as soon as reasonably practicable after they are filed with, or furnished to, the SEC. Our internet website is located at http://www.questdiagnostics.com. The contents of the
  website are not incorporated by reference into this prospectus. You also may request a copy of these filings, at no cost, by writing or telephoning our Investor Relations Department at the following
  address:</FONT></P>
<P style="margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics Incorporated<br>1290 Wall Street West<br>Lyndhurst, New Jersey 07071<br>Attention: Investor Relations<br>(201) 393-5000</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We also incorporate by reference all future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934 prior to the termination of the offering
  made hereby.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">You should rely only on the information contained or incorporated by reference in this prospectus supplement. We have not authorized any other person to provide you with different
  information. If anyone provides you with different or inconsistent information you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where the offer and sale
  is not permitted. You should assume that the information appearing in this prospectus supplement and information incorporated by reference into this prospectus supplement is accurate only as of the
  date of the documents containing the information. Our business, financial condition, cash flows, results of operation and prospects may have changed since that date.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">S-51</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center"><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(This Page Intentionally Left Blank)</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=prospectus2>PROSPECTUS</a></B></FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>SUBJECT TO COMPLETION, DATED JUNE 19, 2007</B></FONT></P>
<P align="center" style="margin:14.8mm 0 0; "><FONT style="font-family:serif; font-size:6.6mm; color:#000cb2; "><B>QUEST DIAGNOSTICS INCORPORATED</B></FONT></P>
<P align="center" style="margin:14.8mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><p align="center"><img src="questcolorlogo.jpg" style="margin:0 0 0 0; border:   ;"></p></B></FONT></P>
<P align="center" style="margin:14.8mm 0 0; "><FONT style="font-family:serif; font-size:5.2mm; color:#000cb2; "><B>Debt Securities<br>Guarantees of Debt Securities</B></FONT></P>
<P style="text-indent:7mm; margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We may offer and sell, from time to time, in one or more offerings, the debt securities we describe in this prospectus, for sale directly to purchasers or through underwriters, dealers or agents to
  be designated at a future date.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our debt securities may be fully and unconditionally guaranteed on an unsecured basis by our subsidiaries.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We will provide the specific terms of these debt securities in supplements or term sheets to this prospectus. <B>We urge you to read carefully this prospectus, the accompanying prospectus
  supplements and term sheets, which will describe the specific terms of the securities offered, before you make your investment decision.</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Investing in our debt securities involves risks that are described in the &#147;Risk Factors&#148; section of our periodic reports filed with the Securities and Exchange Commission or in the applicable
  prospectus supplement.</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus.
  Any representation to the contrary is a criminal offense.</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:8.00pc; height:0.50pt;;"></FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The date of this prospectus is June 19, 2007</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>TABLE OF CONTENTS</B></FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:93.57%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.80%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Page</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#about1>About This Prospectus</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      ii</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#quest1>Quest Diagnostics Incorporated</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      ii</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#where2>Where You Can Find More Information</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      iii</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#cautionary2>Cautionary Statement for Purposes of the &#147;Safe Harbor&#148; Provisions of the Private Securities Litigation Reform Act of 1995</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#use2>Use of Proceeds</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      3</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#ratio2>Ratio of Earnings to Fixed Charges</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      4</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#securities1>Securities We May Issue</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#description3>Description of Senior Debt Securities and Guarantees of Senior Debt Securities</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      6</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#plan1>Plan of Distribution</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      7</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#validity1>Validity of the Securities</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><a href=#experts2>Experts</a></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>



<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">i</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=about1>ABOUT THIS PROSPECTUS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The information contained in this prospectus is not complete and may be changed. You should rely only on the information provided in or incorporated by reference in this prospectus, any
  prospectus supplement, any pricing supplement or documents to which we otherwise refer you. We have not authorized anyone else to provide you with different information. We are not making an
  offer of any securities in any jurisdiction where the offer is not permitted. You should not assume that the information in this prospectus, any prospectus supplement or any document incorporated by
  reference is accurate as of any date other than the date of the document in which such information is contained or such other date referred to in such document, regardless of the time of any sale or
  issuance of a security.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &#147;SEC&#148;) using a &#147;shelf&#148; registration process. This prospectus provides you with
  a general description of the securities we may offer. Each time we sell or issue securities, we will provide a prospectus supplement and, if applicable, a pricing supplement, that will contain specific
  information about the terms of that specific offering of securities and the specific manner in which they may be offered. The prospectus supplement and any applicable pricing supplement may also
  add to, update or change any of the information contained in this prospectus. The prospectus supplement and any applicable pricing supplement may also contain information about any material U.S.
  federal income tax considerations relating to the securities described in the prospectus supplement. You should read both this prospectus, the applicable prospectus supplement and any applicable
  pricing supplement, together with the additional information described under &#147;Where You Can Find More Information.&#148; You should read the entire prospectus and the applicable prospectus
  supplement, including the information incorporated by reference, before making an investment decision. As used in this prospectus, the terms &#147;Quest Diagnostics,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to
  Quest Diagnostics Incorporated and its consolidated subsidiaries, unless the context clearly indicates otherwise.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual document for complete information. All of the
  summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed or will be filed or incorporated by reference as exhibits to the
  registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under &#147;Where You Can Find More Information.&#148;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The registration statement that contains this prospectus (including the exhibits to the registration statement) contains additional information about us and the securities offered under this
  prospectus. That registration statement can be read at the SEC web site (www.sec.gov) or at the SEC offices mentioned under the heading &#147;Where You Can Find More Information.&#148;</FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=quest1>QUEST DIAGNOSTICS INCORPORATED</a></B></FONT></P>
<P style="margin:3.5mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>The Company</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We are the nation&#146;s leading provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve
  health. We offer patients and physicians the broadest access to diagnostic laboratory services through our nationwide network of laboratories and our own patient service centers. We provide
  interpretive consultation through the largest medical and scientific staff in the industry, with approximately 900 M.D.&#146;s and Ph.D.&#146;s around the country. We are the leading provider of esoteric testing,
  including gene-based testing, the leading provider of anatomic pathology services, including dermatopathology, and the leading provider of testing for drugs of abuse. We are also a leading provider of
  testing for clinical trials and risk assessment services for the life insurance industry. We empower healthcare organizations and clinicians with state-of-the-art information technology solutions that can
  improve patient care and medical practice.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">During 2006, we generated net revenues of $6.3 billion and processed approximately 151 million requisitions for testing. Each requisition form accompanies a patient specimen, indicating the tests to </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">ii</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">be performed and the party to be billed for the tests. Our customers include patients, physicians, hospitals, employers, governmental institutions and other commercial clinical laboratories. On May&nbsp;31,
  2007, we acquired AmeriPath Group Holdings, Inc., the ultimate parent of AmeriPath, Inc., which generated net revenues of $752 million during 2006.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We operate a nationwide network of greater than 2,100 of our own patient service centers, principal clinical laboratories located in more than 30 major metropolitan areas throughout the United
  States and approximately 150 smaller &#147;rapid response&#148; laboratories (including, in each case, facilities operated at our joint ventures). We provide full esoteric testing services, including gene-based
  testing, on both coasts through our Quest Diagnostics Nichols Institute laboratory facilities, located in San Juan Capistrano, California and Chantilly, Virginia, and through our Specialty Laboratories
  facility located in Valencia, California, as well as infectious and immunologic disease testing through our Focus Diagnostics laboratory facility, located in Cypress, California. Our AmeriPath subsidiary
  operates 40 outpatient anatomic pathology laboratories and provides inpatient anatomic pathology and medical director services for approximately 200 hospitals throughout the country. We also have
  laboratory facilities in Mexico City, Mexico, San Juan, Puerto Rico and Heston, England.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We are a Delaware corporation. We are the successor to MetPath Inc., a New York corporation that was organized in 1967. From 1982 to 1996, we were a subsidiary of Corning Incorporated, or
  Corning. On December 31, 1996, Corning distributed all of the outstanding shares of our common stock to the stockholders of Corning. In August 1999, we completed the acquisition of SmithKline
  Beecham Clinical Laboratories, Inc., or SBCL, which operated the clinical laboratory business of SmithKline Beecham plc, or SmithKline Beecham.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our principal executive offices are located at 1290 Wall Street West, Lyndhurst, New Jersey 07071, telephone number: (201) 393-5000.</FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=where2>WHERE YOU CAN FIND MORE INFORMATION</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We file annual, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any reports, statements or other information we file with the SEC at
  its public reference rooms at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference rooms. Our filings are also available
  to the public on the Internet, through a database maintained by the SEC at http://www.sec.gov. In addition, you can inspect and copy our reports, proxy statements and other information at the
  offices of the New York Stock Exchange, Inc., 20 Broad Street, New York, New York 10005.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our subsidiary guarantors do not file separate financial statements with the SEC and do not independently publish their financial statements. Instead, our subsidiary guarantors&#146; financial
  condition, results of operations and cash flows are consolidated into our financial statements. Summarized financial information illustrating our subsidiary guarantors&#146; financial condition, results of
  operations and cash flows, on a combined basis, is disclosed in the notes to our consolidated financial statements which are incorporated by reference into this prospectus, as noted below. The
  summarized financial information does not include the subsidiaries recently acquired in our acquisition of AmeriPath Group Holdings, Inc.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The SEC allows us to incorporate by reference into this document the information we filed with it. This means that we can disclose important business, financial and other information to you by
  referring you to other documents separately filed with the SEC. All information incorporated by reference is part of this document, unless and until that information is updated and superseded by the
  information contained in this document or any information incorporated later.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We incorporate by reference the documents listed below:</FONT></P>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      1.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      Our current reports on Form 8-K, filed February 5, 2007, February 16, 2007, April 2, 2007, April 16, 2007, April 19, 2007, May 22, 2007, May 31, 2007, June 6, 2007 and June 14, 2007;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2007;</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">3.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our Annual Report on Form 10-K for the fiscal year ended December 31, 2006;</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>
</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">iii</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<TABLE cellspacing=0 cellpadding=0 style="margin-left:1.67pc;font-size:0.2mm;">

  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:8pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">4.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Item 8. Financial Statements and Supplementary Data; Index to Consolidated Financial Statements&#148; in the Annual Report on Form 10-K of AmeriPath, Inc., for the fiscal year ended
      December 31, 2006; and</FONT></P></TD>
  </TR>
  <TR valign="top">
    <TD style="width:11pt;"><p style="margin-top:0pt;">&nbsp;</p></td>

  </TR>
  <TR valign="top">
    <TD align="right">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">5.</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD>
    <P style="margin:2.1mm 0 0; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="17">
    <P style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">&#147;Item 1. Financial Statements&#148; in the Quarterly Report on Form 10-Q of AmeriPath, Inc., for the quarter ended March 31, 2007.</FONT></P>
    <P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "></FONT></P></TD>
  </TR>

</TABLE>

<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Our filings with the SEC, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, current reports on Form 8-K and amendments to those reports, are available free of
  charge on our website as soon as reasonably practicable after they are filed with, or furnished to, the SEC. Our internet website is located at http://www.questdiagnostics.com. The contents of the
  website are not incorporated by reference into this prospectus. You also may request a copy of these filings, at no cost, by writing or telephoning our Investor Relations Department at the following
  address:</FONT></P>
<P style=" margin:2.1mm 0 0 14.1mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Quest Diagnostics Incorporated<br>1290 Wall Street West<br>Lyndhurst, New Jersey 07071<br>Attention: Investor Relations<br>(201) 393-5000</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We also incorporate by reference all future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities and Exchange Act of 1934 prior to the termination of the
  offering made hereby.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">iv</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=cautionary2>CAUTIONARY STATEMENT FOR PURPOSES OF THE &#147;SAFE HARBOR&#148; PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Some statements and disclosures in this prospectus, or any accompanying prospectus supplement and the documents incorporated herein or therein by reference are forward-looking statements.
  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#147;may,&#148; &#147;believe,&#148; &#147;will,&#148; &#147;expect,&#148; &#147;project,&#148;
  &#147;estimate,&#148; &#147;anticipate,&#148; &#147;plan&#148; or &#147;continue.&#148; These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could
  significantly cause our plans and expectations, including actual results, to differ materially from the forward-looking statements. The Private Securities Litigation Reform Act of 1995, or the Litigation
  Reform Act, provides a &#147;safe harbor&#148; for forward-looking statements to encourage companies to provide prospective information about their companies without fear of litigation.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We would like to take advantage of the &#147;safe harbor&#148; provisions of the Litigation Reform Act in connection with the forward-looking statements included or incorporated by reference in this
  document. Investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented or incorporated by reference in this document. The following
  important factors could cause our actual financial results to differ materially from those projected, forecasted or estimated by us in forward-looking statements:</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(a) Heightened competition, including increased pricing pressure, competition from hospitals, and competition from physicians.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(b) Impact of changes in payer mix, including any shift from fee-for-service to capitated fee arrangements.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(c) Adverse actions by government or other third-party payers, including unilateral reduction of fee schedules payable to us, competitive bidding, an increase in the practice of negotiating for
  exclusive arrangements that involve aggressively priced capitated or fee for service payments by healthcare insurers or other payers and threats by third-party payers against physicians and
  patients that effectively eliminate their choice to use an out-of-network provider under preferred provider organization and similar plans.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(d) The impact upon our testing volume and collected revenue or general or administrative expenses resulting from our compliance with Medicare and Medicaid administrative policies and
  requirements of third-party payers. These include:</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 14.1mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(1) the requirements of Medicare carriers to provide diagnosis codes for many commonly ordered tests and the possibility that third-party payers will increasingly adopt similar
  requirements;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 14.1mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(2) the policy of the Centers for Medicare and Medicaid Services to limit Medicare reimbursement for tests contained in automated chemistry panels to the amount that would have been
  paid if only the covered tests, determined on the basis of demonstrable &#147;medical necessity,&#148; had been ordered;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 14.1mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(3) continued inconsistent practices among the different local carriers administering Medicare;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 14.1mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(4) inability to obtain from patients an advance beneficiary notice form for tests that cannot be billed without prior receipt of the form;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 14.1mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(5) the potential need to monitor charges and lower certain fees to Medicare to comply with the Office of the Inspector General&#146;s proposed rule pertaining to exclusion of providers for
  submitting claims to Medicare containing charges that are substantially in excess of the provider&#146;s usual charges; and</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 14.1mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(6) increased challenges in operating as a non-contracted provider with respect to healthcare insurers.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(e) Adverse results from pending or future government investigations, lawsuits or private actions. These include, in particular, significant monetary damages, loss or suspension of </FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">1</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="margin:0 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">licenses, and/or suspension or exclusion from the Medicare and Medicaid programs and/or criminal penalties.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(f) Failure to efficiently integrate acquired businesses and to manage the costs related to any such integration, or to retain key technical, medical and management personnel.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(g) Inability to obtain professional liability or other insurance coverage or a material increase in premiums for such coverage or reserves for self-insurance.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(h) Denial of certification under the Clinical Laboratory Improvement Amendments of 1988, or CLIA, or denial of other licenses for any of our clinical laboratories under the CLIA
  standards, revocation or suspension of the right to bill the Medicare and Medicaid programs or other adverse regulatory actions by federal, state and local agencies.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(i) Changes in federal, state or local laws or regulations, including changes that result in new or increased federal or state regulation of commercial clinical laboratories, including regulation
  by the Food and Drug Administration.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(j) Inability to achieve expected benefits from our acquisitions of other businesses.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(k) Inability to achieve additional benefits from our Six Sigma and standardization initiatives.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(l) Adverse publicity and news coverage about the clinical laboratory industry or us.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(m) Computer or other IT system failures that affect our ability to perform tests, report test results or properly bill customers, including potential failures resulting from the standardization of
  our IT systems and other system conversions, telecommunications failures, malicious human acts (such as electronic break-ins or computer viruses) or natural disasters.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(n) Development of technologies that substantially alter the practice of laboratory medicine, including technology changes that lead to the development of more cost-effective tests such as (1)
  point-of-care tests that can be performed by physicians in their offices, (2) esoteric tests that can be performed by hospitals in their own laboratories or (3) home testing that can be carried out
  without requiring the services of clinical laboratories.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(o) Issuance of patents or other property rights to our competitors or others that could prevent, limit or interfere with our ability to develop, perform or sell our tests or operate our
  business.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(p) Development of tests by our competitors or others which we may not be able to license, or usage of our technology or similar technologies or our trade secrets by competitors, any of
  which could negatively affect our competitive position.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(q) Regulatory delay or inability to commercialize newly licensed tests or technologies or to obtain appropriate reimbursements for such tests.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(r) Inability to obtain or maintain adequate patent and other proprietary rights protections of our products and services or to successfully enforce our proprietary rights.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(s) Impact of any national healthcare information network and the adoption of standards for health information technology interoperability that are incompatible with existing software and
  hardware infrastructure requiring widespread replacement of systems and/or software.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(t) The impact of the privacy regulations, security regulations and standards for electronic transactions regulations issued under the Health Insurance Portability and Accountability Act of
  1996 and any applicable state laws or regulations.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(u) Inability to promptly or properly bill for our services or to obtain appropriate payments for services that we do bill.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(v) Changes in interest rates and changes in our credit ratings from Standard &amp; Poor&#146;s Rating Services and Moody&#146;s Investor Services causing an unfavorable impact on our cost of and access
  to capital.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(w) Inability to hire and retain qualified personnel or the loss of the services of one or more of our key senior management personnel.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0 7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">(x) Terrorist and other criminal activities, hurricanes, earthquakes or other natural disasters, which could affect our customers, transportation or systems, or our facilities, and for which
  insurance may not adequately reimburse us.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">2</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=use2>USE OF PROCEEDS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Except as may be described otherwise in a prospectus supplement or pricing supplement, we will add the net proceeds from the sale of the securities under this prospectus to our general funds
  and will use them for general corporate purposes, which may include, among other things, funding acquisitions or reducing or refinancing indebtedness.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">3</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=ratio2>RATIO OF EARNINGS TO FIXED CHARGES</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Set forth below is information concerning the historical ratio of earnings to fixed charges for Quest Diagnostics. This ratio shows the extent to which our business generates enough earnings after
  the payment of all expenses other than interest to make required interest payments on our debt.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">For this purpose, earnings consist of pretax income from continuing operations plus fixed charges. Fixed charges consist of interest expense and one-third of rental expense, representing that
  portion of rental expense we deemed representative of an appropriate interest factor.</FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="bottom">
    <TD style="width:39.47%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:14.47%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:2.63%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:3.84%;" colspan="6"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>

  <TR valign="bottom">
    <TD rowspan="2" align="center">
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><font style="font-size:0.2mm">&nbsp;</font></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Three Months<br>Ended March 31,</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="34" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      Year Ended December 31,</B></FONT></P></TD>
  </TR>
  <TR valign="bottom">
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2007</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2006</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2005</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2004</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2003</B></FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <TD colspan="6" align="center" style="border-bottom:solid 0.2mm #000cb2; "><P><FONT style="font-family:serif; font-size:3.1mm; color:#000cb2; "><B>
      2002</B></FONT></P></TD>
  </TR>


  <TR valign="bottom" bgcolor="#e5ffff">
    <TD>
    <P style="text-indent:-3.5mm; margin:0 0 0 3.5mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Ratio of earnings to fixed charges</FONT></P></TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      5.4x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9.9x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      9.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      8.4x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
    <TD width="3">&nbsp;</TD>
    <td><P><font style="font-size:0.2mm">&nbsp;</font></P></td>
    <TD colspan="2">&nbsp;</TD>
    <TD align="right"><P><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
      7.2x</FONT></P></TD>
    <TD colspan="2">&nbsp;</TD>
  </TR>
</TABLE>


<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">4</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=securities1>SECURITIES WE MAY ISSUE</a></B></FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Overview</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">This prospectus is part of a registration statement that we filed with the SEC utilizing a &#147;shelf&#148; registration process. Under this shelf process, we may sell our senior debt securities, or guarantees
  of our debt securities, in one or more offerings.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The terms of the securities will be determined at the time of offering.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We will refer to the debt securities and the guarantees of the debt securities or any combination of those securities, proposed to be sold under this prospectus and the applicable prospectus
  supplement or pricing supplement as the &#147;securities.&#148;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Because we are a well-known seasoned issuer, as defined in Rule 405 of the Securities Act of 1933, as amended, we may add to and offer additional securities including secondary securities and
  guarantees of securities by filing a prospectus supplement or term sheet with the SEC at the time of the offer.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Prospectus Supplement or Pricing Supplement</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement or pricing supplement that will
  contain specific information about the terms of that offering. The prospectus supplement or pricing supplement may also add to or change information contained in this prospectus. If so, the
  prospectus supplement or pricing supplement should be read as superseding this prospectus. You should read both this prospectus and any prospectus supplement or pricing supplement together with
  additional information described under the heading &#147;Where You Can Find More Information.&#148;</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The prospectus supplement or pricing supplement to be provided with this prospectus will describe the terms of any securities that we offer and any initial offering price to the public in that
  offering, the purchase price and net proceeds that we will receive and the other specific terms related to our offering of the securities. For more details on the terms of the securities, you should read
  the exhibits filed with or incorporated by reference in our registration statement, of which this prospectus is a part.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">5</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=description3>DESCRIPTION OF SENIOR DEBT SECURITIES<br>AND GUARANTEES OF SENIOR DEBT SECURITIES</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We may issue senior debt securities from time to time in one or more distinct series. We may also issue guarantees of our senior debt securities from time to time.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">As required by U.S. federal law for all bonds and notes of companies that are publicly offered, the senior debt securities will be governed by a document called an &#147;indenture.&#148; An indenture is a
  contract between us and a financial institution, in this case, The Bank of New York, acting as trustee on your behalf, or other trustee we may select. The indenture will be subject to and governed by
  the Trust Indenture Act of 1939.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We have filed the indenture as an exhibit to our Securities Act filings and Exchange Act reports that we have filed with the SEC. See &#147;Where You Can Find More Information&#148; for information
  on how to obtain a copy of the indenture.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The senior debt securities will be issued under an indenture dated as of June 27, 2001 as supplemented by a first supplemental indenture, dated as of June 27, 2001, each among Quest
  Diagnostics, as issuer, the Initial Subsidiary Guarantors, as guarantors, and The Bank of New York, as trustee, as further supplemented by a second supplemental indenture, dated as of November 26,
  2001, among Quest Diagnostics, the Subsidiary Guarantors and The Bank of New York, as further supplemented by a third supplemental indenture, dated as of April 4, 2002, among Quest
  Diagnostics, the additional Subsidiary Guarantors and The Bank of New York, as further supplemented by a fourth supplemental indenture, dated as of March 19, 2003, among Quest Diagnostics, the
  additional Subsidiary Guarantors and The Bank of New York, as further supplemented by a fifth supplemental indenture, dated as of April 16, 2004, among Quest Diagnostics, the additional
  Subsidiary Guarantors and The Bank of New York, as further supplemented by a sixth supplemental indenture, dated as of October 31, 2005, among Quest Diagnostics, the additional Subsidiary
  Guarantors and The Bank of New York, as further supplemented by a seventh supplemental indenture, dated as of November 21, 2005, among Quest Diagnostics, the additional Subsidiary
  Guarantors and The Bank of New York and as further supplemented by an eighth supplemental indenture, dated as of July 31, 2006, among Quest Diagnostics, the additional Subsidiary Guarantors
  and The Bank of New York and as further supplemented by the ninth supplemental indenture dated September 30, 2006, among Quest Diagnostics, the additional Subsidiary Guarantors and The
  Bank of New York (collectively, the &#147;Indenture&#148;). The Indenture for the senior debt securities may also be modified by future supplemental indentures. The terms of the senior debt securities include
  those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939. A copy of the Indenture is available for inspection at the office of the trustee.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">6</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=plan1>PLAN OF DISTRIBUTION</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We may sell the securities to or through agents or underwriters or directly to one or more purchasers.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>By Agents</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We may use agents to sell the securities. The agents will agree to use their reasonable best efforts to solicit purchases of the period of their appointment.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>By Underwriters</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We may sell the securities to underwriters. The underwriters may resell the securities in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying
  prices determined at the time of sale. The obligations of the underwriters to purchase the securities will be subject to certain conditions. Each underwriter will be obligated to purchase all the
  securities allocated to it under the underwriting agreement. The underwriters may change any initial public offering price and any discounts or concessions they give to dealers.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>Direct Sales</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We may sell securities directly to investors. In this case, no underwriters or agents would be involved.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">As one of the means of direct issuance of securities, we may utilize the services of any available electronic auction system to conduct an electronic &#147;dutch auction&#148; of the offered securities among
  potential purchasers who are eligible to participate in the auction of those offered securities, if so described in the prospectus supplement or pricing supplement.</FONT></P>
<P style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>General Information</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Any underwriters or agents will be identified and their compensation described in a prospectus supplement or pricing supplement.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">We may have agreements with the underwriters, dealers and agents to indemnify them against certain civil liabilities, including liabilities under the Securities Act or to contribute to payments
  they may be required to make.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">Underwriters, dealers and agents may engage in transactions with, or perform services for, us or our subsidiaries in the ordinary course of their business.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">7</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P align="center" style="margin:4.2mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=validity1>VALIDITY OF THE SECURITIES</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The validity of any securities issued hereunder will be passed upon for our company by Shearman &amp; Sterling LLP, New York, New York.</FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B><a name=experts2>EXPERTS</a></B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The consolidated financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting of Quest Diagnostics (which is included in Management&#146;s
  Report on Internal Control over Financial Reporting) incorporated in this prospectus by reference to Quest Diagnostics&#146; Annual Report on Form 10-K for the year ended December 31, 2006, have
  been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and
  accounting.</FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">The consolidated financial statements of AmeriPath, Inc. incorporated by reference in this prospectus and registration statement for the year ended December 31, 2006 have been audited by
  Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon incorporated by reference herein. Such consolidated financial statements are incorporated herein by reference in reliance
  upon such report given on the authority of such firm as experts in accounting and auditing.</FONT></P>
<P align="center" style="margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">8</FONT></P>
<p><hr color=#000000 noshade></p>
<p style="page-break-before: always">
<PAGE>
<P style="text-indent:7mm; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:100%; height:3.00pt;;"><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:100%; height:1.00pt;margin-top:-8pt;"></FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:5.2mm; color:#000cb2; "><B>$800,000,000</B></FONT></P>
<P align="center" style="margin:6.3mm 0 0; "><FONT style="font-family:serif; font-size:5.2mm; color:#000cb2; "><B><p align="center"><img src="questcolorlogo.jpg" style="margin:16.8701mm 0 0 0; border:   ;"></p></B></FONT></P>
<P align="center" style="margin:14.8mm 0 0; "><FONT style="font-family:serif; font-size:5.2mm; color:#000cb2; "><B>$375,000,000 6.40% Senior Notes due 2017<br>$425,000,000 6.95% Senior Notes due 2037</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; "><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:12.00pc; height:0.50pt;;"></FONT></P>
<P align="center" style="margin:4.9mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; "><B>PROSPECTUS SUPPLEMENT<br>June 19, 2007</B></FONT></P>
<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; "><hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:12.00pc; height:0.50pt;;"></FONT></P>
<table cellspacing="0" style="margin-left:0.00%;margin-right:0.00%;width:100.00%;" >
<TR valign="top">
    <TD style="width:33.33%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:33.33%"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
    <TD style="width:33.33%;"><P><font style="font-size:0.6mm;">&nbsp;</font></P></TD>
  </TR>


  <TR valign="top">
    <TD><P><em><FONT style="font-size:4mm; color:#000cb2; "><B>
      MORGAN STANLEY&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></em></P></TD>
    <TD><div align="center"><em><FONT style="font-size:4mm; color:#000cb2; "><B>BANC OF AMERICA SECURITIES LLC</B></FONT></em></div></TD>
    <TD><div align="right"><em><FONT style="font-size:4mm; color:#000cb2; "><B>MERRILL LYNCH &amp; CO.</B></FONT></em></div></TD>
  </TR>
  <TR valign="top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  </TR>
  <TR valign="top">
    <TD><P><em><FONT style="font-size:4mm; color:#000cb2; "><B>
      Barclays Capital <font style="word-spacing: 11.50pc;">&nbsp;</font>&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></em></P></TD>
    <TD><div align="center"><em><FONT style="font-size:4mm; color:#000cb2; "><B>JPMorgan&nbsp;</B></FONT></em></div></TD>
    <TD><div align="right"><em><FONT style="font-size:4mm; color:#000cb2; "><B>Wachovia Securities</B></FONT></em></div></TD>
  </TR>
</TABLE>


<P style="text-indent:7mm; margin:2.1mm 0 0; "><FONT style="font-family:serif; font-size:3.8mm; color:#000cb2; ">
<hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:100%; height:1.00pt;;">
<hr noshade="noshade" color="PANTONE_288_CVC" align="center" style="width:100%; height:3.00pt;margin-top:-8pt;"></FONT></P>
<p><hr color=#000000 noshade></p>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>questcolorlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 questcolorlogo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`)D%D
M;V)E`&3``````0,`%00#!@H-```$90``!WL```L#```/A/_;`(0`!@0$!`4$
M!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,#`P,#`P0#`X/$`\.#!,3%!03$QP;
M&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?_\(`$0@`-0"1`P$1
M``(1`0,1`?_$`-D```("`P$````````````````%!`8!`@,'`0$``P$!````
M`````````````@,$`040``$$`@$#`P('``````````(``0,$$042$"$4(#`3
M,15`<$$R0B,&$0`"`0(#!@,#"P,%```````!`@,`$2$Q$D%1(C(3!&%QH1"1
M(R`P@;'!T>%"4F(4\/%RDC-#)!42```&`@$%```````````````0(`$1(3!A
M0'`Q<8$B$P$``@(!`P,#!0$!`0`````!`!$A,4%187$0@:$P\)$@L<'1X?%P
M0/_:``P#`0`"$0,1```!]4`7J43-+66%JB(0E:Y2]:82N0G@9K@```*TQUAB
M@*P;+_0'J5]ET<G+`YN24VJ\```4LZQ5#5R$L%58?5GN)V?FX^:@``#BCN[N
MZ%&>9EVU-L-6M55MC]0>U7F1,SM5_-R.AW2R[L<G-C=V*A3'GV5LA*F:]8H<
MM%R>A$0[I<W%*CLDQ6Y`T,BI1)3HKS%"BQM=48;&V>D/7W=``````#BCV2AJ
M_+'B1$+*V>B/5RZ````````'_]H`"`$!``$%`NEG85*Z+_1U5!OJ,CL[.UR?
MX*U.L$E:&_)63VF:<MM6%>:+S5;9S2^NW:L6:^EJO/=M4I([UZB51:/8%'-+
M$$L<=HJD?C0G5>"V5BK7M5@FHR26*T$T,_JV$<]B'5UI=>$F_K1R5=Y3DEVF
MKLW+-RGX,F7XPW9+$-?[='%ZBF!@`N0=*X;,]GNSDGN5:=>L&QUL5J+1699*
MDVNV#VUIB'QA$FUMXPR,O(YX)8=1>>2M8D_KH@1A<I@'VVJ3RSVXR!?>JB>S
M;9]:+6Z5)^3O6CLJ36W*=?0Q63=V9V:E39'#%(/BUN4^OB>:I1`8O&K\A@@$
MA@A$O%K)ZM9QM'"$GF0+<TB@M5[$M>6;9:VU&SNRH:VQ=(`$`]LX8C=6_&\>
MPU#D+19UWV3FV,>]_]H`"`$"``$%`OR%_]H`"`$#``$%`NA&S+YV33-T)\,(
M]F/"Y=_D9<T)9]@B=VB'+D'<PPH33LF+"X]L/D6=DX=Q;'K-LJ,>*>9D,S*2
M-R<AX]&+*;CZ\^AN7*7NXBS(X\J$NS@65%]/XFLIVP)]G?Z?J/[11+Y67)T'
M=@7'*>-V:%GZ<66%Q9."$%Q986%Q9<61+DI1P[/A.8OT`'+W<="QA\=`X?@/
M_]H`"`$"`@8_`N@O_]H`"`$#`@8_`L#ZR?)04'M\<,+%*EL<B%N'#>"I'I&Q
M;BG*4ZQWWX-\/__:``@!`0$&/P+V6ED`;](Q/NKAC<^X59KQG]V7I5QB#D:D
MES*##SI)9_BR2C46/CCAN^BNZCEU2KVQ%F_-I;?44)4_%!*MLPSICFB'2S7'
MH,R*,2*6TD*Q%L-6VVZIE*:1&^D'#9\Q)_Y[7T-ID(YC_C6J07$7$U]^RG[:
M-2QOP#P.51JYO(XNP&RAVSGX3\O@?QIHWY7%C70;C2/A6?B"^38&IHUF1^X[
MO'4#@2,;#P%=M*50"$$%;G\P\J:%=+IJ)C<G('>*$ME617!68&QT;B-M39&.
M5]>J^.(W?+:#MY%5_P#DO^D^6^ISW)58\"&O3&"#5JYGY;_75Y8^C(>'J9^M
M"2,J(PH`)/W>=(.J&EYK+LJZY[`:=QV^I%)5DU7)MGA:U?R^WAYL.$78?1L^
M6[CBT7N%Q.&R@V6H7L<_:_=1I:-FL=>`*?VJ'LD.&%_,_<*TQ+YMM-,0MIAR
MM]AJ2+-X>2^5CE]5#KH3U&QD&(Q]DV.4KWKNIKE5:;5%LPU`7KN@MVD2.[%C
M94PPT^)KM3,3)&T%R@QX\,3[Z>1RR]QACJ/Z\+[,C2?Q[ZFBDN,[Z1>_G7;S
MQ,3.Q3&]]9;,&@9!KBED;I3*=]^%AX5W&8-Y,B1E7;Q2GX8[975;\S;3XT.@
M>M'$AUQ%N*U^8'>+5RR^E6,KW'[C4Z9]XN*2GG\.+/94A[SNY(A'8:=1N3_0
MK_H=\Y?]#LWX&GG:;IY<*DW;'Z*/<2NQ3)`2<=YJQ%P<Q6$$?^D5ID177<PO
M0;I+J`L#894MX`_;A;*B66S7Q.RG22,=(OJCB;BTCUH-TDU+RFPP\JU+&H;?
M:M:QJ&W@4WPDX^;`8T%Z2Z5Y1884$Z*&PMB/3P&-?[9]U,X'PI3=3X[10EB-
MF%,9^WMW%L&&_9NJXSH23%N@/S',^5!$%E7`#YR[+<^QOY-NCMO1Z#26W,H^
MN]<3,!X"_P!HKXA8OL,H`7TOZUAEL^?_`/_:``@!`0,!/R'T^S`G"Z]X9PO5
M_L8'9VD_N3\P$ID!D24>6*'7`OW@.4N?2M#MC%`\M0\*REUB<3%%IL.;YF:\
M*+;NEMH7E_%R]E>G`Y+I>6,M6N+0N\W:]#Z#%F6@*&W[^>D0ZB>;P&^^?::8
M`V5S?#<I;1U&5!?,MU+5^?5=H)ZV'V96G:P.FAJ!-662X$[\`(%M`RYHSIP"
MCX8*@:W2`IM",UV<]I<BE:ELQ2XCRC$V4-&'7O\`K8-JRHY,8*81Z1K;&+'O
MTEHHLB6FF@3[S"P2RC5X&HA;TJ)YBEG*XHPR&#1.NE7JQ2I:+17Y::@0*%'1
M""_,!%-AWH6DRTY_780>M#8'6"6(`!0LNDX?54C"80T'70I"4YE;HOH7MDAL
MHUGW=5AT#*92OR##958=\%JI;0KVEOB9S%NS0'7T`B`<ET8W"R#L+F9A6$:C
M^IMB3U>;^8I2&U5S#.I073+GD:G0P.5DJB%F!%LH(;L1X:!N5#O+SXE5C*`B
M!<XHA72&4<-5-TT\1>UBD"`)V''O*K0%VB7NP=O1R@-*3_681(Z8HH:,TWS#
M>'V279RXVQ`,*V=9U,?!#E(H6PTXX#<!?[?A=!Z:C\V$F1)H!X_KA0`T0?AG
MD*)`X,3D16U62V]E:?:+F*H<0*S2[O4Z*';4U:L5-HBH`2]UYYFVAM0;=OOS
M,Z6>7F7G&<D0^VPUMT5B"<9&KE]G5?$_Y*9$@X@L_DGQ^0G(G2(6NFOADHK?
M6X@)0TDZWL*]F_[PM!J6@/J"A55GDZ/4[/IVV?UUS?2LRR#XL_`M>T3Y`%?B
M0!.MB/A#\I@8X::KM]?_V@`(`0(#`3\A_P#!?__:``@!`P,!/R'TVC'I,?V]
M+QA-G*Q*G,:#K'VIM4L/9^AVD^\3<\1"J8-[E+;3+"I1K@YE%%D+@XQ,+&;<
MWN*GHOZV$&+P@G")<E,L!J7MY]%&I44?K</$&_4JC4:)@N(1[Q&G)-ISZ++R
MP,G>(\J_$+99/W1[7?\`LMXC,"F\>\%,\B[_`(AR]XK0=0:UD#4\T[C#?'*X
MJ4WI9KJ,RUZ=LB'<[$.]7!!28O4[$#`SL$[$0-42LSG#'5D%P]&4=0*^HA]/
M$3IW"IFS\_\`P?_:``P#`0`"$0,1```0D-%@I,$DDDE$@E-`DDD,!!!$DD@D
MAE(L)D%AE(D,I(`D!L!!M,DDDDDD$%DLDDDDDDG_V@`(`0$#`3\0]%WN39M7
M:MUH2CE'LW4)H%RA[-XQ)YH0[I"(@6(F$8HK8.LL-.+%RSDO6C:.A`PEQ`V?
M!#9/-O/:!0MOO#(PH#B5!@<3J3EG`/`3)PNE0C<D:3?;,J]V4725S!3!7-_K
M4!5H,JZJ%`K8:&8J3(O:O<Y0Z`JIZBRRBXB5/8*^SRXIFY5BCP7)AMUTZJZ<
M_KX3N,5U;ZR@E(8::L>$V,#6^^?I3A*=G$OG:<;!8(A?_)90!<`^UP^`REX8
MA+E8`MFJ1,Z`*PB"T1-KCG%):?P0@XZA/#\?K&8+(W`Y$,ID$YE5-`1<K86;
MIC,86,TZ:7!&L&#:[B4:1LL/R,TM=@3T1AF5!0$+(R&"M9Z2G6]052P#X3+O
M$.@2A=;TFY6V1%C6ED=>.N/UXGV#L.P-\:C*89$*RT7D]7(Q"G%=%Y"&2.0>
M?-E4._D&"XX`"(SM^VCB%"N\&6*=AG6R+U8!%@&4$QT$VI_O`BK^(`4'H*>A
M`9EIT5G,`EA><[`5,L8C6E,--2#,K##BQJ)$V"Z*G;U`%XW,&^,6J#,%C]HG
MAJT^*-IF]NH_4^(4NM<E/#%2RY>]S>M'$*R.2!5*DRZ"C:KZ\Q9NN(.BEKJ5
MU`51I6SGK;YMM:K,_P")_:/]`JX1I(25$JD6&,5[J@0E+@!=J%].#<\1S4:L
M`;L!7F=R-*RC5:K1D\WL0=LK#<6"4<.Z](:I$$0V(X2)J^U=/634LE$2>A0@
MH15E:X<`F@<2RM13(W#&)ISRN5:<O6(G,!4FKVS@]#'^O(Z%:AL!4O&]!CL;
MYB5!>Y:P;Y.8I?!NK,+/8"WR7%CU:,RM%2W-;E5VEN`HM%#99=F6_M/^8_.L
MIR9Z)9#IX9K`='+_`"R^\QT4S&RQ'PI@4.L0@RU(B<B0NY<G@WGXQ3H=V#!2
M'0%`?4*O+7J;K,7/(>GSB57V>7R-15R#5&\5[D7@PY1^3'[DO<@N'X?_`!3M
MY:=&,,57U__:``@!`@,!/Q#_`,%__]H`"`$#`P$_$/3J9TYG!^")TWY01+)V
M)("PB[\].GM,X0O>F)*/*GQ!6\&N/@VDHL%T@^_/CO'"E%'T%%MJ>OV_Y,II
MD^8P"\X\1*ED7$/L'9_V$RTQ;N<!D'AQ^TI1N7Y_!&D]O/4\0Y-)>'SU)@0`
M*&ZZ)S-%Y'ZTZ`\^/]B30PS%&6^=7+'98O?S#"&$JC+?'$MJR.W,%$O/[5\P
M\J=#/^?K$29[)4'KZO2R><8GWH+_`%*P/?F-*.UC/P;[ZCC5;;X]"(2&B-SC
MD):!D96XPQ7=^V6D[-/9EB&PQY?#X8@<GXOYBO\`G\FQA!R"@^<CM#[O=TC<
M?4[O\Q:;Q=L[V/4JNT[,HM?(PB\<CSVSOB*V@<+;^_:/(W17_L1/V'>98*\#
M,02F!:_$0^@)WF:Z7XB#=0P%%-^W[Q!D+"S4R#2S6"#;`N!;`N;N3>(L!2CM
M#GV.G8^ZG;?Q%<=3_(?3,<.EL^R#4=%?/GQ#`&`^HY:>F1$WS]P?W_$'-?Q_
..L/(O\/B_F%5CZ_\`_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
